<LCTL_TEXT lang="spa">
<DOC grammar="none" id="L0C04ATFS" lang="spa" raw_text_char_length="9577" raw_text_md5="6359662eb0526ab052c0ec2bafbcecbc" tokenization="tokenization_parameters.v5.0">
<TEXT>
<SEG end_char="88" id="segment-0" start_char="1">
<ORIGINAL_TEXT>A discussion of natural immunity and vaccines in light of recent COVID-19 mutant strains</ORIGINAL_TEXT>
<TOKEN end_char="1" id="token-0-0" morph="none" pos="word" start_char="1">A</TOKEN>
<TOKEN end_char="12" id="token-0-1" morph="none" pos="word" start_char="3">discussion</TOKEN>
<TOKEN end_char="15" id="token-0-2" morph="none" pos="word" start_char="14">of</TOKEN>
<TOKEN end_char="23" id="token-0-3" morph="none" pos="word" start_char="17">natural</TOKEN>
<TOKEN end_char="32" id="token-0-4" morph="none" pos="word" start_char="25">immunity</TOKEN>
<TOKEN end_char="36" id="token-0-5" morph="none" pos="word" start_char="34">and</TOKEN>
<TOKEN end_char="45" id="token-0-6" morph="none" pos="word" start_char="38">vaccines</TOKEN>
<TOKEN end_char="48" id="token-0-7" morph="none" pos="word" start_char="47">in</TOKEN>
<TOKEN end_char="54" id="token-0-8" morph="none" pos="word" start_char="50">light</TOKEN>
<TOKEN end_char="57" id="token-0-9" morph="none" pos="word" start_char="56">of</TOKEN>
<TOKEN end_char="64" id="token-0-10" morph="none" pos="word" start_char="59">recent</TOKEN>
<TOKEN end_char="73" id="token-0-11" morph="none" pos="unknown" start_char="66">COVID-19</TOKEN>
<TOKEN end_char="80" id="token-0-12" morph="none" pos="word" start_char="75">mutant</TOKEN>
<TOKEN end_char="88" id="token-0-13" morph="none" pos="word" start_char="82">strains</TOKEN>
</SEG>
<SEG end_char="187" id="segment-1" start_char="92">
<ORIGINAL_TEXT>We are now in a race between COVID-19 vaccine distribution and a virus that is rapidly mutating.</ORIGINAL_TEXT>
<TOKEN end_char="93" id="token-1-0" morph="none" pos="word" start_char="92">We</TOKEN>
<TOKEN end_char="97" id="token-1-1" morph="none" pos="word" start_char="95">are</TOKEN>
<TOKEN end_char="101" id="token-1-2" morph="none" pos="word" start_char="99">now</TOKEN>
<TOKEN end_char="104" id="token-1-3" morph="none" pos="word" start_char="103">in</TOKEN>
<TOKEN end_char="106" id="token-1-4" morph="none" pos="word" start_char="106">a</TOKEN>
<TOKEN end_char="111" id="token-1-5" morph="none" pos="word" start_char="108">race</TOKEN>
<TOKEN end_char="119" id="token-1-6" morph="none" pos="word" start_char="113">between</TOKEN>
<TOKEN end_char="128" id="token-1-7" morph="none" pos="unknown" start_char="121">COVID-19</TOKEN>
<TOKEN end_char="136" id="token-1-8" morph="none" pos="word" start_char="130">vaccine</TOKEN>
<TOKEN end_char="149" id="token-1-9" morph="none" pos="word" start_char="138">distribution</TOKEN>
<TOKEN end_char="153" id="token-1-10" morph="none" pos="word" start_char="151">and</TOKEN>
<TOKEN end_char="155" id="token-1-11" morph="none" pos="word" start_char="155">a</TOKEN>
<TOKEN end_char="161" id="token-1-12" morph="none" pos="word" start_char="157">virus</TOKEN>
<TOKEN end_char="166" id="token-1-13" morph="none" pos="word" start_char="163">that</TOKEN>
<TOKEN end_char="169" id="token-1-14" morph="none" pos="word" start_char="168">is</TOKEN>
<TOKEN end_char="177" id="token-1-15" morph="none" pos="word" start_char="171">rapidly</TOKEN>
<TOKEN end_char="186" id="token-1-16" morph="none" pos="word" start_char="179">mutating</TOKEN>
<TOKEN end_char="187" id="token-1-17" morph="none" pos="punct" start_char="187">.</TOKEN>
</SEG>
<SEG end_char="283" id="segment-2" start_char="189">
<ORIGINAL_TEXT>Health-care workers have been prioritized to be among some of the first to receive the vaccine.</ORIGINAL_TEXT>
<TOKEN end_char="199" id="token-2-0" morph="none" pos="unknown" start_char="189">Health-care</TOKEN>
<TOKEN end_char="207" id="token-2-1" morph="none" pos="word" start_char="201">workers</TOKEN>
<TOKEN end_char="212" id="token-2-2" morph="none" pos="word" start_char="209">have</TOKEN>
<TOKEN end_char="217" id="token-2-3" morph="none" pos="word" start_char="214">been</TOKEN>
<TOKEN end_char="229" id="token-2-4" morph="none" pos="word" start_char="219">prioritized</TOKEN>
<TOKEN end_char="232" id="token-2-5" morph="none" pos="word" start_char="231">to</TOKEN>
<TOKEN end_char="235" id="token-2-6" morph="none" pos="word" start_char="234">be</TOKEN>
<TOKEN end_char="241" id="token-2-7" morph="none" pos="word" start_char="237">among</TOKEN>
<TOKEN end_char="246" id="token-2-8" morph="none" pos="word" start_char="243">some</TOKEN>
<TOKEN end_char="249" id="token-2-9" morph="none" pos="word" start_char="248">of</TOKEN>
<TOKEN end_char="253" id="token-2-10" morph="none" pos="word" start_char="251">the</TOKEN>
<TOKEN end_char="259" id="token-2-11" morph="none" pos="word" start_char="255">first</TOKEN>
<TOKEN end_char="262" id="token-2-12" morph="none" pos="word" start_char="261">to</TOKEN>
<TOKEN end_char="270" id="token-2-13" morph="none" pos="word" start_char="264">receive</TOKEN>
<TOKEN end_char="274" id="token-2-14" morph="none" pos="word" start_char="272">the</TOKEN>
<TOKEN end_char="282" id="token-2-15" morph="none" pos="word" start_char="276">vaccine</TOKEN>
<TOKEN end_char="283" id="token-2-16" morph="none" pos="punct" start_char="283">.</TOKEN>
</SEG>
<SEG end_char="374" id="segment-3" start_char="285">
<ORIGINAL_TEXT>New information is constantly coming to light, and the messages can often be inconsistent.</ORIGINAL_TEXT>
<TOKEN end_char="287" id="token-3-0" morph="none" pos="word" start_char="285">New</TOKEN>
<TOKEN end_char="299" id="token-3-1" morph="none" pos="word" start_char="289">information</TOKEN>
<TOKEN end_char="302" id="token-3-2" morph="none" pos="word" start_char="301">is</TOKEN>
<TOKEN end_char="313" id="token-3-3" morph="none" pos="word" start_char="304">constantly</TOKEN>
<TOKEN end_char="320" id="token-3-4" morph="none" pos="word" start_char="315">coming</TOKEN>
<TOKEN end_char="323" id="token-3-5" morph="none" pos="word" start_char="322">to</TOKEN>
<TOKEN end_char="329" id="token-3-6" morph="none" pos="word" start_char="325">light</TOKEN>
<TOKEN end_char="330" id="token-3-7" morph="none" pos="punct" start_char="330">,</TOKEN>
<TOKEN end_char="334" id="token-3-8" morph="none" pos="word" start_char="332">and</TOKEN>
<TOKEN end_char="338" id="token-3-9" morph="none" pos="word" start_char="336">the</TOKEN>
<TOKEN end_char="347" id="token-3-10" morph="none" pos="word" start_char="340">messages</TOKEN>
<TOKEN end_char="351" id="token-3-11" morph="none" pos="word" start_char="349">can</TOKEN>
<TOKEN end_char="357" id="token-3-12" morph="none" pos="word" start_char="353">often</TOKEN>
<TOKEN end_char="360" id="token-3-13" morph="none" pos="word" start_char="359">be</TOKEN>
<TOKEN end_char="373" id="token-3-14" morph="none" pos="word" start_char="362">inconsistent</TOKEN>
<TOKEN end_char="374" id="token-3-15" morph="none" pos="punct" start_char="374">.</TOKEN>
</SEG>
<SEG end_char="440" id="segment-4" start_char="376">
<ORIGINAL_TEXT>Here, we will attempt to address a few of these pertinent issues.</ORIGINAL_TEXT>
<TOKEN end_char="379" id="token-4-0" morph="none" pos="word" start_char="376">Here</TOKEN>
<TOKEN end_char="380" id="token-4-1" morph="none" pos="punct" start_char="380">,</TOKEN>
<TOKEN end_char="383" id="token-4-2" morph="none" pos="word" start_char="382">we</TOKEN>
<TOKEN end_char="388" id="token-4-3" morph="none" pos="word" start_char="385">will</TOKEN>
<TOKEN end_char="396" id="token-4-4" morph="none" pos="word" start_char="390">attempt</TOKEN>
<TOKEN end_char="399" id="token-4-5" morph="none" pos="word" start_char="398">to</TOKEN>
<TOKEN end_char="407" id="token-4-6" morph="none" pos="word" start_char="401">address</TOKEN>
<TOKEN end_char="409" id="token-4-7" morph="none" pos="word" start_char="409">a</TOKEN>
<TOKEN end_char="413" id="token-4-8" morph="none" pos="word" start_char="411">few</TOKEN>
<TOKEN end_char="416" id="token-4-9" morph="none" pos="word" start_char="415">of</TOKEN>
<TOKEN end_char="422" id="token-4-10" morph="none" pos="word" start_char="418">these</TOKEN>
<TOKEN end_char="432" id="token-4-11" morph="none" pos="word" start_char="424">pertinent</TOKEN>
<TOKEN end_char="439" id="token-4-12" morph="none" pos="word" start_char="434">issues</TOKEN>
<TOKEN end_char="440" id="token-4-13" morph="none" pos="punct" start_char="440">.</TOKEN>
</SEG>
<SEG end_char="588" id="segment-5" start_char="442">
<ORIGINAL_TEXT>The contents in this article are in no way definitive, and further peer-reviewed studies are needed to validate many of these preliminary findings.</ORIGINAL_TEXT>
<TOKEN end_char="444" id="token-5-0" morph="none" pos="word" start_char="442">The</TOKEN>
<TOKEN end_char="453" id="token-5-1" morph="none" pos="word" start_char="446">contents</TOKEN>
<TOKEN end_char="456" id="token-5-2" morph="none" pos="word" start_char="455">in</TOKEN>
<TOKEN end_char="461" id="token-5-3" morph="none" pos="word" start_char="458">this</TOKEN>
<TOKEN end_char="469" id="token-5-4" morph="none" pos="word" start_char="463">article</TOKEN>
<TOKEN end_char="473" id="token-5-5" morph="none" pos="word" start_char="471">are</TOKEN>
<TOKEN end_char="476" id="token-5-6" morph="none" pos="word" start_char="475">in</TOKEN>
<TOKEN end_char="479" id="token-5-7" morph="none" pos="word" start_char="478">no</TOKEN>
<TOKEN end_char="483" id="token-5-8" morph="none" pos="word" start_char="481">way</TOKEN>
<TOKEN end_char="494" id="token-5-9" morph="none" pos="word" start_char="485">definitive</TOKEN>
<TOKEN end_char="495" id="token-5-10" morph="none" pos="punct" start_char="495">,</TOKEN>
<TOKEN end_char="499" id="token-5-11" morph="none" pos="word" start_char="497">and</TOKEN>
<TOKEN end_char="507" id="token-5-12" morph="none" pos="word" start_char="501">further</TOKEN>
<TOKEN end_char="521" id="token-5-13" morph="none" pos="unknown" start_char="509">peer-reviewed</TOKEN>
<TOKEN end_char="529" id="token-5-14" morph="none" pos="word" start_char="523">studies</TOKEN>
<TOKEN end_char="533" id="token-5-15" morph="none" pos="word" start_char="531">are</TOKEN>
<TOKEN end_char="540" id="token-5-16" morph="none" pos="word" start_char="535">needed</TOKEN>
<TOKEN end_char="543" id="token-5-17" morph="none" pos="word" start_char="542">to</TOKEN>
<TOKEN end_char="552" id="token-5-18" morph="none" pos="word" start_char="545">validate</TOKEN>
<TOKEN end_char="557" id="token-5-19" morph="none" pos="word" start_char="554">many</TOKEN>
<TOKEN end_char="560" id="token-5-20" morph="none" pos="word" start_char="559">of</TOKEN>
<TOKEN end_char="566" id="token-5-21" morph="none" pos="word" start_char="562">these</TOKEN>
<TOKEN end_char="578" id="token-5-22" morph="none" pos="word" start_char="568">preliminary</TOKEN>
<TOKEN end_char="587" id="token-5-23" morph="none" pos="word" start_char="580">findings</TOKEN>
<TOKEN end_char="588" id="token-5-24" morph="none" pos="punct" start_char="588">.</TOKEN>
</SEG>
<SEG end_char="640" id="segment-6" start_char="591">
<ORIGINAL_TEXT>Antibody response to vaccines and natural immunity</ORIGINAL_TEXT>
<TOKEN end_char="598" id="token-6-0" morph="none" pos="word" start_char="591">Antibody</TOKEN>
<TOKEN end_char="607" id="token-6-1" morph="none" pos="word" start_char="600">response</TOKEN>
<TOKEN end_char="610" id="token-6-2" morph="none" pos="word" start_char="609">to</TOKEN>
<TOKEN end_char="619" id="token-6-3" morph="none" pos="word" start_char="612">vaccines</TOKEN>
<TOKEN end_char="623" id="token-6-4" morph="none" pos="word" start_char="621">and</TOKEN>
<TOKEN end_char="631" id="token-6-5" morph="none" pos="word" start_char="625">natural</TOKEN>
<TOKEN end_char="640" id="token-6-6" morph="none" pos="word" start_char="633">immunity</TOKEN>
</SEG>
<SEG end_char="819" id="segment-7" start_char="644">
<ORIGINAL_TEXT>Although there is conflicting data, studies have shown waning immunity in patients who have previously had COVID-19, especially those who have had asymptomatic or mild disease.</ORIGINAL_TEXT>
<TOKEN end_char="651" id="token-7-0" morph="none" pos="word" start_char="644">Although</TOKEN>
<TOKEN end_char="657" id="token-7-1" morph="none" pos="word" start_char="653">there</TOKEN>
<TOKEN end_char="660" id="token-7-2" morph="none" pos="word" start_char="659">is</TOKEN>
<TOKEN end_char="672" id="token-7-3" morph="none" pos="word" start_char="662">conflicting</TOKEN>
<TOKEN end_char="677" id="token-7-4" morph="none" pos="word" start_char="674">data</TOKEN>
<TOKEN end_char="678" id="token-7-5" morph="none" pos="punct" start_char="678">,</TOKEN>
<TOKEN end_char="686" id="token-7-6" morph="none" pos="word" start_char="680">studies</TOKEN>
<TOKEN end_char="691" id="token-7-7" morph="none" pos="word" start_char="688">have</TOKEN>
<TOKEN end_char="697" id="token-7-8" morph="none" pos="word" start_char="693">shown</TOKEN>
<TOKEN end_char="704" id="token-7-9" morph="none" pos="word" start_char="699">waning</TOKEN>
<TOKEN end_char="713" id="token-7-10" morph="none" pos="word" start_char="706">immunity</TOKEN>
<TOKEN end_char="716" id="token-7-11" morph="none" pos="word" start_char="715">in</TOKEN>
<TOKEN end_char="725" id="token-7-12" morph="none" pos="word" start_char="718">patients</TOKEN>
<TOKEN end_char="729" id="token-7-13" morph="none" pos="word" start_char="727">who</TOKEN>
<TOKEN end_char="734" id="token-7-14" morph="none" pos="word" start_char="731">have</TOKEN>
<TOKEN end_char="745" id="token-7-15" morph="none" pos="word" start_char="736">previously</TOKEN>
<TOKEN end_char="749" id="token-7-16" morph="none" pos="word" start_char="747">had</TOKEN>
<TOKEN end_char="758" id="token-7-17" morph="none" pos="unknown" start_char="751">COVID-19</TOKEN>
<TOKEN end_char="759" id="token-7-18" morph="none" pos="punct" start_char="759">,</TOKEN>
<TOKEN end_char="770" id="token-7-19" morph="none" pos="word" start_char="761">especially</TOKEN>
<TOKEN end_char="776" id="token-7-20" morph="none" pos="word" start_char="772">those</TOKEN>
<TOKEN end_char="780" id="token-7-21" morph="none" pos="word" start_char="778">who</TOKEN>
<TOKEN end_char="785" id="token-7-22" morph="none" pos="word" start_char="782">have</TOKEN>
<TOKEN end_char="789" id="token-7-23" morph="none" pos="word" start_char="787">had</TOKEN>
<TOKEN end_char="802" id="token-7-24" morph="none" pos="word" start_char="791">asymptomatic</TOKEN>
<TOKEN end_char="805" id="token-7-25" morph="none" pos="word" start_char="804">or</TOKEN>
<TOKEN end_char="810" id="token-7-26" morph="none" pos="word" start_char="807">mild</TOKEN>
<TOKEN end_char="818" id="token-7-27" morph="none" pos="word" start_char="812">disease</TOKEN>
<TOKEN end_char="819" id="token-7-28" morph="none" pos="punct" start_char="819">.</TOKEN>
</SEG>
<SEG end_char="1088" id="segment-8" start_char="821">
<ORIGINAL_TEXT>In a study from of the University of California, Los Angeles (UCLA), patients with mild to moderate disease had IgG titers (long-term antibodies) measured one month out from infection and witnessed mean levels quickly begin to fade over the course of the next 90 days.</ORIGINAL_TEXT>
<TOKEN end_char="822" id="token-8-0" morph="none" pos="word" start_char="821">In</TOKEN>
<TOKEN end_char="824" id="token-8-1" morph="none" pos="word" start_char="824">a</TOKEN>
<TOKEN end_char="830" id="token-8-2" morph="none" pos="word" start_char="826">study</TOKEN>
<TOKEN end_char="835" id="token-8-3" morph="none" pos="word" start_char="832">from</TOKEN>
<TOKEN end_char="838" id="token-8-4" morph="none" pos="word" start_char="837">of</TOKEN>
<TOKEN end_char="842" id="token-8-5" morph="none" pos="word" start_char="840">the</TOKEN>
<TOKEN end_char="853" id="token-8-6" morph="none" pos="word" start_char="844">University</TOKEN>
<TOKEN end_char="856" id="token-8-7" morph="none" pos="word" start_char="855">of</TOKEN>
<TOKEN end_char="867" id="token-8-8" morph="none" pos="word" start_char="858">California</TOKEN>
<TOKEN end_char="868" id="token-8-9" morph="none" pos="punct" start_char="868">,</TOKEN>
<TOKEN end_char="872" id="token-8-10" morph="none" pos="word" start_char="870">Los</TOKEN>
<TOKEN end_char="880" id="token-8-11" morph="none" pos="word" start_char="874">Angeles</TOKEN>
<TOKEN end_char="882" id="token-8-12" morph="none" pos="punct" start_char="882">(</TOKEN>
<TOKEN end_char="886" id="token-8-13" morph="none" pos="word" start_char="883">UCLA</TOKEN>
<TOKEN end_char="888" id="token-8-14" morph="none" pos="punct" start_char="887">),</TOKEN>
<TOKEN end_char="897" id="token-8-15" morph="none" pos="word" start_char="890">patients</TOKEN>
<TOKEN end_char="902" id="token-8-16" morph="none" pos="word" start_char="899">with</TOKEN>
<TOKEN end_char="907" id="token-8-17" morph="none" pos="word" start_char="904">mild</TOKEN>
<TOKEN end_char="910" id="token-8-18" morph="none" pos="word" start_char="909">to</TOKEN>
<TOKEN end_char="919" id="token-8-19" morph="none" pos="word" start_char="912">moderate</TOKEN>
<TOKEN end_char="927" id="token-8-20" morph="none" pos="word" start_char="921">disease</TOKEN>
<TOKEN end_char="931" id="token-8-21" morph="none" pos="word" start_char="929">had</TOKEN>
<TOKEN end_char="935" id="token-8-22" morph="none" pos="word" start_char="933">IgG</TOKEN>
<TOKEN end_char="942" id="token-8-23" morph="none" pos="word" start_char="937">titers</TOKEN>
<TOKEN end_char="944" id="token-8-24" morph="none" pos="punct" start_char="944">(</TOKEN>
<TOKEN end_char="953" id="token-8-25" morph="none" pos="unknown" start_char="945">long-term</TOKEN>
<TOKEN end_char="964" id="token-8-26" morph="none" pos="word" start_char="955">antibodies</TOKEN>
<TOKEN end_char="965" id="token-8-27" morph="none" pos="punct" start_char="965">)</TOKEN>
<TOKEN end_char="974" id="token-8-28" morph="none" pos="word" start_char="967">measured</TOKEN>
<TOKEN end_char="978" id="token-8-29" morph="none" pos="word" start_char="976">one</TOKEN>
<TOKEN end_char="984" id="token-8-30" morph="none" pos="word" start_char="980">month</TOKEN>
<TOKEN end_char="988" id="token-8-31" morph="none" pos="word" start_char="986">out</TOKEN>
<TOKEN end_char="993" id="token-8-32" morph="none" pos="word" start_char="990">from</TOKEN>
<TOKEN end_char="1003" id="token-8-33" morph="none" pos="word" start_char="995">infection</TOKEN>
<TOKEN end_char="1007" id="token-8-34" morph="none" pos="word" start_char="1005">and</TOKEN>
<TOKEN end_char="1017" id="token-8-35" morph="none" pos="word" start_char="1009">witnessed</TOKEN>
<TOKEN end_char="1022" id="token-8-36" morph="none" pos="word" start_char="1019">mean</TOKEN>
<TOKEN end_char="1029" id="token-8-37" morph="none" pos="word" start_char="1024">levels</TOKEN>
<TOKEN end_char="1037" id="token-8-38" morph="none" pos="word" start_char="1031">quickly</TOKEN>
<TOKEN end_char="1043" id="token-8-39" morph="none" pos="word" start_char="1039">begin</TOKEN>
<TOKEN end_char="1046" id="token-8-40" morph="none" pos="word" start_char="1045">to</TOKEN>
<TOKEN end_char="1051" id="token-8-41" morph="none" pos="word" start_char="1048">fade</TOKEN>
<TOKEN end_char="1056" id="token-8-42" morph="none" pos="word" start_char="1053">over</TOKEN>
<TOKEN end_char="1060" id="token-8-43" morph="none" pos="word" start_char="1058">the</TOKEN>
<TOKEN end_char="1067" id="token-8-44" morph="none" pos="word" start_char="1062">course</TOKEN>
<TOKEN end_char="1070" id="token-8-45" morph="none" pos="word" start_char="1069">of</TOKEN>
<TOKEN end_char="1074" id="token-8-46" morph="none" pos="word" start_char="1072">the</TOKEN>
<TOKEN end_char="1079" id="token-8-47" morph="none" pos="word" start_char="1076">next</TOKEN>
<TOKEN end_char="1082" id="token-8-48" morph="none" pos="word" start_char="1081">90</TOKEN>
<TOKEN end_char="1087" id="token-8-49" morph="none" pos="word" start_char="1084">days</TOKEN>
<TOKEN end_char="1088" id="token-8-50" morph="none" pos="punct" start_char="1088">.</TOKEN>
</SEG>
<SEG end_char="1091" id="segment-9" start_char="1091">
<ORIGINAL_TEXT>1</ORIGINAL_TEXT>
<TOKEN end_char="1091" id="token-9-0" morph="none" pos="word" start_char="1091">1</TOKEN>
</SEG>
<SEG end_char="1227" id="segment-10" start_char="1094">
<ORIGINAL_TEXT>Data from multiple other studies also show a wide spectrum in antibody levels that often exhibit high correlation to disease severity.</ORIGINAL_TEXT>
<TOKEN end_char="1097" id="token-10-0" morph="none" pos="word" start_char="1094">Data</TOKEN>
<TOKEN end_char="1102" id="token-10-1" morph="none" pos="word" start_char="1099">from</TOKEN>
<TOKEN end_char="1111" id="token-10-2" morph="none" pos="word" start_char="1104">multiple</TOKEN>
<TOKEN end_char="1117" id="token-10-3" morph="none" pos="word" start_char="1113">other</TOKEN>
<TOKEN end_char="1125" id="token-10-4" morph="none" pos="word" start_char="1119">studies</TOKEN>
<TOKEN end_char="1130" id="token-10-5" morph="none" pos="word" start_char="1127">also</TOKEN>
<TOKEN end_char="1135" id="token-10-6" morph="none" pos="word" start_char="1132">show</TOKEN>
<TOKEN end_char="1137" id="token-10-7" morph="none" pos="word" start_char="1137">a</TOKEN>
<TOKEN end_char="1142" id="token-10-8" morph="none" pos="word" start_char="1139">wide</TOKEN>
<TOKEN end_char="1151" id="token-10-9" morph="none" pos="word" start_char="1144">spectrum</TOKEN>
<TOKEN end_char="1154" id="token-10-10" morph="none" pos="word" start_char="1153">in</TOKEN>
<TOKEN end_char="1163" id="token-10-11" morph="none" pos="word" start_char="1156">antibody</TOKEN>
<TOKEN end_char="1170" id="token-10-12" morph="none" pos="word" start_char="1165">levels</TOKEN>
<TOKEN end_char="1175" id="token-10-13" morph="none" pos="word" start_char="1172">that</TOKEN>
<TOKEN end_char="1181" id="token-10-14" morph="none" pos="word" start_char="1177">often</TOKEN>
<TOKEN end_char="1189" id="token-10-15" morph="none" pos="word" start_char="1183">exhibit</TOKEN>
<TOKEN end_char="1194" id="token-10-16" morph="none" pos="word" start_char="1191">high</TOKEN>
<TOKEN end_char="1206" id="token-10-17" morph="none" pos="word" start_char="1196">correlation</TOKEN>
<TOKEN end_char="1209" id="token-10-18" morph="none" pos="word" start_char="1208">to</TOKEN>
<TOKEN end_char="1217" id="token-10-19" morph="none" pos="word" start_char="1211">disease</TOKEN>
<TOKEN end_char="1226" id="token-10-20" morph="none" pos="word" start_char="1219">severity</TOKEN>
<TOKEN end_char="1227" id="token-10-21" morph="none" pos="punct" start_char="1227">.</TOKEN>
</SEG>
<SEG end_char="1230" id="segment-11" start_char="1230">
<ORIGINAL_TEXT>2</ORIGINAL_TEXT>
<TOKEN end_char="1230" id="token-11-0" morph="none" pos="word" start_char="1230">2</TOKEN>
</SEG>
<SEG end_char="1323" id="segment-12" start_char="1234">
<ORIGINAL_TEXT>The data in regard to vaccine antibody production, however, has been much more consistent.</ORIGINAL_TEXT>
<TOKEN end_char="1236" id="token-12-0" morph="none" pos="word" start_char="1234">The</TOKEN>
<TOKEN end_char="1241" id="token-12-1" morph="none" pos="word" start_char="1238">data</TOKEN>
<TOKEN end_char="1244" id="token-12-2" morph="none" pos="word" start_char="1243">in</TOKEN>
<TOKEN end_char="1251" id="token-12-3" morph="none" pos="word" start_char="1246">regard</TOKEN>
<TOKEN end_char="1254" id="token-12-4" morph="none" pos="word" start_char="1253">to</TOKEN>
<TOKEN end_char="1262" id="token-12-5" morph="none" pos="word" start_char="1256">vaccine</TOKEN>
<TOKEN end_char="1271" id="token-12-6" morph="none" pos="word" start_char="1264">antibody</TOKEN>
<TOKEN end_char="1282" id="token-12-7" morph="none" pos="word" start_char="1273">production</TOKEN>
<TOKEN end_char="1283" id="token-12-8" morph="none" pos="punct" start_char="1283">,</TOKEN>
<TOKEN end_char="1291" id="token-12-9" morph="none" pos="word" start_char="1285">however</TOKEN>
<TOKEN end_char="1292" id="token-12-10" morph="none" pos="punct" start_char="1292">,</TOKEN>
<TOKEN end_char="1296" id="token-12-11" morph="none" pos="word" start_char="1294">has</TOKEN>
<TOKEN end_char="1301" id="token-12-12" morph="none" pos="word" start_char="1298">been</TOKEN>
<TOKEN end_char="1306" id="token-12-13" morph="none" pos="word" start_char="1303">much</TOKEN>
<TOKEN end_char="1311" id="token-12-14" morph="none" pos="word" start_char="1308">more</TOKEN>
<TOKEN end_char="1322" id="token-12-15" morph="none" pos="word" start_char="1313">consistent</TOKEN>
<TOKEN end_char="1323" id="token-12-16" morph="none" pos="punct" start_char="1323">.</TOKEN>
</SEG>
<SEG end_char="1585" id="segment-13" start_char="1325">
<ORIGINAL_TEXT>Both vaccines with emergency use authorization (Pfizer and Moderna) are reporting results of neutralizing antibody geometric mean titers (GMTs) several times greater than mean levels in convalescent serum panels from patients with previous exposure to COVID-19.</ORIGINAL_TEXT>
<TOKEN end_char="1328" id="token-13-0" morph="none" pos="word" start_char="1325">Both</TOKEN>
<TOKEN end_char="1337" id="token-13-1" morph="none" pos="word" start_char="1330">vaccines</TOKEN>
<TOKEN end_char="1342" id="token-13-2" morph="none" pos="word" start_char="1339">with</TOKEN>
<TOKEN end_char="1352" id="token-13-3" morph="none" pos="word" start_char="1344">emergency</TOKEN>
<TOKEN end_char="1356" id="token-13-4" morph="none" pos="word" start_char="1354">use</TOKEN>
<TOKEN end_char="1370" id="token-13-5" morph="none" pos="word" start_char="1358">authorization</TOKEN>
<TOKEN end_char="1372" id="token-13-6" morph="none" pos="punct" start_char="1372">(</TOKEN>
<TOKEN end_char="1378" id="token-13-7" morph="none" pos="word" start_char="1373">Pfizer</TOKEN>
<TOKEN end_char="1382" id="token-13-8" morph="none" pos="word" start_char="1380">and</TOKEN>
<TOKEN end_char="1390" id="token-13-9" morph="none" pos="word" start_char="1384">Moderna</TOKEN>
<TOKEN end_char="1391" id="token-13-10" morph="none" pos="punct" start_char="1391">)</TOKEN>
<TOKEN end_char="1395" id="token-13-11" morph="none" pos="word" start_char="1393">are</TOKEN>
<TOKEN end_char="1405" id="token-13-12" morph="none" pos="word" start_char="1397">reporting</TOKEN>
<TOKEN end_char="1413" id="token-13-13" morph="none" pos="word" start_char="1407">results</TOKEN>
<TOKEN end_char="1416" id="token-13-14" morph="none" pos="word" start_char="1415">of</TOKEN>
<TOKEN end_char="1429" id="token-13-15" morph="none" pos="word" start_char="1418">neutralizing</TOKEN>
<TOKEN end_char="1438" id="token-13-16" morph="none" pos="word" start_char="1431">antibody</TOKEN>
<TOKEN end_char="1448" id="token-13-17" morph="none" pos="word" start_char="1440">geometric</TOKEN>
<TOKEN end_char="1453" id="token-13-18" morph="none" pos="word" start_char="1450">mean</TOKEN>
<TOKEN end_char="1460" id="token-13-19" morph="none" pos="word" start_char="1455">titers</TOKEN>
<TOKEN end_char="1462" id="token-13-20" morph="none" pos="punct" start_char="1462">(</TOKEN>
<TOKEN end_char="1466" id="token-13-21" morph="none" pos="word" start_char="1463">GMTs</TOKEN>
<TOKEN end_char="1467" id="token-13-22" morph="none" pos="punct" start_char="1467">)</TOKEN>
<TOKEN end_char="1475" id="token-13-23" morph="none" pos="word" start_char="1469">several</TOKEN>
<TOKEN end_char="1481" id="token-13-24" morph="none" pos="word" start_char="1477">times</TOKEN>
<TOKEN end_char="1489" id="token-13-25" morph="none" pos="word" start_char="1483">greater</TOKEN>
<TOKEN end_char="1494" id="token-13-26" morph="none" pos="word" start_char="1491">than</TOKEN>
<TOKEN end_char="1499" id="token-13-27" morph="none" pos="word" start_char="1496">mean</TOKEN>
<TOKEN end_char="1506" id="token-13-28" morph="none" pos="word" start_char="1501">levels</TOKEN>
<TOKEN end_char="1509" id="token-13-29" morph="none" pos="word" start_char="1508">in</TOKEN>
<TOKEN end_char="1522" id="token-13-30" morph="none" pos="word" start_char="1511">convalescent</TOKEN>
<TOKEN end_char="1528" id="token-13-31" morph="none" pos="word" start_char="1524">serum</TOKEN>
<TOKEN end_char="1535" id="token-13-32" morph="none" pos="word" start_char="1530">panels</TOKEN>
<TOKEN end_char="1540" id="token-13-33" morph="none" pos="word" start_char="1537">from</TOKEN>
<TOKEN end_char="1549" id="token-13-34" morph="none" pos="word" start_char="1542">patients</TOKEN>
<TOKEN end_char="1554" id="token-13-35" morph="none" pos="word" start_char="1551">with</TOKEN>
<TOKEN end_char="1563" id="token-13-36" morph="none" pos="word" start_char="1556">previous</TOKEN>
<TOKEN end_char="1572" id="token-13-37" morph="none" pos="word" start_char="1565">exposure</TOKEN>
<TOKEN end_char="1575" id="token-13-38" morph="none" pos="word" start_char="1574">to</TOKEN>
<TOKEN end_char="1584" id="token-13-39" morph="none" pos="unknown" start_char="1577">COVID-19</TOKEN>
<TOKEN end_char="1585" id="token-13-40" morph="none" pos="punct" start_char="1585">.</TOKEN>
</SEG>
<SEG end_char="1590" id="segment-14" start_char="1588">
<ORIGINAL_TEXT>3,4</ORIGINAL_TEXT>
<TOKEN end_char="1590" id="token-14-0" morph="none" pos="unknown" start_char="1588">3,4</TOKEN>
<TRANSLATED_TEXT>3.4</TRANSLATED_TEXT><DETECTED_LANGUAGE /></SEG>
<SEG end_char="1698" id="segment-15" start_char="1593">
<ORIGINAL_TEXT>The current assumption is that greater antibody production will confer greater immunity to the individual.</ORIGINAL_TEXT>
<TOKEN end_char="1595" id="token-15-0" morph="none" pos="word" start_char="1593">The</TOKEN>
<TOKEN end_char="1603" id="token-15-1" morph="none" pos="word" start_char="1597">current</TOKEN>
<TOKEN end_char="1614" id="token-15-2" morph="none" pos="word" start_char="1605">assumption</TOKEN>
<TOKEN end_char="1617" id="token-15-3" morph="none" pos="word" start_char="1616">is</TOKEN>
<TOKEN end_char="1622" id="token-15-4" morph="none" pos="word" start_char="1619">that</TOKEN>
<TOKEN end_char="1630" id="token-15-5" morph="none" pos="word" start_char="1624">greater</TOKEN>
<TOKEN end_char="1639" id="token-15-6" morph="none" pos="word" start_char="1632">antibody</TOKEN>
<TOKEN end_char="1650" id="token-15-7" morph="none" pos="word" start_char="1641">production</TOKEN>
<TOKEN end_char="1655" id="token-15-8" morph="none" pos="word" start_char="1652">will</TOKEN>
<TOKEN end_char="1662" id="token-15-9" morph="none" pos="word" start_char="1657">confer</TOKEN>
<TOKEN end_char="1670" id="token-15-10" morph="none" pos="word" start_char="1664">greater</TOKEN>
<TOKEN end_char="1679" id="token-15-11" morph="none" pos="word" start_char="1672">immunity</TOKEN>
<TOKEN end_char="1682" id="token-15-12" morph="none" pos="word" start_char="1681">to</TOKEN>
<TOKEN end_char="1686" id="token-15-13" morph="none" pos="word" start_char="1684">the</TOKEN>
<TOKEN end_char="1697" id="token-15-14" morph="none" pos="word" start_char="1688">individual</TOKEN>
<TOKEN end_char="1698" id="token-15-15" morph="none" pos="punct" start_char="1698">.</TOKEN>
</SEG>
<SEG end_char="1761" id="segment-16" start_char="1701">
<ORIGINAL_TEXT>Vaccine response in patients with previous COVID-19 infection</ORIGINAL_TEXT>
<TOKEN end_char="1707" id="token-16-0" morph="none" pos="word" start_char="1701">Vaccine</TOKEN>
<TOKEN end_char="1716" id="token-16-1" morph="none" pos="word" start_char="1709">response</TOKEN>
<TOKEN end_char="1719" id="token-16-2" morph="none" pos="word" start_char="1718">in</TOKEN>
<TOKEN end_char="1728" id="token-16-3" morph="none" pos="word" start_char="1721">patients</TOKEN>
<TOKEN end_char="1733" id="token-16-4" morph="none" pos="word" start_char="1730">with</TOKEN>
<TOKEN end_char="1742" id="token-16-5" morph="none" pos="word" start_char="1735">previous</TOKEN>
<TOKEN end_char="1751" id="token-16-6" morph="none" pos="unknown" start_char="1744">COVID-19</TOKEN>
<TOKEN end_char="1761" id="token-16-7" morph="none" pos="word" start_char="1753">infection</TOKEN>
</SEG>
<SEG end_char="1883" id="segment-17" start_char="1765">
<ORIGINAL_TEXT>A topic of debate has risen as to whether those patients who have previously contracted COVID-19 should get vaccinated.</ORIGINAL_TEXT>
<TOKEN end_char="1765" id="token-17-0" morph="none" pos="word" start_char="1765">A</TOKEN>
<TOKEN end_char="1771" id="token-17-1" morph="none" pos="word" start_char="1767">topic</TOKEN>
<TOKEN end_char="1774" id="token-17-2" morph="none" pos="word" start_char="1773">of</TOKEN>
<TOKEN end_char="1781" id="token-17-3" morph="none" pos="word" start_char="1776">debate</TOKEN>
<TOKEN end_char="1785" id="token-17-4" morph="none" pos="word" start_char="1783">has</TOKEN>
<TOKEN end_char="1791" id="token-17-5" morph="none" pos="word" start_char="1787">risen</TOKEN>
<TOKEN end_char="1794" id="token-17-6" morph="none" pos="word" start_char="1793">as</TOKEN>
<TOKEN end_char="1797" id="token-17-7" morph="none" pos="word" start_char="1796">to</TOKEN>
<TOKEN end_char="1805" id="token-17-8" morph="none" pos="word" start_char="1799">whether</TOKEN>
<TOKEN end_char="1811" id="token-17-9" morph="none" pos="word" start_char="1807">those</TOKEN>
<TOKEN end_char="1820" id="token-17-10" morph="none" pos="word" start_char="1813">patients</TOKEN>
<TOKEN end_char="1824" id="token-17-11" morph="none" pos="word" start_char="1822">who</TOKEN>
<TOKEN end_char="1829" id="token-17-12" morph="none" pos="word" start_char="1826">have</TOKEN>
<TOKEN end_char="1840" id="token-17-13" morph="none" pos="word" start_char="1831">previously</TOKEN>
<TOKEN end_char="1851" id="token-17-14" morph="none" pos="word" start_char="1842">contracted</TOKEN>
<TOKEN end_char="1860" id="token-17-15" morph="none" pos="unknown" start_char="1853">COVID-19</TOKEN>
<TOKEN end_char="1867" id="token-17-16" morph="none" pos="word" start_char="1862">should</TOKEN>
<TOKEN end_char="1871" id="token-17-17" morph="none" pos="word" start_char="1869">get</TOKEN>
<TOKEN end_char="1882" id="token-17-18" morph="none" pos="word" start_char="1873">vaccinated</TOKEN>
<TOKEN end_char="1883" id="token-17-19" morph="none" pos="punct" start_char="1883">.</TOKEN>
</SEG>
<SEG end_char="2049" id="segment-18" start_char="1885">
<ORIGINAL_TEXT>To shed further insight into this complex mosaic of interaction regarding immune response, vaccines, and COVID-19, many are looking at the data coming out of Israel.</ORIGINAL_TEXT>
<TOKEN end_char="1886" id="token-18-0" morph="none" pos="word" start_char="1885">To</TOKEN>
<TOKEN end_char="1891" id="token-18-1" morph="none" pos="word" start_char="1888">shed</TOKEN>
<TOKEN end_char="1899" id="token-18-2" morph="none" pos="word" start_char="1893">further</TOKEN>
<TOKEN end_char="1907" id="token-18-3" morph="none" pos="word" start_char="1901">insight</TOKEN>
<TOKEN end_char="1912" id="token-18-4" morph="none" pos="word" start_char="1909">into</TOKEN>
<TOKEN end_char="1917" id="token-18-5" morph="none" pos="word" start_char="1914">this</TOKEN>
<TOKEN end_char="1925" id="token-18-6" morph="none" pos="word" start_char="1919">complex</TOKEN>
<TOKEN end_char="1932" id="token-18-7" morph="none" pos="word" start_char="1927">mosaic</TOKEN>
<TOKEN end_char="1935" id="token-18-8" morph="none" pos="word" start_char="1934">of</TOKEN>
<TOKEN end_char="1947" id="token-18-9" morph="none" pos="word" start_char="1937">interaction</TOKEN>
<TOKEN end_char="1957" id="token-18-10" morph="none" pos="word" start_char="1949">regarding</TOKEN>
<TOKEN end_char="1964" id="token-18-11" morph="none" pos="word" start_char="1959">immune</TOKEN>
<TOKEN end_char="1973" id="token-18-12" morph="none" pos="word" start_char="1966">response</TOKEN>
<TOKEN end_char="1974" id="token-18-13" morph="none" pos="punct" start_char="1974">,</TOKEN>
<TOKEN end_char="1983" id="token-18-14" morph="none" pos="word" start_char="1976">vaccines</TOKEN>
<TOKEN end_char="1984" id="token-18-15" morph="none" pos="punct" start_char="1984">,</TOKEN>
<TOKEN end_char="1988" id="token-18-16" morph="none" pos="word" start_char="1986">and</TOKEN>
<TOKEN end_char="1997" id="token-18-17" morph="none" pos="unknown" start_char="1990">COVID-19</TOKEN>
<TOKEN end_char="1998" id="token-18-18" morph="none" pos="punct" start_char="1998">,</TOKEN>
<TOKEN end_char="2003" id="token-18-19" morph="none" pos="word" start_char="2000">many</TOKEN>
<TOKEN end_char="2007" id="token-18-20" morph="none" pos="word" start_char="2005">are</TOKEN>
<TOKEN end_char="2015" id="token-18-21" morph="none" pos="word" start_char="2009">looking</TOKEN>
<TOKEN end_char="2018" id="token-18-22" morph="none" pos="word" start_char="2017">at</TOKEN>
<TOKEN end_char="2022" id="token-18-23" morph="none" pos="word" start_char="2020">the</TOKEN>
<TOKEN end_char="2027" id="token-18-24" morph="none" pos="word" start_char="2024">data</TOKEN>
<TOKEN end_char="2034" id="token-18-25" morph="none" pos="word" start_char="2029">coming</TOKEN>
<TOKEN end_char="2038" id="token-18-26" morph="none" pos="word" start_char="2036">out</TOKEN>
<TOKEN end_char="2041" id="token-18-27" morph="none" pos="word" start_char="2040">of</TOKEN>
<TOKEN end_char="2048" id="token-18-28" morph="none" pos="word" start_char="2043">Israel</TOKEN>
<TOKEN end_char="2049" id="token-18-29" morph="none" pos="punct" start_char="2049">.</TOKEN>
</SEG>
<SEG end_char="2183" id="segment-19" start_char="2051">
<ORIGINAL_TEXT>Israel is leading the world in vaccination rates, with over 30% of its population already vaccinated at the time of this publication.</ORIGINAL_TEXT>
<TOKEN end_char="2056" id="token-19-0" morph="none" pos="word" start_char="2051">Israel</TOKEN>
<TOKEN end_char="2059" id="token-19-1" morph="none" pos="word" start_char="2058">is</TOKEN>
<TOKEN end_char="2067" id="token-19-2" morph="none" pos="word" start_char="2061">leading</TOKEN>
<TOKEN end_char="2071" id="token-19-3" morph="none" pos="word" start_char="2069">the</TOKEN>
<TOKEN end_char="2077" id="token-19-4" morph="none" pos="word" start_char="2073">world</TOKEN>
<TOKEN end_char="2080" id="token-19-5" morph="none" pos="word" start_char="2079">in</TOKEN>
<TOKEN end_char="2092" id="token-19-6" morph="none" pos="word" start_char="2082">vaccination</TOKEN>
<TOKEN end_char="2098" id="token-19-7" morph="none" pos="word" start_char="2094">rates</TOKEN>
<TOKEN end_char="2099" id="token-19-8" morph="none" pos="punct" start_char="2099">,</TOKEN>
<TOKEN end_char="2104" id="token-19-9" morph="none" pos="word" start_char="2101">with</TOKEN>
<TOKEN end_char="2109" id="token-19-10" morph="none" pos="word" start_char="2106">over</TOKEN>
<TOKEN end_char="2112" id="token-19-11" morph="none" pos="word" start_char="2111">30</TOKEN>
<TOKEN end_char="2113" id="token-19-12" morph="none" pos="punct" start_char="2113">%</TOKEN>
<TOKEN end_char="2116" id="token-19-13" morph="none" pos="word" start_char="2115">of</TOKEN>
<TOKEN end_char="2120" id="token-19-14" morph="none" pos="word" start_char="2118">its</TOKEN>
<TOKEN end_char="2131" id="token-19-15" morph="none" pos="word" start_char="2122">population</TOKEN>
<TOKEN end_char="2139" id="token-19-16" morph="none" pos="word" start_char="2133">already</TOKEN>
<TOKEN end_char="2150" id="token-19-17" morph="none" pos="word" start_char="2141">vaccinated</TOKEN>
<TOKEN end_char="2153" id="token-19-18" morph="none" pos="word" start_char="2152">at</TOKEN>
<TOKEN end_char="2157" id="token-19-19" morph="none" pos="word" start_char="2155">the</TOKEN>
<TOKEN end_char="2162" id="token-19-20" morph="none" pos="word" start_char="2159">time</TOKEN>
<TOKEN end_char="2165" id="token-19-21" morph="none" pos="word" start_char="2164">of</TOKEN>
<TOKEN end_char="2170" id="token-19-22" morph="none" pos="word" start_char="2167">this</TOKEN>
<TOKEN end_char="2182" id="token-19-23" morph="none" pos="word" start_char="2172">publication</TOKEN>
<TOKEN end_char="2183" id="token-19-24" morph="none" pos="punct" start_char="2183">.</TOKEN>
</SEG>
<SEG end_char="2186" id="segment-20" start_char="2186">
<ORIGINAL_TEXT>5</ORIGINAL_TEXT>
<TOKEN end_char="2186" id="token-20-0" morph="none" pos="word" start_char="2186">5</TOKEN>
</SEG>
<SEG end_char="2352" id="segment-21" start_char="2190">
<ORIGINAL_TEXT>In a recent study (yet to be peer-reviewed), 514 Israeli health-care workers were analyzed for immunogenicity 21 days after receiving their first vaccination dose.</ORIGINAL_TEXT>
<TOKEN end_char="2191" id="token-21-0" morph="none" pos="word" start_char="2190">In</TOKEN>
<TOKEN end_char="2193" id="token-21-1" morph="none" pos="word" start_char="2193">a</TOKEN>
<TOKEN end_char="2200" id="token-21-2" morph="none" pos="word" start_char="2195">recent</TOKEN>
<TOKEN end_char="2206" id="token-21-3" morph="none" pos="word" start_char="2202">study</TOKEN>
<TOKEN end_char="2208" id="token-21-4" morph="none" pos="punct" start_char="2208">(</TOKEN>
<TOKEN end_char="2211" id="token-21-5" morph="none" pos="word" start_char="2209">yet</TOKEN>
<TOKEN end_char="2214" id="token-21-6" morph="none" pos="word" start_char="2213">to</TOKEN>
<TOKEN end_char="2217" id="token-21-7" morph="none" pos="word" start_char="2216">be</TOKEN>
<TOKEN end_char="2231" id="token-21-8" morph="none" pos="unknown" start_char="2219">peer-reviewed</TOKEN>
<TOKEN end_char="2233" id="token-21-9" morph="none" pos="punct" start_char="2232">),</TOKEN>
<TOKEN end_char="2237" id="token-21-10" morph="none" pos="word" start_char="2235">514</TOKEN>
<TOKEN end_char="2245" id="token-21-11" morph="none" pos="word" start_char="2239">Israeli</TOKEN>
<TOKEN end_char="2257" id="token-21-12" morph="none" pos="unknown" start_char="2247">health-care</TOKEN>
<TOKEN end_char="2265" id="token-21-13" morph="none" pos="word" start_char="2259">workers</TOKEN>
<TOKEN end_char="2270" id="token-21-14" morph="none" pos="word" start_char="2267">were</TOKEN>
<TOKEN end_char="2279" id="token-21-15" morph="none" pos="word" start_char="2272">analyzed</TOKEN>
<TOKEN end_char="2283" id="token-21-16" morph="none" pos="word" start_char="2281">for</TOKEN>
<TOKEN end_char="2298" id="token-21-17" morph="none" pos="word" start_char="2285">immunogenicity</TOKEN>
<TOKEN end_char="2301" id="token-21-18" morph="none" pos="word" start_char="2300">21</TOKEN>
<TOKEN end_char="2306" id="token-21-19" morph="none" pos="word" start_char="2303">days</TOKEN>
<TOKEN end_char="2312" id="token-21-20" morph="none" pos="word" start_char="2308">after</TOKEN>
<TOKEN end_char="2322" id="token-21-21" morph="none" pos="word" start_char="2314">receiving</TOKEN>
<TOKEN end_char="2328" id="token-21-22" morph="none" pos="word" start_char="2324">their</TOKEN>
<TOKEN end_char="2334" id="token-21-23" morph="none" pos="word" start_char="2330">first</TOKEN>
<TOKEN end_char="2346" id="token-21-24" morph="none" pos="word" start_char="2336">vaccination</TOKEN>
<TOKEN end_char="2351" id="token-21-25" morph="none" pos="word" start_char="2348">dose</TOKEN>
<TOKEN end_char="2352" id="token-21-26" morph="none" pos="punct" start_char="2352">.</TOKEN>
</SEG>
<SEG end_char="2355" id="segment-22" start_char="2355">
<ORIGINAL_TEXT>6</ORIGINAL_TEXT>
<TOKEN end_char="2355" id="token-22-0" morph="none" pos="word" start_char="2355">6</TOKEN>
</SEG>
<SEG end_char="2544" id="segment-23" start_char="2358">
<ORIGINAL_TEXT>In reaction to dose one, patients with prior COVID-19 infections had neutralizing antibodies at an order of magnitude (almost tenfold) higher than those with no evidence of prior disease.</ORIGINAL_TEXT>
<TOKEN end_char="2359" id="token-23-0" morph="none" pos="word" start_char="2358">In</TOKEN>
<TOKEN end_char="2368" id="token-23-1" morph="none" pos="word" start_char="2361">reaction</TOKEN>
<TOKEN end_char="2371" id="token-23-2" morph="none" pos="word" start_char="2370">to</TOKEN>
<TOKEN end_char="2376" id="token-23-3" morph="none" pos="word" start_char="2373">dose</TOKEN>
<TOKEN end_char="2380" id="token-23-4" morph="none" pos="word" start_char="2378">one</TOKEN>
<TOKEN end_char="2381" id="token-23-5" morph="none" pos="punct" start_char="2381">,</TOKEN>
<TOKEN end_char="2390" id="token-23-6" morph="none" pos="word" start_char="2383">patients</TOKEN>
<TOKEN end_char="2395" id="token-23-7" morph="none" pos="word" start_char="2392">with</TOKEN>
<TOKEN end_char="2401" id="token-23-8" morph="none" pos="word" start_char="2397">prior</TOKEN>
<TOKEN end_char="2410" id="token-23-9" morph="none" pos="unknown" start_char="2403">COVID-19</TOKEN>
<TOKEN end_char="2421" id="token-23-10" morph="none" pos="word" start_char="2412">infections</TOKEN>
<TOKEN end_char="2425" id="token-23-11" morph="none" pos="word" start_char="2423">had</TOKEN>
<TOKEN end_char="2438" id="token-23-12" morph="none" pos="word" start_char="2427">neutralizing</TOKEN>
<TOKEN end_char="2449" id="token-23-13" morph="none" pos="word" start_char="2440">antibodies</TOKEN>
<TOKEN end_char="2452" id="token-23-14" morph="none" pos="word" start_char="2451">at</TOKEN>
<TOKEN end_char="2455" id="token-23-15" morph="none" pos="word" start_char="2454">an</TOKEN>
<TOKEN end_char="2461" id="token-23-16" morph="none" pos="word" start_char="2457">order</TOKEN>
<TOKEN end_char="2464" id="token-23-17" morph="none" pos="word" start_char="2463">of</TOKEN>
<TOKEN end_char="2474" id="token-23-18" morph="none" pos="word" start_char="2466">magnitude</TOKEN>
<TOKEN end_char="2476" id="token-23-19" morph="none" pos="punct" start_char="2476">(</TOKEN>
<TOKEN end_char="2482" id="token-23-20" morph="none" pos="word" start_char="2477">almost</TOKEN>
<TOKEN end_char="2490" id="token-23-21" morph="none" pos="word" start_char="2484">tenfold</TOKEN>
<TOKEN end_char="2491" id="token-23-22" morph="none" pos="punct" start_char="2491">)</TOKEN>
<TOKEN end_char="2498" id="token-23-23" morph="none" pos="word" start_char="2493">higher</TOKEN>
<TOKEN end_char="2503" id="token-23-24" morph="none" pos="word" start_char="2500">than</TOKEN>
<TOKEN end_char="2509" id="token-23-25" morph="none" pos="word" start_char="2505">those</TOKEN>
<TOKEN end_char="2514" id="token-23-26" morph="none" pos="word" start_char="2511">with</TOKEN>
<TOKEN end_char="2517" id="token-23-27" morph="none" pos="word" start_char="2516">no</TOKEN>
<TOKEN end_char="2526" id="token-23-28" morph="none" pos="word" start_char="2519">evidence</TOKEN>
<TOKEN end_char="2529" id="token-23-29" morph="none" pos="word" start_char="2528">of</TOKEN>
<TOKEN end_char="2535" id="token-23-30" morph="none" pos="word" start_char="2531">prior</TOKEN>
<TOKEN end_char="2543" id="token-23-31" morph="none" pos="word" start_char="2537">disease</TOKEN>
<TOKEN end_char="2544" id="token-23-32" morph="none" pos="punct" start_char="2544">.</TOKEN>
</SEG>
<SEG end_char="2864" id="segment-24" start_char="2547">
<ORIGINAL_TEXT>An even more compelling observation was after a single vaccine dose, patients who previously had COVID-19 but no longer presented evidence of antibodies (IgG negative) at the beginning of the study still exhibited a similar antibody response exponentially higher than those patients with no history of prior infection.</ORIGINAL_TEXT>
<TOKEN end_char="2548" id="token-24-0" morph="none" pos="word" start_char="2547">An</TOKEN>
<TOKEN end_char="2553" id="token-24-1" morph="none" pos="word" start_char="2550">even</TOKEN>
<TOKEN end_char="2558" id="token-24-2" morph="none" pos="word" start_char="2555">more</TOKEN>
<TOKEN end_char="2569" id="token-24-3" morph="none" pos="word" start_char="2560">compelling</TOKEN>
<TOKEN end_char="2581" id="token-24-4" morph="none" pos="word" start_char="2571">observation</TOKEN>
<TOKEN end_char="2585" id="token-24-5" morph="none" pos="word" start_char="2583">was</TOKEN>
<TOKEN end_char="2591" id="token-24-6" morph="none" pos="word" start_char="2587">after</TOKEN>
<TOKEN end_char="2593" id="token-24-7" morph="none" pos="word" start_char="2593">a</TOKEN>
<TOKEN end_char="2600" id="token-24-8" morph="none" pos="word" start_char="2595">single</TOKEN>
<TOKEN end_char="2608" id="token-24-9" morph="none" pos="word" start_char="2602">vaccine</TOKEN>
<TOKEN end_char="2613" id="token-24-10" morph="none" pos="word" start_char="2610">dose</TOKEN>
<TOKEN end_char="2614" id="token-24-11" morph="none" pos="punct" start_char="2614">,</TOKEN>
<TOKEN end_char="2623" id="token-24-12" morph="none" pos="word" start_char="2616">patients</TOKEN>
<TOKEN end_char="2627" id="token-24-13" morph="none" pos="word" start_char="2625">who</TOKEN>
<TOKEN end_char="2638" id="token-24-14" morph="none" pos="word" start_char="2629">previously</TOKEN>
<TOKEN end_char="2642" id="token-24-15" morph="none" pos="word" start_char="2640">had</TOKEN>
<TOKEN end_char="2651" id="token-24-16" morph="none" pos="unknown" start_char="2644">COVID-19</TOKEN>
<TOKEN end_char="2655" id="token-24-17" morph="none" pos="word" start_char="2653">but</TOKEN>
<TOKEN end_char="2658" id="token-24-18" morph="none" pos="word" start_char="2657">no</TOKEN>
<TOKEN end_char="2665" id="token-24-19" morph="none" pos="word" start_char="2660">longer</TOKEN>
<TOKEN end_char="2675" id="token-24-20" morph="none" pos="word" start_char="2667">presented</TOKEN>
<TOKEN end_char="2684" id="token-24-21" morph="none" pos="word" start_char="2677">evidence</TOKEN>
<TOKEN end_char="2687" id="token-24-22" morph="none" pos="word" start_char="2686">of</TOKEN>
<TOKEN end_char="2698" id="token-24-23" morph="none" pos="word" start_char="2689">antibodies</TOKEN>
<TOKEN end_char="2700" id="token-24-24" morph="none" pos="punct" start_char="2700">(</TOKEN>
<TOKEN end_char="2703" id="token-24-25" morph="none" pos="word" start_char="2701">IgG</TOKEN>
<TOKEN end_char="2712" id="token-24-26" morph="none" pos="word" start_char="2705">negative</TOKEN>
<TOKEN end_char="2713" id="token-24-27" morph="none" pos="punct" start_char="2713">)</TOKEN>
<TOKEN end_char="2716" id="token-24-28" morph="none" pos="word" start_char="2715">at</TOKEN>
<TOKEN end_char="2720" id="token-24-29" morph="none" pos="word" start_char="2718">the</TOKEN>
<TOKEN end_char="2730" id="token-24-30" morph="none" pos="word" start_char="2722">beginning</TOKEN>
<TOKEN end_char="2733" id="token-24-31" morph="none" pos="word" start_char="2732">of</TOKEN>
<TOKEN end_char="2737" id="token-24-32" morph="none" pos="word" start_char="2735">the</TOKEN>
<TOKEN end_char="2743" id="token-24-33" morph="none" pos="word" start_char="2739">study</TOKEN>
<TOKEN end_char="2749" id="token-24-34" morph="none" pos="word" start_char="2745">still</TOKEN>
<TOKEN end_char="2759" id="token-24-35" morph="none" pos="word" start_char="2751">exhibited</TOKEN>
<TOKEN end_char="2761" id="token-24-36" morph="none" pos="word" start_char="2761">a</TOKEN>
<TOKEN end_char="2769" id="token-24-37" morph="none" pos="word" start_char="2763">similar</TOKEN>
<TOKEN end_char="2778" id="token-24-38" morph="none" pos="word" start_char="2771">antibody</TOKEN>
<TOKEN end_char="2787" id="token-24-39" morph="none" pos="word" start_char="2780">response</TOKEN>
<TOKEN end_char="2801" id="token-24-40" morph="none" pos="word" start_char="2789">exponentially</TOKEN>
<TOKEN end_char="2808" id="token-24-41" morph="none" pos="word" start_char="2803">higher</TOKEN>
<TOKEN end_char="2813" id="token-24-42" morph="none" pos="word" start_char="2810">than</TOKEN>
<TOKEN end_char="2819" id="token-24-43" morph="none" pos="word" start_char="2815">those</TOKEN>
<TOKEN end_char="2828" id="token-24-44" morph="none" pos="word" start_char="2821">patients</TOKEN>
<TOKEN end_char="2833" id="token-24-45" morph="none" pos="word" start_char="2830">with</TOKEN>
<TOKEN end_char="2836" id="token-24-46" morph="none" pos="word" start_char="2835">no</TOKEN>
<TOKEN end_char="2844" id="token-24-47" morph="none" pos="word" start_char="2838">history</TOKEN>
<TOKEN end_char="2847" id="token-24-48" morph="none" pos="word" start_char="2846">of</TOKEN>
<TOKEN end_char="2853" id="token-24-49" morph="none" pos="word" start_char="2849">prior</TOKEN>
<TOKEN end_char="2863" id="token-24-50" morph="none" pos="word" start_char="2855">infection</TOKEN>
<TOKEN end_char="2864" id="token-24-51" morph="none" pos="punct" start_char="2864">.</TOKEN>
</SEG>
<SEG end_char="3050" id="segment-25" start_char="2868">
<ORIGINAL_TEXT>Further studies should be conducted to validate and expand these findings as this may have consequences for vaccination policy regarding individuals previously infected with COVID-19.</ORIGINAL_TEXT>
<TOKEN end_char="2874" id="token-25-0" morph="none" pos="word" start_char="2868">Further</TOKEN>
<TOKEN end_char="2882" id="token-25-1" morph="none" pos="word" start_char="2876">studies</TOKEN>
<TOKEN end_char="2889" id="token-25-2" morph="none" pos="word" start_char="2884">should</TOKEN>
<TOKEN end_char="2892" id="token-25-3" morph="none" pos="word" start_char="2891">be</TOKEN>
<TOKEN end_char="2902" id="token-25-4" morph="none" pos="word" start_char="2894">conducted</TOKEN>
<TOKEN end_char="2905" id="token-25-5" morph="none" pos="word" start_char="2904">to</TOKEN>
<TOKEN end_char="2914" id="token-25-6" morph="none" pos="word" start_char="2907">validate</TOKEN>
<TOKEN end_char="2918" id="token-25-7" morph="none" pos="word" start_char="2916">and</TOKEN>
<TOKEN end_char="2925" id="token-25-8" morph="none" pos="word" start_char="2920">expand</TOKEN>
<TOKEN end_char="2931" id="token-25-9" morph="none" pos="word" start_char="2927">these</TOKEN>
<TOKEN end_char="2940" id="token-25-10" morph="none" pos="word" start_char="2933">findings</TOKEN>
<TOKEN end_char="2943" id="token-25-11" morph="none" pos="word" start_char="2942">as</TOKEN>
<TOKEN end_char="2948" id="token-25-12" morph="none" pos="word" start_char="2945">this</TOKEN>
<TOKEN end_char="2952" id="token-25-13" morph="none" pos="word" start_char="2950">may</TOKEN>
<TOKEN end_char="2957" id="token-25-14" morph="none" pos="word" start_char="2954">have</TOKEN>
<TOKEN end_char="2970" id="token-25-15" morph="none" pos="word" start_char="2959">consequences</TOKEN>
<TOKEN end_char="2974" id="token-25-16" morph="none" pos="word" start_char="2972">for</TOKEN>
<TOKEN end_char="2986" id="token-25-17" morph="none" pos="word" start_char="2976">vaccination</TOKEN>
<TOKEN end_char="2993" id="token-25-18" morph="none" pos="word" start_char="2988">policy</TOKEN>
<TOKEN end_char="3003" id="token-25-19" morph="none" pos="word" start_char="2995">regarding</TOKEN>
<TOKEN end_char="3015" id="token-25-20" morph="none" pos="word" start_char="3005">individuals</TOKEN>
<TOKEN end_char="3026" id="token-25-21" morph="none" pos="word" start_char="3017">previously</TOKEN>
<TOKEN end_char="3035" id="token-25-22" morph="none" pos="word" start_char="3028">infected</TOKEN>
<TOKEN end_char="3040" id="token-25-23" morph="none" pos="word" start_char="3037">with</TOKEN>
<TOKEN end_char="3049" id="token-25-24" morph="none" pos="unknown" start_char="3042">COVID-19</TOKEN>
<TOKEN end_char="3050" id="token-25-25" morph="none" pos="punct" start_char="3050">.</TOKEN>
</SEG>
<SEG end_char="3244" id="segment-26" start_char="3052">
<ORIGINAL_TEXT>This is especially important at a time when vaccine scarcity is an issue and creating a protocol regarding single- versus double-dose effectiveness in mass populations is being heavily debated.</ORIGINAL_TEXT>
<TOKEN end_char="3055" id="token-26-0" morph="none" pos="word" start_char="3052">This</TOKEN>
<TOKEN end_char="3058" id="token-26-1" morph="none" pos="word" start_char="3057">is</TOKEN>
<TOKEN end_char="3069" id="token-26-2" morph="none" pos="word" start_char="3060">especially</TOKEN>
<TOKEN end_char="3079" id="token-26-3" morph="none" pos="word" start_char="3071">important</TOKEN>
<TOKEN end_char="3082" id="token-26-4" morph="none" pos="word" start_char="3081">at</TOKEN>
<TOKEN end_char="3084" id="token-26-5" morph="none" pos="word" start_char="3084">a</TOKEN>
<TOKEN end_char="3089" id="token-26-6" morph="none" pos="word" start_char="3086">time</TOKEN>
<TOKEN end_char="3094" id="token-26-7" morph="none" pos="word" start_char="3091">when</TOKEN>
<TOKEN end_char="3102" id="token-26-8" morph="none" pos="word" start_char="3096">vaccine</TOKEN>
<TOKEN end_char="3111" id="token-26-9" morph="none" pos="word" start_char="3104">scarcity</TOKEN>
<TOKEN end_char="3114" id="token-26-10" morph="none" pos="word" start_char="3113">is</TOKEN>
<TOKEN end_char="3117" id="token-26-11" morph="none" pos="word" start_char="3116">an</TOKEN>
<TOKEN end_char="3123" id="token-26-12" morph="none" pos="word" start_char="3119">issue</TOKEN>
<TOKEN end_char="3127" id="token-26-13" morph="none" pos="word" start_char="3125">and</TOKEN>
<TOKEN end_char="3136" id="token-26-14" morph="none" pos="word" start_char="3129">creating</TOKEN>
<TOKEN end_char="3138" id="token-26-15" morph="none" pos="word" start_char="3138">a</TOKEN>
<TOKEN end_char="3147" id="token-26-16" morph="none" pos="word" start_char="3140">protocol</TOKEN>
<TOKEN end_char="3157" id="token-26-17" morph="none" pos="word" start_char="3149">regarding</TOKEN>
<TOKEN end_char="3164" id="token-26-18" morph="none" pos="word" start_char="3159">single</TOKEN>
<TOKEN end_char="3165" id="token-26-19" morph="none" pos="punct" start_char="3165">-</TOKEN>
<TOKEN end_char="3172" id="token-26-20" morph="none" pos="word" start_char="3167">versus</TOKEN>
<TOKEN end_char="3184" id="token-26-21" morph="none" pos="unknown" start_char="3174">double-dose</TOKEN>
<TOKEN end_char="3198" id="token-26-22" morph="none" pos="word" start_char="3186">effectiveness</TOKEN>
<TOKEN end_char="3201" id="token-26-23" morph="none" pos="word" start_char="3200">in</TOKEN>
<TOKEN end_char="3206" id="token-26-24" morph="none" pos="word" start_char="3203">mass</TOKEN>
<TOKEN end_char="3218" id="token-26-25" morph="none" pos="word" start_char="3208">populations</TOKEN>
<TOKEN end_char="3221" id="token-26-26" morph="none" pos="word" start_char="3220">is</TOKEN>
<TOKEN end_char="3227" id="token-26-27" morph="none" pos="word" start_char="3223">being</TOKEN>
<TOKEN end_char="3235" id="token-26-28" morph="none" pos="word" start_char="3229">heavily</TOKEN>
<TOKEN end_char="3243" id="token-26-29" morph="none" pos="word" start_char="3237">debated</TOKEN>
<TOKEN end_char="3244" id="token-26-30" morph="none" pos="punct" start_char="3244">.</TOKEN>
</SEG>
<SEG end_char="3314" id="segment-27" start_char="3247">
<ORIGINAL_TEXT>Natural immunity and vaccine effectiveness against COVID-19 variants</ORIGINAL_TEXT>
<TOKEN end_char="3253" id="token-27-0" morph="none" pos="word" start_char="3247">Natural</TOKEN>
<TOKEN end_char="3262" id="token-27-1" morph="none" pos="word" start_char="3255">immunity</TOKEN>
<TOKEN end_char="3266" id="token-27-2" morph="none" pos="word" start_char="3264">and</TOKEN>
<TOKEN end_char="3274" id="token-27-3" morph="none" pos="word" start_char="3268">vaccine</TOKEN>
<TOKEN end_char="3288" id="token-27-4" morph="none" pos="word" start_char="3276">effectiveness</TOKEN>
<TOKEN end_char="3296" id="token-27-5" morph="none" pos="word" start_char="3290">against</TOKEN>
<TOKEN end_char="3305" id="token-27-6" morph="none" pos="unknown" start_char="3298">COVID-19</TOKEN>
<TOKEN end_char="3314" id="token-27-7" morph="none" pos="word" start_char="3307">variants</TOKEN>
</SEG>
<SEG end_char="3407" id="segment-28" start_char="3318">
<ORIGINAL_TEXT>Judging vaccine effectiveness now becomes a more difficult task because of viral variants.</ORIGINAL_TEXT>
<TOKEN end_char="3324" id="token-28-0" morph="none" pos="word" start_char="3318">Judging</TOKEN>
<TOKEN end_char="3332" id="token-28-1" morph="none" pos="word" start_char="3326">vaccine</TOKEN>
<TOKEN end_char="3346" id="token-28-2" morph="none" pos="word" start_char="3334">effectiveness</TOKEN>
<TOKEN end_char="3350" id="token-28-3" morph="none" pos="word" start_char="3348">now</TOKEN>
<TOKEN end_char="3358" id="token-28-4" morph="none" pos="word" start_char="3352">becomes</TOKEN>
<TOKEN end_char="3360" id="token-28-5" morph="none" pos="word" start_char="3360">a</TOKEN>
<TOKEN end_char="3365" id="token-28-6" morph="none" pos="word" start_char="3362">more</TOKEN>
<TOKEN end_char="3375" id="token-28-7" morph="none" pos="word" start_char="3367">difficult</TOKEN>
<TOKEN end_char="3380" id="token-28-8" morph="none" pos="word" start_char="3377">task</TOKEN>
<TOKEN end_char="3388" id="token-28-9" morph="none" pos="word" start_char="3382">because</TOKEN>
<TOKEN end_char="3391" id="token-28-10" morph="none" pos="word" start_char="3390">of</TOKEN>
<TOKEN end_char="3397" id="token-28-11" morph="none" pos="word" start_char="3393">viral</TOKEN>
<TOKEN end_char="3406" id="token-28-12" morph="none" pos="word" start_char="3399">variants</TOKEN>
<TOKEN end_char="3407" id="token-28-13" morph="none" pos="punct" start_char="3407">.</TOKEN>
</SEG>
<SEG end_char="3568" id="segment-29" start_char="3409">
<ORIGINAL_TEXT>Manaus, Brazil, is currently seeing a resurgence of the virus where herd immunity should have already been reached due to high seroprevalence in the population.</ORIGINAL_TEXT>
<TOKEN end_char="3414" id="token-29-0" morph="none" pos="word" start_char="3409">Manaus</TOKEN>
<TOKEN end_char="3415" id="token-29-1" morph="none" pos="punct" start_char="3415">,</TOKEN>
<TOKEN end_char="3422" id="token-29-2" morph="none" pos="word" start_char="3417">Brazil</TOKEN>
<TOKEN end_char="3423" id="token-29-3" morph="none" pos="punct" start_char="3423">,</TOKEN>
<TOKEN end_char="3426" id="token-29-4" morph="none" pos="word" start_char="3425">is</TOKEN>
<TOKEN end_char="3436" id="token-29-5" morph="none" pos="word" start_char="3428">currently</TOKEN>
<TOKEN end_char="3443" id="token-29-6" morph="none" pos="word" start_char="3438">seeing</TOKEN>
<TOKEN end_char="3445" id="token-29-7" morph="none" pos="word" start_char="3445">a</TOKEN>
<TOKEN end_char="3456" id="token-29-8" morph="none" pos="word" start_char="3447">resurgence</TOKEN>
<TOKEN end_char="3459" id="token-29-9" morph="none" pos="word" start_char="3458">of</TOKEN>
<TOKEN end_char="3463" id="token-29-10" morph="none" pos="word" start_char="3461">the</TOKEN>
<TOKEN end_char="3469" id="token-29-11" morph="none" pos="word" start_char="3465">virus</TOKEN>
<TOKEN end_char="3475" id="token-29-12" morph="none" pos="word" start_char="3471">where</TOKEN>
<TOKEN end_char="3480" id="token-29-13" morph="none" pos="word" start_char="3477">herd</TOKEN>
<TOKEN end_char="3489" id="token-29-14" morph="none" pos="word" start_char="3482">immunity</TOKEN>
<TOKEN end_char="3496" id="token-29-15" morph="none" pos="word" start_char="3491">should</TOKEN>
<TOKEN end_char="3501" id="token-29-16" morph="none" pos="word" start_char="3498">have</TOKEN>
<TOKEN end_char="3509" id="token-29-17" morph="none" pos="word" start_char="3503">already</TOKEN>
<TOKEN end_char="3514" id="token-29-18" morph="none" pos="word" start_char="3511">been</TOKEN>
<TOKEN end_char="3522" id="token-29-19" morph="none" pos="word" start_char="3516">reached</TOKEN>
<TOKEN end_char="3526" id="token-29-20" morph="none" pos="word" start_char="3524">due</TOKEN>
<TOKEN end_char="3529" id="token-29-21" morph="none" pos="word" start_char="3528">to</TOKEN>
<TOKEN end_char="3534" id="token-29-22" morph="none" pos="word" start_char="3531">high</TOKEN>
<TOKEN end_char="3549" id="token-29-23" morph="none" pos="word" start_char="3536">seroprevalence</TOKEN>
<TOKEN end_char="3552" id="token-29-24" morph="none" pos="word" start_char="3551">in</TOKEN>
<TOKEN end_char="3556" id="token-29-25" morph="none" pos="word" start_char="3554">the</TOKEN>
<TOKEN end_char="3567" id="token-29-26" morph="none" pos="word" start_char="3558">population</TOKEN>
<TOKEN end_char="3568" id="token-29-27" morph="none" pos="punct" start_char="3568">.</TOKEN>
</SEG>
<SEG end_char="3571" id="segment-30" start_char="3571">
<ORIGINAL_TEXT>7</ORIGINAL_TEXT>
<TOKEN end_char="3571" id="token-30-0" morph="none" pos="word" start_char="3571">7</TOKEN>
</SEG>
<SEG end_char="3700" id="segment-31" start_char="3574">
<ORIGINAL_TEXT>One theory that warrants further testing is that new variants may have acquired mutations that are facilitating immune evasion.</ORIGINAL_TEXT>
<TOKEN end_char="3576" id="token-31-0" morph="none" pos="word" start_char="3574">One</TOKEN>
<TOKEN end_char="3583" id="token-31-1" morph="none" pos="word" start_char="3578">theory</TOKEN>
<TOKEN end_char="3588" id="token-31-2" morph="none" pos="word" start_char="3585">that</TOKEN>
<TOKEN end_char="3597" id="token-31-3" morph="none" pos="word" start_char="3590">warrants</TOKEN>
<TOKEN end_char="3605" id="token-31-4" morph="none" pos="word" start_char="3599">further</TOKEN>
<TOKEN end_char="3613" id="token-31-5" morph="none" pos="word" start_char="3607">testing</TOKEN>
<TOKEN end_char="3616" id="token-31-6" morph="none" pos="word" start_char="3615">is</TOKEN>
<TOKEN end_char="3621" id="token-31-7" morph="none" pos="word" start_char="3618">that</TOKEN>
<TOKEN end_char="3625" id="token-31-8" morph="none" pos="word" start_char="3623">new</TOKEN>
<TOKEN end_char="3634" id="token-31-9" morph="none" pos="word" start_char="3627">variants</TOKEN>
<TOKEN end_char="3638" id="token-31-10" morph="none" pos="word" start_char="3636">may</TOKEN>
<TOKEN end_char="3643" id="token-31-11" morph="none" pos="word" start_char="3640">have</TOKEN>
<TOKEN end_char="3652" id="token-31-12" morph="none" pos="word" start_char="3645">acquired</TOKEN>
<TOKEN end_char="3662" id="token-31-13" morph="none" pos="word" start_char="3654">mutations</TOKEN>
<TOKEN end_char="3667" id="token-31-14" morph="none" pos="word" start_char="3664">that</TOKEN>
<TOKEN end_char="3671" id="token-31-15" morph="none" pos="word" start_char="3669">are</TOKEN>
<TOKEN end_char="3684" id="token-31-16" morph="none" pos="word" start_char="3673">facilitating</TOKEN>
<TOKEN end_char="3691" id="token-31-17" morph="none" pos="word" start_char="3686">immune</TOKEN>
<TOKEN end_char="3699" id="token-31-18" morph="none" pos="word" start_char="3693">evasion</TOKEN>
<TOKEN end_char="3700" id="token-31-19" morph="none" pos="punct" start_char="3700">.</TOKEN>
</SEG>
<SEG end_char="3908" id="segment-32" start_char="3703">
<ORIGINAL_TEXT>In a recent study, it was shown that the South African variant of the virus was able to escape neutralization when tested with convalescent plasma from patients infected by the parent COVID-19 virus strain.</ORIGINAL_TEXT>
<TOKEN end_char="3704" id="token-32-0" morph="none" pos="word" start_char="3703">In</TOKEN>
<TOKEN end_char="3706" id="token-32-1" morph="none" pos="word" start_char="3706">a</TOKEN>
<TOKEN end_char="3713" id="token-32-2" morph="none" pos="word" start_char="3708">recent</TOKEN>
<TOKEN end_char="3719" id="token-32-3" morph="none" pos="word" start_char="3715">study</TOKEN>
<TOKEN end_char="3720" id="token-32-4" morph="none" pos="punct" start_char="3720">,</TOKEN>
<TOKEN end_char="3723" id="token-32-5" morph="none" pos="word" start_char="3722">it</TOKEN>
<TOKEN end_char="3727" id="token-32-6" morph="none" pos="word" start_char="3725">was</TOKEN>
<TOKEN end_char="3733" id="token-32-7" morph="none" pos="word" start_char="3729">shown</TOKEN>
<TOKEN end_char="3738" id="token-32-8" morph="none" pos="word" start_char="3735">that</TOKEN>
<TOKEN end_char="3742" id="token-32-9" morph="none" pos="word" start_char="3740">the</TOKEN>
<TOKEN end_char="3748" id="token-32-10" morph="none" pos="word" start_char="3744">South</TOKEN>
<TOKEN end_char="3756" id="token-32-11" morph="none" pos="word" start_char="3750">African</TOKEN>
<TOKEN end_char="3764" id="token-32-12" morph="none" pos="word" start_char="3758">variant</TOKEN>
<TOKEN end_char="3767" id="token-32-13" morph="none" pos="word" start_char="3766">of</TOKEN>
<TOKEN end_char="3771" id="token-32-14" morph="none" pos="word" start_char="3769">the</TOKEN>
<TOKEN end_char="3777" id="token-32-15" morph="none" pos="word" start_char="3773">virus</TOKEN>
<TOKEN end_char="3781" id="token-32-16" morph="none" pos="word" start_char="3779">was</TOKEN>
<TOKEN end_char="3786" id="token-32-17" morph="none" pos="word" start_char="3783">able</TOKEN>
<TOKEN end_char="3789" id="token-32-18" morph="none" pos="word" start_char="3788">to</TOKEN>
<TOKEN end_char="3796" id="token-32-19" morph="none" pos="word" start_char="3791">escape</TOKEN>
<TOKEN end_char="3811" id="token-32-20" morph="none" pos="word" start_char="3798">neutralization</TOKEN>
<TOKEN end_char="3816" id="token-32-21" morph="none" pos="word" start_char="3813">when</TOKEN>
<TOKEN end_char="3823" id="token-32-22" morph="none" pos="word" start_char="3818">tested</TOKEN>
<TOKEN end_char="3828" id="token-32-23" morph="none" pos="word" start_char="3825">with</TOKEN>
<TOKEN end_char="3841" id="token-32-24" morph="none" pos="word" start_char="3830">convalescent</TOKEN>
<TOKEN end_char="3848" id="token-32-25" morph="none" pos="word" start_char="3843">plasma</TOKEN>
<TOKEN end_char="3853" id="token-32-26" morph="none" pos="word" start_char="3850">from</TOKEN>
<TOKEN end_char="3862" id="token-32-27" morph="none" pos="word" start_char="3855">patients</TOKEN>
<TOKEN end_char="3871" id="token-32-28" morph="none" pos="word" start_char="3864">infected</TOKEN>
<TOKEN end_char="3874" id="token-32-29" morph="none" pos="word" start_char="3873">by</TOKEN>
<TOKEN end_char="3878" id="token-32-30" morph="none" pos="word" start_char="3876">the</TOKEN>
<TOKEN end_char="3885" id="token-32-31" morph="none" pos="word" start_char="3880">parent</TOKEN>
<TOKEN end_char="3894" id="token-32-32" morph="none" pos="unknown" start_char="3887">COVID-19</TOKEN>
<TOKEN end_char="3900" id="token-32-33" morph="none" pos="word" start_char="3896">virus</TOKEN>
<TOKEN end_char="3907" id="token-32-34" morph="none" pos="word" start_char="3902">strain</TOKEN>
<TOKEN end_char="3908" id="token-32-35" morph="none" pos="punct" start_char="3908">.</TOKEN>
</SEG>
<SEG end_char="3911" id="segment-33" start_char="3911">
<ORIGINAL_TEXT>8</ORIGINAL_TEXT>
<TOKEN end_char="3911" id="token-33-0" morph="none" pos="word" start_char="3911">8</TOKEN>
</SEG>
<SEG end_char="4144" id="segment-34" start_char="3914">
<ORIGINAL_TEXT>In yet another study performed recently by Moderna, serum from vaccinated individuals showed an ability to effectively neutralize the South African variant, but at the cost of a sixfold reduction in neutralizing antibodies in GMTs.</ORIGINAL_TEXT>
<TOKEN end_char="3915" id="token-34-0" morph="none" pos="word" start_char="3914">In</TOKEN>
<TOKEN end_char="3919" id="token-34-1" morph="none" pos="word" start_char="3917">yet</TOKEN>
<TOKEN end_char="3927" id="token-34-2" morph="none" pos="word" start_char="3921">another</TOKEN>
<TOKEN end_char="3933" id="token-34-3" morph="none" pos="word" start_char="3929">study</TOKEN>
<TOKEN end_char="3943" id="token-34-4" morph="none" pos="word" start_char="3935">performed</TOKEN>
<TOKEN end_char="3952" id="token-34-5" morph="none" pos="word" start_char="3945">recently</TOKEN>
<TOKEN end_char="3955" id="token-34-6" morph="none" pos="word" start_char="3954">by</TOKEN>
<TOKEN end_char="3963" id="token-34-7" morph="none" pos="word" start_char="3957">Moderna</TOKEN>
<TOKEN end_char="3964" id="token-34-8" morph="none" pos="punct" start_char="3964">,</TOKEN>
<TOKEN end_char="3970" id="token-34-9" morph="none" pos="word" start_char="3966">serum</TOKEN>
<TOKEN end_char="3975" id="token-34-10" morph="none" pos="word" start_char="3972">from</TOKEN>
<TOKEN end_char="3986" id="token-34-11" morph="none" pos="word" start_char="3977">vaccinated</TOKEN>
<TOKEN end_char="3998" id="token-34-12" morph="none" pos="word" start_char="3988">individuals</TOKEN>
<TOKEN end_char="4005" id="token-34-13" morph="none" pos="word" start_char="4000">showed</TOKEN>
<TOKEN end_char="4008" id="token-34-14" morph="none" pos="word" start_char="4007">an</TOKEN>
<TOKEN end_char="4016" id="token-34-15" morph="none" pos="word" start_char="4010">ability</TOKEN>
<TOKEN end_char="4019" id="token-34-16" morph="none" pos="word" start_char="4018">to</TOKEN>
<TOKEN end_char="4031" id="token-34-17" morph="none" pos="word" start_char="4021">effectively</TOKEN>
<TOKEN end_char="4042" id="token-34-18" morph="none" pos="word" start_char="4033">neutralize</TOKEN>
<TOKEN end_char="4046" id="token-34-19" morph="none" pos="word" start_char="4044">the</TOKEN>
<TOKEN end_char="4052" id="token-34-20" morph="none" pos="word" start_char="4048">South</TOKEN>
<TOKEN end_char="4060" id="token-34-21" morph="none" pos="word" start_char="4054">African</TOKEN>
<TOKEN end_char="4068" id="token-34-22" morph="none" pos="word" start_char="4062">variant</TOKEN>
<TOKEN end_char="4069" id="token-34-23" morph="none" pos="punct" start_char="4069">,</TOKEN>
<TOKEN end_char="4073" id="token-34-24" morph="none" pos="word" start_char="4071">but</TOKEN>
<TOKEN end_char="4076" id="token-34-25" morph="none" pos="word" start_char="4075">at</TOKEN>
<TOKEN end_char="4080" id="token-34-26" morph="none" pos="word" start_char="4078">the</TOKEN>
<TOKEN end_char="4085" id="token-34-27" morph="none" pos="word" start_char="4082">cost</TOKEN>
<TOKEN end_char="4088" id="token-34-28" morph="none" pos="word" start_char="4087">of</TOKEN>
<TOKEN end_char="4090" id="token-34-29" morph="none" pos="word" start_char="4090">a</TOKEN>
<TOKEN end_char="4098" id="token-34-30" morph="none" pos="word" start_char="4092">sixfold</TOKEN>
<TOKEN end_char="4108" id="token-34-31" morph="none" pos="word" start_char="4100">reduction</TOKEN>
<TOKEN end_char="4111" id="token-34-32" morph="none" pos="word" start_char="4110">in</TOKEN>
<TOKEN end_char="4124" id="token-34-33" morph="none" pos="word" start_char="4113">neutralizing</TOKEN>
<TOKEN end_char="4135" id="token-34-34" morph="none" pos="word" start_char="4126">antibodies</TOKEN>
<TOKEN end_char="4138" id="token-34-35" morph="none" pos="word" start_char="4137">in</TOKEN>
<TOKEN end_char="4143" id="token-34-36" morph="none" pos="word" start_char="4140">GMTs</TOKEN>
<TOKEN end_char="4144" id="token-34-37" morph="none" pos="punct" start_char="4144">.</TOKEN>
</SEG>
<SEG end_char="4147" id="segment-35" start_char="4147">
<ORIGINAL_TEXT>9</ORIGINAL_TEXT>
<TOKEN end_char="4147" id="token-35-0" morph="none" pos="word" start_char="4147">9</TOKEN>
</SEG>
<SEG end_char="4352" id="segment-36" start_char="4151">
<ORIGINAL_TEXT>An argument has been made that these pessimistic views regarding the variants are nothing more than in vitro outcomes and don’t cover all the bases in terms of humoral and cell-mediated immune response.</ORIGINAL_TEXT>
<TOKEN end_char="4152" id="token-36-0" morph="none" pos="word" start_char="4151">An</TOKEN>
<TOKEN end_char="4161" id="token-36-1" morph="none" pos="word" start_char="4154">argument</TOKEN>
<TOKEN end_char="4165" id="token-36-2" morph="none" pos="word" start_char="4163">has</TOKEN>
<TOKEN end_char="4170" id="token-36-3" morph="none" pos="word" start_char="4167">been</TOKEN>
<TOKEN end_char="4175" id="token-36-4" morph="none" pos="word" start_char="4172">made</TOKEN>
<TOKEN end_char="4180" id="token-36-5" morph="none" pos="word" start_char="4177">that</TOKEN>
<TOKEN end_char="4186" id="token-36-6" morph="none" pos="word" start_char="4182">these</TOKEN>
<TOKEN end_char="4198" id="token-36-7" morph="none" pos="word" start_char="4188">pessimistic</TOKEN>
<TOKEN end_char="4204" id="token-36-8" morph="none" pos="word" start_char="4200">views</TOKEN>
<TOKEN end_char="4214" id="token-36-9" morph="none" pos="word" start_char="4206">regarding</TOKEN>
<TOKEN end_char="4218" id="token-36-10" morph="none" pos="word" start_char="4216">the</TOKEN>
<TOKEN end_char="4227" id="token-36-11" morph="none" pos="word" start_char="4220">variants</TOKEN>
<TOKEN end_char="4231" id="token-36-12" morph="none" pos="word" start_char="4229">are</TOKEN>
<TOKEN end_char="4239" id="token-36-13" morph="none" pos="word" start_char="4233">nothing</TOKEN>
<TOKEN end_char="4244" id="token-36-14" morph="none" pos="word" start_char="4241">more</TOKEN>
<TOKEN end_char="4249" id="token-36-15" morph="none" pos="word" start_char="4246">than</TOKEN>
<TOKEN end_char="4252" id="token-36-16" morph="none" pos="word" start_char="4251">in</TOKEN>
<TOKEN end_char="4258" id="token-36-17" morph="none" pos="word" start_char="4254">vitro</TOKEN>
<TOKEN end_char="4267" id="token-36-18" morph="none" pos="word" start_char="4260">outcomes</TOKEN>
<TOKEN end_char="4271" id="token-36-19" morph="none" pos="word" start_char="4269">and</TOKEN>
<TOKEN end_char="4277" id="token-36-20" morph="none" pos="word" start_char="4273">don’t</TOKEN>
<TOKEN end_char="4283" id="token-36-21" morph="none" pos="word" start_char="4279">cover</TOKEN>
<TOKEN end_char="4287" id="token-36-22" morph="none" pos="word" start_char="4285">all</TOKEN>
<TOKEN end_char="4291" id="token-36-23" morph="none" pos="word" start_char="4289">the</TOKEN>
<TOKEN end_char="4297" id="token-36-24" morph="none" pos="word" start_char="4293">bases</TOKEN>
<TOKEN end_char="4300" id="token-36-25" morph="none" pos="word" start_char="4299">in</TOKEN>
<TOKEN end_char="4306" id="token-36-26" morph="none" pos="word" start_char="4302">terms</TOKEN>
<TOKEN end_char="4309" id="token-36-27" morph="none" pos="word" start_char="4308">of</TOKEN>
<TOKEN end_char="4317" id="token-36-28" morph="none" pos="word" start_char="4311">humoral</TOKEN>
<TOKEN end_char="4321" id="token-36-29" morph="none" pos="word" start_char="4319">and</TOKEN>
<TOKEN end_char="4335" id="token-36-30" morph="none" pos="unknown" start_char="4323">cell-mediated</TOKEN>
<TOKEN end_char="4342" id="token-36-31" morph="none" pos="word" start_char="4337">immune</TOKEN>
<TOKEN end_char="4351" id="token-36-32" morph="none" pos="word" start_char="4344">response</TOKEN>
<TOKEN end_char="4352" id="token-36-33" morph="none" pos="punct" start_char="4352">.</TOKEN>
</SEG>
<SEG end_char="4617" id="segment-37" start_char="4354">
<ORIGINAL_TEXT>Yet the latest results from the Novavax phase 3 trials unfortunately confirm that the variants are indeed showing evidence of immune evasion and that other elements of the immune response, such as T-cell mediation, aren’t playing the active role that we had hoped.</ORIGINAL_TEXT>
<TOKEN end_char="4356" id="token-37-0" morph="none" pos="word" start_char="4354">Yet</TOKEN>
<TOKEN end_char="4360" id="token-37-1" morph="none" pos="word" start_char="4358">the</TOKEN>
<TOKEN end_char="4367" id="token-37-2" morph="none" pos="word" start_char="4362">latest</TOKEN>
<TOKEN end_char="4375" id="token-37-3" morph="none" pos="word" start_char="4369">results</TOKEN>
<TOKEN end_char="4380" id="token-37-4" morph="none" pos="word" start_char="4377">from</TOKEN>
<TOKEN end_char="4384" id="token-37-5" morph="none" pos="word" start_char="4382">the</TOKEN>
<TOKEN end_char="4392" id="token-37-6" morph="none" pos="word" start_char="4386">Novavax</TOKEN>
<TOKEN end_char="4398" id="token-37-7" morph="none" pos="word" start_char="4394">phase</TOKEN>
<TOKEN end_char="4400" id="token-37-8" morph="none" pos="word" start_char="4400">3</TOKEN>
<TOKEN end_char="4407" id="token-37-9" morph="none" pos="word" start_char="4402">trials</TOKEN>
<TOKEN end_char="4421" id="token-37-10" morph="none" pos="word" start_char="4409">unfortunately</TOKEN>
<TOKEN end_char="4429" id="token-37-11" morph="none" pos="word" start_char="4423">confirm</TOKEN>
<TOKEN end_char="4434" id="token-37-12" morph="none" pos="word" start_char="4431">that</TOKEN>
<TOKEN end_char="4438" id="token-37-13" morph="none" pos="word" start_char="4436">the</TOKEN>
<TOKEN end_char="4447" id="token-37-14" morph="none" pos="word" start_char="4440">variants</TOKEN>
<TOKEN end_char="4451" id="token-37-15" morph="none" pos="word" start_char="4449">are</TOKEN>
<TOKEN end_char="4458" id="token-37-16" morph="none" pos="word" start_char="4453">indeed</TOKEN>
<TOKEN end_char="4466" id="token-37-17" morph="none" pos="word" start_char="4460">showing</TOKEN>
<TOKEN end_char="4475" id="token-37-18" morph="none" pos="word" start_char="4468">evidence</TOKEN>
<TOKEN end_char="4478" id="token-37-19" morph="none" pos="word" start_char="4477">of</TOKEN>
<TOKEN end_char="4485" id="token-37-20" morph="none" pos="word" start_char="4480">immune</TOKEN>
<TOKEN end_char="4493" id="token-37-21" morph="none" pos="word" start_char="4487">evasion</TOKEN>
<TOKEN end_char="4497" id="token-37-22" morph="none" pos="word" start_char="4495">and</TOKEN>
<TOKEN end_char="4502" id="token-37-23" morph="none" pos="word" start_char="4499">that</TOKEN>
<TOKEN end_char="4508" id="token-37-24" morph="none" pos="word" start_char="4504">other</TOKEN>
<TOKEN end_char="4517" id="token-37-25" morph="none" pos="word" start_char="4510">elements</TOKEN>
<TOKEN end_char="4520" id="token-37-26" morph="none" pos="word" start_char="4519">of</TOKEN>
<TOKEN end_char="4524" id="token-37-27" morph="none" pos="word" start_char="4522">the</TOKEN>
<TOKEN end_char="4531" id="token-37-28" morph="none" pos="word" start_char="4526">immune</TOKEN>
<TOKEN end_char="4540" id="token-37-29" morph="none" pos="word" start_char="4533">response</TOKEN>
<TOKEN end_char="4541" id="token-37-30" morph="none" pos="punct" start_char="4541">,</TOKEN>
<TOKEN end_char="4546" id="token-37-31" morph="none" pos="word" start_char="4543">such</TOKEN>
<TOKEN end_char="4549" id="token-37-32" morph="none" pos="word" start_char="4548">as</TOKEN>
<TOKEN end_char="4556" id="token-37-33" morph="none" pos="unknown" start_char="4551">T-cell</TOKEN>
<TOKEN end_char="4566" id="token-37-34" morph="none" pos="word" start_char="4558">mediation</TOKEN>
<TOKEN end_char="4567" id="token-37-35" morph="none" pos="punct" start_char="4567">,</TOKEN>
<TOKEN end_char="4574" id="token-37-36" morph="none" pos="word" start_char="4569">aren’t</TOKEN>
<TOKEN end_char="4582" id="token-37-37" morph="none" pos="word" start_char="4576">playing</TOKEN>
<TOKEN end_char="4586" id="token-37-38" morph="none" pos="word" start_char="4584">the</TOKEN>
<TOKEN end_char="4593" id="token-37-39" morph="none" pos="word" start_char="4588">active</TOKEN>
<TOKEN end_char="4598" id="token-37-40" morph="none" pos="word" start_char="4595">role</TOKEN>
<TOKEN end_char="4603" id="token-37-41" morph="none" pos="word" start_char="4600">that</TOKEN>
<TOKEN end_char="4606" id="token-37-42" morph="none" pos="word" start_char="4605">we</TOKEN>
<TOKEN end_char="4610" id="token-37-43" morph="none" pos="word" start_char="4608">had</TOKEN>
<TOKEN end_char="4616" id="token-37-44" morph="none" pos="word" start_char="4612">hoped</TOKEN>
<TOKEN end_char="4617" id="token-37-45" morph="none" pos="punct" start_char="4617">.</TOKEN>
</SEG>
<SEG end_char="4764" id="segment-38" start_char="4620">
<ORIGINAL_TEXT>Against the UK variant of the virus, the Novavax vaccine was showing almost 90% effectiveness, which is similar to its mRNA vaccine counterparts.</ORIGINAL_TEXT>
<TOKEN end_char="4626" id="token-38-0" morph="none" pos="word" start_char="4620">Against</TOKEN>
<TOKEN end_char="4630" id="token-38-1" morph="none" pos="word" start_char="4628">the</TOKEN>
<TOKEN end_char="4633" id="token-38-2" morph="none" pos="word" start_char="4632">UK</TOKEN>
<TOKEN end_char="4641" id="token-38-3" morph="none" pos="word" start_char="4635">variant</TOKEN>
<TOKEN end_char="4644" id="token-38-4" morph="none" pos="word" start_char="4643">of</TOKEN>
<TOKEN end_char="4648" id="token-38-5" morph="none" pos="word" start_char="4646">the</TOKEN>
<TOKEN end_char="4654" id="token-38-6" morph="none" pos="word" start_char="4650">virus</TOKEN>
<TOKEN end_char="4655" id="token-38-7" morph="none" pos="punct" start_char="4655">,</TOKEN>
<TOKEN end_char="4659" id="token-38-8" morph="none" pos="word" start_char="4657">the</TOKEN>
<TOKEN end_char="4667" id="token-38-9" morph="none" pos="word" start_char="4661">Novavax</TOKEN>
<TOKEN end_char="4675" id="token-38-10" morph="none" pos="word" start_char="4669">vaccine</TOKEN>
<TOKEN end_char="4679" id="token-38-11" morph="none" pos="word" start_char="4677">was</TOKEN>
<TOKEN end_char="4687" id="token-38-12" morph="none" pos="word" start_char="4681">showing</TOKEN>
<TOKEN end_char="4694" id="token-38-13" morph="none" pos="word" start_char="4689">almost</TOKEN>
<TOKEN end_char="4697" id="token-38-14" morph="none" pos="word" start_char="4696">90</TOKEN>
<TOKEN end_char="4698" id="token-38-15" morph="none" pos="punct" start_char="4698">%</TOKEN>
<TOKEN end_char="4712" id="token-38-16" morph="none" pos="word" start_char="4700">effectiveness</TOKEN>
<TOKEN end_char="4713" id="token-38-17" morph="none" pos="punct" start_char="4713">,</TOKEN>
<TOKEN end_char="4719" id="token-38-18" morph="none" pos="word" start_char="4715">which</TOKEN>
<TOKEN end_char="4722" id="token-38-19" morph="none" pos="word" start_char="4721">is</TOKEN>
<TOKEN end_char="4730" id="token-38-20" morph="none" pos="word" start_char="4724">similar</TOKEN>
<TOKEN end_char="4733" id="token-38-21" morph="none" pos="word" start_char="4732">to</TOKEN>
<TOKEN end_char="4737" id="token-38-22" morph="none" pos="word" start_char="4735">its</TOKEN>
<TOKEN end_char="4742" id="token-38-23" morph="none" pos="word" start_char="4739">mRNA</TOKEN>
<TOKEN end_char="4750" id="token-38-24" morph="none" pos="word" start_char="4744">vaccine</TOKEN>
<TOKEN end_char="4763" id="token-38-25" morph="none" pos="word" start_char="4752">counterparts</TOKEN>
<TOKEN end_char="4764" id="token-38-26" morph="none" pos="punct" start_char="4764">.</TOKEN>
</SEG>
<SEG end_char="4954" id="segment-39" start_char="4766">
<ORIGINAL_TEXT>However, in South Africa, where 90% of trial patients were confirmed with the South African variant, efficacy of the vaccine dropped to 60% in preventing mild, moderate, and severe disease.</ORIGINAL_TEXT>
<TOKEN end_char="4772" id="token-39-0" morph="none" pos="word" start_char="4766">However</TOKEN>
<TOKEN end_char="4773" id="token-39-1" morph="none" pos="punct" start_char="4773">,</TOKEN>
<TOKEN end_char="4776" id="token-39-2" morph="none" pos="word" start_char="4775">in</TOKEN>
<TOKEN end_char="4782" id="token-39-3" morph="none" pos="word" start_char="4778">South</TOKEN>
<TOKEN end_char="4789" id="token-39-4" morph="none" pos="word" start_char="4784">Africa</TOKEN>
<TOKEN end_char="4790" id="token-39-5" morph="none" pos="punct" start_char="4790">,</TOKEN>
<TOKEN end_char="4796" id="token-39-6" morph="none" pos="word" start_char="4792">where</TOKEN>
<TOKEN end_char="4799" id="token-39-7" morph="none" pos="word" start_char="4798">90</TOKEN>
<TOKEN end_char="4800" id="token-39-8" morph="none" pos="punct" start_char="4800">%</TOKEN>
<TOKEN end_char="4803" id="token-39-9" morph="none" pos="word" start_char="4802">of</TOKEN>
<TOKEN end_char="4809" id="token-39-10" morph="none" pos="word" start_char="4805">trial</TOKEN>
<TOKEN end_char="4818" id="token-39-11" morph="none" pos="word" start_char="4811">patients</TOKEN>
<TOKEN end_char="4823" id="token-39-12" morph="none" pos="word" start_char="4820">were</TOKEN>
<TOKEN end_char="4833" id="token-39-13" morph="none" pos="word" start_char="4825">confirmed</TOKEN>
<TOKEN end_char="4838" id="token-39-14" morph="none" pos="word" start_char="4835">with</TOKEN>
<TOKEN end_char="4842" id="token-39-15" morph="none" pos="word" start_char="4840">the</TOKEN>
<TOKEN end_char="4848" id="token-39-16" morph="none" pos="word" start_char="4844">South</TOKEN>
<TOKEN end_char="4856" id="token-39-17" morph="none" pos="word" start_char="4850">African</TOKEN>
<TOKEN end_char="4864" id="token-39-18" morph="none" pos="word" start_char="4858">variant</TOKEN>
<TOKEN end_char="4865" id="token-39-19" morph="none" pos="punct" start_char="4865">,</TOKEN>
<TOKEN end_char="4874" id="token-39-20" morph="none" pos="word" start_char="4867">efficacy</TOKEN>
<TOKEN end_char="4877" id="token-39-21" morph="none" pos="word" start_char="4876">of</TOKEN>
<TOKEN end_char="4881" id="token-39-22" morph="none" pos="word" start_char="4879">the</TOKEN>
<TOKEN end_char="4889" id="token-39-23" morph="none" pos="word" start_char="4883">vaccine</TOKEN>
<TOKEN end_char="4897" id="token-39-24" morph="none" pos="word" start_char="4891">dropped</TOKEN>
<TOKEN end_char="4900" id="token-39-25" morph="none" pos="word" start_char="4899">to</TOKEN>
<TOKEN end_char="4903" id="token-39-26" morph="none" pos="word" start_char="4902">60</TOKEN>
<TOKEN end_char="4904" id="token-39-27" morph="none" pos="punct" start_char="4904">%</TOKEN>
<TOKEN end_char="4907" id="token-39-28" morph="none" pos="word" start_char="4906">in</TOKEN>
<TOKEN end_char="4918" id="token-39-29" morph="none" pos="word" start_char="4909">preventing</TOKEN>
<TOKEN end_char="4923" id="token-39-30" morph="none" pos="word" start_char="4920">mild</TOKEN>
<TOKEN end_char="4924" id="token-39-31" morph="none" pos="punct" start_char="4924">,</TOKEN>
<TOKEN end_char="4933" id="token-39-32" morph="none" pos="word" start_char="4926">moderate</TOKEN>
<TOKEN end_char="4934" id="token-39-33" morph="none" pos="punct" start_char="4934">,</TOKEN>
<TOKEN end_char="4938" id="token-39-34" morph="none" pos="word" start_char="4936">and</TOKEN>
<TOKEN end_char="4945" id="token-39-35" morph="none" pos="word" start_char="4940">severe</TOKEN>
<TOKEN end_char="4953" id="token-39-36" morph="none" pos="word" start_char="4947">disease</TOKEN>
<TOKEN end_char="4954" id="token-39-37" morph="none" pos="punct" start_char="4954">.</TOKEN>
</SEG>
<SEG end_char="4958" id="segment-40" start_char="4957">
<ORIGINAL_TEXT>10</ORIGINAL_TEXT>
<TOKEN end_char="4958" id="token-40-0" morph="none" pos="word" start_char="4957">10</TOKEN>
</SEG>
<SEG end_char="5237" id="segment-41" start_char="4961">
<ORIGINAL_TEXT>As the Novavax vaccine also targets the spike protein and has similar rates of effectiveness against the parent wild-type and UK strains, it is reasonable to assume that the mRNA vaccines would be similarly less effective at preventing disease against the South African strain.</ORIGINAL_TEXT>
<TOKEN end_char="4962" id="token-41-0" morph="none" pos="word" start_char="4961">As</TOKEN>
<TOKEN end_char="4966" id="token-41-1" morph="none" pos="word" start_char="4964">the</TOKEN>
<TOKEN end_char="4974" id="token-41-2" morph="none" pos="word" start_char="4968">Novavax</TOKEN>
<TOKEN end_char="4982" id="token-41-3" morph="none" pos="word" start_char="4976">vaccine</TOKEN>
<TOKEN end_char="4987" id="token-41-4" morph="none" pos="word" start_char="4984">also</TOKEN>
<TOKEN end_char="4995" id="token-41-5" morph="none" pos="word" start_char="4989">targets</TOKEN>
<TOKEN end_char="4999" id="token-41-6" morph="none" pos="word" start_char="4997">the</TOKEN>
<TOKEN end_char="5005" id="token-41-7" morph="none" pos="word" start_char="5001">spike</TOKEN>
<TOKEN end_char="5013" id="token-41-8" morph="none" pos="word" start_char="5007">protein</TOKEN>
<TOKEN end_char="5017" id="token-41-9" morph="none" pos="word" start_char="5015">and</TOKEN>
<TOKEN end_char="5021" id="token-41-10" morph="none" pos="word" start_char="5019">has</TOKEN>
<TOKEN end_char="5029" id="token-41-11" morph="none" pos="word" start_char="5023">similar</TOKEN>
<TOKEN end_char="5035" id="token-41-12" morph="none" pos="word" start_char="5031">rates</TOKEN>
<TOKEN end_char="5038" id="token-41-13" morph="none" pos="word" start_char="5037">of</TOKEN>
<TOKEN end_char="5052" id="token-41-14" morph="none" pos="word" start_char="5040">effectiveness</TOKEN>
<TOKEN end_char="5060" id="token-41-15" morph="none" pos="word" start_char="5054">against</TOKEN>
<TOKEN end_char="5064" id="token-41-16" morph="none" pos="word" start_char="5062">the</TOKEN>
<TOKEN end_char="5071" id="token-41-17" morph="none" pos="word" start_char="5066">parent</TOKEN>
<TOKEN end_char="5081" id="token-41-18" morph="none" pos="unknown" start_char="5073">wild-type</TOKEN>
<TOKEN end_char="5085" id="token-41-19" morph="none" pos="word" start_char="5083">and</TOKEN>
<TOKEN end_char="5088" id="token-41-20" morph="none" pos="word" start_char="5087">UK</TOKEN>
<TOKEN end_char="5096" id="token-41-21" morph="none" pos="word" start_char="5090">strains</TOKEN>
<TOKEN end_char="5097" id="token-41-22" morph="none" pos="punct" start_char="5097">,</TOKEN>
<TOKEN end_char="5100" id="token-41-23" morph="none" pos="word" start_char="5099">it</TOKEN>
<TOKEN end_char="5103" id="token-41-24" morph="none" pos="word" start_char="5102">is</TOKEN>
<TOKEN end_char="5114" id="token-41-25" morph="none" pos="word" start_char="5105">reasonable</TOKEN>
<TOKEN end_char="5117" id="token-41-26" morph="none" pos="word" start_char="5116">to</TOKEN>
<TOKEN end_char="5124" id="token-41-27" morph="none" pos="word" start_char="5119">assume</TOKEN>
<TOKEN end_char="5129" id="token-41-28" morph="none" pos="word" start_char="5126">that</TOKEN>
<TOKEN end_char="5133" id="token-41-29" morph="none" pos="word" start_char="5131">the</TOKEN>
<TOKEN end_char="5138" id="token-41-30" morph="none" pos="word" start_char="5135">mRNA</TOKEN>
<TOKEN end_char="5147" id="token-41-31" morph="none" pos="word" start_char="5140">vaccines</TOKEN>
<TOKEN end_char="5153" id="token-41-32" morph="none" pos="word" start_char="5149">would</TOKEN>
<TOKEN end_char="5156" id="token-41-33" morph="none" pos="word" start_char="5155">be</TOKEN>
<TOKEN end_char="5166" id="token-41-34" morph="none" pos="word" start_char="5158">similarly</TOKEN>
<TOKEN end_char="5171" id="token-41-35" morph="none" pos="word" start_char="5168">less</TOKEN>
<TOKEN end_char="5181" id="token-41-36" morph="none" pos="word" start_char="5173">effective</TOKEN>
<TOKEN end_char="5184" id="token-41-37" morph="none" pos="word" start_char="5183">at</TOKEN>
<TOKEN end_char="5195" id="token-41-38" morph="none" pos="word" start_char="5186">preventing</TOKEN>
<TOKEN end_char="5203" id="token-41-39" morph="none" pos="word" start_char="5197">disease</TOKEN>
<TOKEN end_char="5211" id="token-41-40" morph="none" pos="word" start_char="5205">against</TOKEN>
<TOKEN end_char="5215" id="token-41-41" morph="none" pos="word" start_char="5213">the</TOKEN>
<TOKEN end_char="5221" id="token-41-42" morph="none" pos="word" start_char="5217">South</TOKEN>
<TOKEN end_char="5229" id="token-41-43" morph="none" pos="word" start_char="5223">African</TOKEN>
<TOKEN end_char="5236" id="token-41-44" morph="none" pos="word" start_char="5231">strain</TOKEN>
<TOKEN end_char="5237" id="token-41-45" morph="none" pos="punct" start_char="5237">.</TOKEN>
</SEG>
<SEG end_char="5339" id="segment-42" start_char="5240">
<ORIGINAL_TEXT>Moderna and Novavax have stated they are formulating a new vaccine booster targeting these variants.</ORIGINAL_TEXT>
<TOKEN end_char="5246" id="token-42-0" morph="none" pos="word" start_char="5240">Moderna</TOKEN>
<TOKEN end_char="5250" id="token-42-1" morph="none" pos="word" start_char="5248">and</TOKEN>
<TOKEN end_char="5258" id="token-42-2" morph="none" pos="word" start_char="5252">Novavax</TOKEN>
<TOKEN end_char="5263" id="token-42-3" morph="none" pos="word" start_char="5260">have</TOKEN>
<TOKEN end_char="5270" id="token-42-4" morph="none" pos="word" start_char="5265">stated</TOKEN>
<TOKEN end_char="5275" id="token-42-5" morph="none" pos="word" start_char="5272">they</TOKEN>
<TOKEN end_char="5279" id="token-42-6" morph="none" pos="word" start_char="5277">are</TOKEN>
<TOKEN end_char="5291" id="token-42-7" morph="none" pos="word" start_char="5281">formulating</TOKEN>
<TOKEN end_char="5293" id="token-42-8" morph="none" pos="word" start_char="5293">a</TOKEN>
<TOKEN end_char="5297" id="token-42-9" morph="none" pos="word" start_char="5295">new</TOKEN>
<TOKEN end_char="5305" id="token-42-10" morph="none" pos="word" start_char="5299">vaccine</TOKEN>
<TOKEN end_char="5313" id="token-42-11" morph="none" pos="word" start_char="5307">booster</TOKEN>
<TOKEN end_char="5323" id="token-42-12" morph="none" pos="word" start_char="5315">targeting</TOKEN>
<TOKEN end_char="5329" id="token-42-13" morph="none" pos="word" start_char="5325">these</TOKEN>
<TOKEN end_char="5338" id="token-42-14" morph="none" pos="word" start_char="5331">variants</TOKEN>
<TOKEN end_char="5339" id="token-42-15" morph="none" pos="punct" start_char="5339">.</TOKEN>
</SEG>
<SEG end_char="5484" id="segment-43" start_char="5341">
<ORIGINAL_TEXT>Paradoxically, the selective pressures of the vaccine may accelerate the emergence of further variants that could result in total immune escape.</ORIGINAL_TEXT>
<TOKEN end_char="5353" id="token-43-0" morph="none" pos="word" start_char="5341">Paradoxically</TOKEN>
<TOKEN end_char="5354" id="token-43-1" morph="none" pos="punct" start_char="5354">,</TOKEN>
<TOKEN end_char="5358" id="token-43-2" morph="none" pos="word" start_char="5356">the</TOKEN>
<TOKEN end_char="5368" id="token-43-3" morph="none" pos="word" start_char="5360">selective</TOKEN>
<TOKEN end_char="5378" id="token-43-4" morph="none" pos="word" start_char="5370">pressures</TOKEN>
<TOKEN end_char="5381" id="token-43-5" morph="none" pos="word" start_char="5380">of</TOKEN>
<TOKEN end_char="5385" id="token-43-6" morph="none" pos="word" start_char="5383">the</TOKEN>
<TOKEN end_char="5393" id="token-43-7" morph="none" pos="word" start_char="5387">vaccine</TOKEN>
<TOKEN end_char="5397" id="token-43-8" morph="none" pos="word" start_char="5395">may</TOKEN>
<TOKEN end_char="5408" id="token-43-9" morph="none" pos="word" start_char="5399">accelerate</TOKEN>
<TOKEN end_char="5412" id="token-43-10" morph="none" pos="word" start_char="5410">the</TOKEN>
<TOKEN end_char="5422" id="token-43-11" morph="none" pos="word" start_char="5414">emergence</TOKEN>
<TOKEN end_char="5425" id="token-43-12" morph="none" pos="word" start_char="5424">of</TOKEN>
<TOKEN end_char="5433" id="token-43-13" morph="none" pos="word" start_char="5427">further</TOKEN>
<TOKEN end_char="5442" id="token-43-14" morph="none" pos="word" start_char="5435">variants</TOKEN>
<TOKEN end_char="5447" id="token-43-15" morph="none" pos="word" start_char="5444">that</TOKEN>
<TOKEN end_char="5453" id="token-43-16" morph="none" pos="word" start_char="5449">could</TOKEN>
<TOKEN end_char="5460" id="token-43-17" morph="none" pos="word" start_char="5455">result</TOKEN>
<TOKEN end_char="5463" id="token-43-18" morph="none" pos="word" start_char="5462">in</TOKEN>
<TOKEN end_char="5469" id="token-43-19" morph="none" pos="word" start_char="5465">total</TOKEN>
<TOKEN end_char="5476" id="token-43-20" morph="none" pos="word" start_char="5471">immune</TOKEN>
<TOKEN end_char="5483" id="token-43-21" morph="none" pos="word" start_char="5478">escape</TOKEN>
<TOKEN end_char="5484" id="token-43-22" morph="none" pos="punct" start_char="5484">.</TOKEN>
</SEG>
<SEG end_char="5488" id="segment-44" start_char="5487">
<ORIGINAL_TEXT>11</ORIGINAL_TEXT>
<TOKEN end_char="5488" id="token-44-0" morph="none" pos="word" start_char="5487">11</TOKEN>
</SEG>
<SEG end_char="5631" id="segment-45" start_char="5491">
<ORIGINAL_TEXT>Masking and social distancing remain effective strategies to reduce viral transmission in light of uncertainties about vaccine effectiveness.</ORIGINAL_TEXT>
<TOKEN end_char="5497" id="token-45-0" morph="none" pos="word" start_char="5491">Masking</TOKEN>
<TOKEN end_char="5501" id="token-45-1" morph="none" pos="word" start_char="5499">and</TOKEN>
<TOKEN end_char="5508" id="token-45-2" morph="none" pos="word" start_char="5503">social</TOKEN>
<TOKEN end_char="5519" id="token-45-3" morph="none" pos="word" start_char="5510">distancing</TOKEN>
<TOKEN end_char="5526" id="token-45-4" morph="none" pos="word" start_char="5521">remain</TOKEN>
<TOKEN end_char="5536" id="token-45-5" morph="none" pos="word" start_char="5528">effective</TOKEN>
<TOKEN end_char="5547" id="token-45-6" morph="none" pos="word" start_char="5538">strategies</TOKEN>
<TOKEN end_char="5550" id="token-45-7" morph="none" pos="word" start_char="5549">to</TOKEN>
<TOKEN end_char="5557" id="token-45-8" morph="none" pos="word" start_char="5552">reduce</TOKEN>
<TOKEN end_char="5563" id="token-45-9" morph="none" pos="word" start_char="5559">viral</TOKEN>
<TOKEN end_char="5576" id="token-45-10" morph="none" pos="word" start_char="5565">transmission</TOKEN>
<TOKEN end_char="5579" id="token-45-11" morph="none" pos="word" start_char="5578">in</TOKEN>
<TOKEN end_char="5585" id="token-45-12" morph="none" pos="word" start_char="5581">light</TOKEN>
<TOKEN end_char="5588" id="token-45-13" morph="none" pos="word" start_char="5587">of</TOKEN>
<TOKEN end_char="5602" id="token-45-14" morph="none" pos="word" start_char="5590">uncertainties</TOKEN>
<TOKEN end_char="5608" id="token-45-15" morph="none" pos="word" start_char="5604">about</TOKEN>
<TOKEN end_char="5616" id="token-45-16" morph="none" pos="word" start_char="5610">vaccine</TOKEN>
<TOKEN end_char="5630" id="token-45-17" morph="none" pos="word" start_char="5618">effectiveness</TOKEN>
<TOKEN end_char="5631" id="token-45-18" morph="none" pos="punct" start_char="5631">.</TOKEN>
</SEG>
<SEG end_char="5635" id="segment-46" start_char="5634">
<ORIGINAL_TEXT>12</ORIGINAL_TEXT>
<TOKEN end_char="5635" id="token-46-0" morph="none" pos="word" start_char="5634">12</TOKEN>
</SEG>
<SEG end_char="5651" id="segment-47" start_char="5639">
<ORIGINAL_TEXT>To summarize:</ORIGINAL_TEXT>
<TOKEN end_char="5640" id="token-47-0" morph="none" pos="word" start_char="5639">To</TOKEN>
<TOKEN end_char="5650" id="token-47-1" morph="none" pos="word" start_char="5642">summarize</TOKEN>
<TOKEN end_char="5651" id="token-47-2" morph="none" pos="punct" start_char="5651">:</TOKEN>
<TRANSLATED_TEXT>Samenvattend:</TRANSLATED_TEXT><DETECTED_LANGUAGE>it</DETECTED_LANGUAGE></SEG>
<SEG end_char="5801" id="segment-48" start_char="5654">
<ORIGINAL_TEXT>Vaccines are currently displaying evidence of greater antibody production in comparison to convalescent serum from patients with previous infection.</ORIGINAL_TEXT>
<TOKEN end_char="5661" id="token-48-0" morph="none" pos="word" start_char="5654">Vaccines</TOKEN>
<TOKEN end_char="5665" id="token-48-1" morph="none" pos="word" start_char="5663">are</TOKEN>
<TOKEN end_char="5675" id="token-48-2" morph="none" pos="word" start_char="5667">currently</TOKEN>
<TOKEN end_char="5686" id="token-48-3" morph="none" pos="word" start_char="5677">displaying</TOKEN>
<TOKEN end_char="5695" id="token-48-4" morph="none" pos="word" start_char="5688">evidence</TOKEN>
<TOKEN end_char="5698" id="token-48-5" morph="none" pos="word" start_char="5697">of</TOKEN>
<TOKEN end_char="5706" id="token-48-6" morph="none" pos="word" start_char="5700">greater</TOKEN>
<TOKEN end_char="5715" id="token-48-7" morph="none" pos="word" start_char="5708">antibody</TOKEN>
<TOKEN end_char="5726" id="token-48-8" morph="none" pos="word" start_char="5717">production</TOKEN>
<TOKEN end_char="5729" id="token-48-9" morph="none" pos="word" start_char="5728">in</TOKEN>
<TOKEN end_char="5740" id="token-48-10" morph="none" pos="word" start_char="5731">comparison</TOKEN>
<TOKEN end_char="5743" id="token-48-11" morph="none" pos="word" start_char="5742">to</TOKEN>
<TOKEN end_char="5756" id="token-48-12" morph="none" pos="word" start_char="5745">convalescent</TOKEN>
<TOKEN end_char="5762" id="token-48-13" morph="none" pos="word" start_char="5758">serum</TOKEN>
<TOKEN end_char="5767" id="token-48-14" morph="none" pos="word" start_char="5764">from</TOKEN>
<TOKEN end_char="5776" id="token-48-15" morph="none" pos="word" start_char="5769">patients</TOKEN>
<TOKEN end_char="5781" id="token-48-16" morph="none" pos="word" start_char="5778">with</TOKEN>
<TOKEN end_char="5790" id="token-48-17" morph="none" pos="word" start_char="5783">previous</TOKEN>
<TOKEN end_char="5800" id="token-48-18" morph="none" pos="word" start_char="5792">infection</TOKEN>
<TOKEN end_char="5801" id="token-48-19" morph="none" pos="punct" start_char="5801">.</TOKEN>
</SEG>
<SEG end_char="5896" id="segment-49" start_char="5804">
<ORIGINAL_TEXT>Patients previously exposed to COVID-19 may experience even greater benefit from vaccination.</ORIGINAL_TEXT>
<TOKEN end_char="5811" id="token-49-0" morph="none" pos="word" start_char="5804">Patients</TOKEN>
<TOKEN end_char="5822" id="token-49-1" morph="none" pos="word" start_char="5813">previously</TOKEN>
<TOKEN end_char="5830" id="token-49-2" morph="none" pos="word" start_char="5824">exposed</TOKEN>
<TOKEN end_char="5833" id="token-49-3" morph="none" pos="word" start_char="5832">to</TOKEN>
<TOKEN end_char="5842" id="token-49-4" morph="none" pos="unknown" start_char="5835">COVID-19</TOKEN>
<TOKEN end_char="5846" id="token-49-5" morph="none" pos="word" start_char="5844">may</TOKEN>
<TOKEN end_char="5857" id="token-49-6" morph="none" pos="word" start_char="5848">experience</TOKEN>
<TOKEN end_char="5862" id="token-49-7" morph="none" pos="word" start_char="5859">even</TOKEN>
<TOKEN end_char="5870" id="token-49-8" morph="none" pos="word" start_char="5864">greater</TOKEN>
<TOKEN end_char="5878" id="token-49-9" morph="none" pos="word" start_char="5872">benefit</TOKEN>
<TOKEN end_char="5883" id="token-49-10" morph="none" pos="word" start_char="5880">from</TOKEN>
<TOKEN end_char="5895" id="token-49-11" morph="none" pos="word" start_char="5885">vaccination</TOKEN>
<TOKEN end_char="5896" id="token-49-12" morph="none" pos="punct" start_char="5896">.</TOKEN>
</SEG>
<SEG end_char="6012" id="segment-50" start_char="5899">
<ORIGINAL_TEXT>Some mutant variants are showing an ability to evade neutralization in convalescent plasma from wild-type strains.</ORIGINAL_TEXT>
<TOKEN end_char="5902" id="token-50-0" morph="none" pos="word" start_char="5899">Some</TOKEN>
<TOKEN end_char="5909" id="token-50-1" morph="none" pos="word" start_char="5904">mutant</TOKEN>
<TOKEN end_char="5918" id="token-50-2" morph="none" pos="word" start_char="5911">variants</TOKEN>
<TOKEN end_char="5922" id="token-50-3" morph="none" pos="word" start_char="5920">are</TOKEN>
<TOKEN end_char="5930" id="token-50-4" morph="none" pos="word" start_char="5924">showing</TOKEN>
<TOKEN end_char="5933" id="token-50-5" morph="none" pos="word" start_char="5932">an</TOKEN>
<TOKEN end_char="5941" id="token-50-6" morph="none" pos="word" start_char="5935">ability</TOKEN>
<TOKEN end_char="5944" id="token-50-7" morph="none" pos="word" start_char="5943">to</TOKEN>
<TOKEN end_char="5950" id="token-50-8" morph="none" pos="word" start_char="5946">evade</TOKEN>
<TOKEN end_char="5965" id="token-50-9" morph="none" pos="word" start_char="5952">neutralization</TOKEN>
<TOKEN end_char="5968" id="token-50-10" morph="none" pos="word" start_char="5967">in</TOKEN>
<TOKEN end_char="5981" id="token-50-11" morph="none" pos="word" start_char="5970">convalescent</TOKEN>
<TOKEN end_char="5988" id="token-50-12" morph="none" pos="word" start_char="5983">plasma</TOKEN>
<TOKEN end_char="5993" id="token-50-13" morph="none" pos="word" start_char="5990">from</TOKEN>
<TOKEN end_char="6003" id="token-50-14" morph="none" pos="unknown" start_char="5995">wild-type</TOKEN>
<TOKEN end_char="6011" id="token-50-15" morph="none" pos="word" start_char="6005">strains</TOKEN>
<TOKEN end_char="6012" id="token-50-16" morph="none" pos="punct" start_char="6012">.</TOKEN>
</SEG>
<SEG end_char="6119" id="segment-51" start_char="6014">
<ORIGINAL_TEXT>Vaccines, though less effective against many variants, still currently exhibit evidence of neutralization.</ORIGINAL_TEXT>
<TOKEN end_char="6021" id="token-51-0" morph="none" pos="word" start_char="6014">Vaccines</TOKEN>
<TOKEN end_char="6022" id="token-51-1" morph="none" pos="punct" start_char="6022">,</TOKEN>
<TOKEN end_char="6029" id="token-51-2" morph="none" pos="word" start_char="6024">though</TOKEN>
<TOKEN end_char="6034" id="token-51-3" morph="none" pos="word" start_char="6031">less</TOKEN>
<TOKEN end_char="6044" id="token-51-4" morph="none" pos="word" start_char="6036">effective</TOKEN>
<TOKEN end_char="6052" id="token-51-5" morph="none" pos="word" start_char="6046">against</TOKEN>
<TOKEN end_char="6057" id="token-51-6" morph="none" pos="word" start_char="6054">many</TOKEN>
<TOKEN end_char="6066" id="token-51-7" morph="none" pos="word" start_char="6059">variants</TOKEN>
<TOKEN end_char="6067" id="token-51-8" morph="none" pos="punct" start_char="6067">,</TOKEN>
<TOKEN end_char="6073" id="token-51-9" morph="none" pos="word" start_char="6069">still</TOKEN>
<TOKEN end_char="6083" id="token-51-10" morph="none" pos="word" start_char="6075">currently</TOKEN>
<TOKEN end_char="6091" id="token-51-11" morph="none" pos="word" start_char="6085">exhibit</TOKEN>
<TOKEN end_char="6100" id="token-51-12" morph="none" pos="word" start_char="6093">evidence</TOKEN>
<TOKEN end_char="6103" id="token-51-13" morph="none" pos="word" start_char="6102">of</TOKEN>
<TOKEN end_char="6118" id="token-51-14" morph="none" pos="word" start_char="6105">neutralization</TOKEN>
<TOKEN end_char="6119" id="token-51-15" morph="none" pos="punct" start_char="6119">.</TOKEN>
</SEG>
<SEG end_char="6224" id="segment-52" start_char="6121">
<ORIGINAL_TEXT>Modified versions of the vaccine will likely be needed to address mutations that enhance immune evasion.</ORIGINAL_TEXT>
<TOKEN end_char="6128" id="token-52-0" morph="none" pos="word" start_char="6121">Modified</TOKEN>
<TOKEN end_char="6137" id="token-52-1" morph="none" pos="word" start_char="6130">versions</TOKEN>
<TOKEN end_char="6140" id="token-52-2" morph="none" pos="word" start_char="6139">of</TOKEN>
<TOKEN end_char="6144" id="token-52-3" morph="none" pos="word" start_char="6142">the</TOKEN>
<TOKEN end_char="6152" id="token-52-4" morph="none" pos="word" start_char="6146">vaccine</TOKEN>
<TOKEN end_char="6157" id="token-52-5" morph="none" pos="word" start_char="6154">will</TOKEN>
<TOKEN end_char="6164" id="token-52-6" morph="none" pos="word" start_char="6159">likely</TOKEN>
<TOKEN end_char="6167" id="token-52-7" morph="none" pos="word" start_char="6166">be</TOKEN>
<TOKEN end_char="6174" id="token-52-8" morph="none" pos="word" start_char="6169">needed</TOKEN>
<TOKEN end_char="6177" id="token-52-9" morph="none" pos="word" start_char="6176">to</TOKEN>
<TOKEN end_char="6185" id="token-52-10" morph="none" pos="word" start_char="6179">address</TOKEN>
<TOKEN end_char="6195" id="token-52-11" morph="none" pos="word" start_char="6187">mutations</TOKEN>
<TOKEN end_char="6200" id="token-52-12" morph="none" pos="word" start_char="6197">that</TOKEN>
<TOKEN end_char="6208" id="token-52-13" morph="none" pos="word" start_char="6202">enhance</TOKEN>
<TOKEN end_char="6215" id="token-52-14" morph="none" pos="word" start_char="6210">immune</TOKEN>
<TOKEN end_char="6223" id="token-52-15" morph="none" pos="word" start_char="6217">evasion</TOKEN>
<TOKEN end_char="6224" id="token-52-16" morph="none" pos="punct" start_char="6224">.</TOKEN>
</SEG>
<SEG end_char="6243" id="segment-53" start_char="6228">
<ORIGINAL_TEXT>Related articles</ORIGINAL_TEXT>
<TOKEN end_char="6234" id="token-53-0" morph="none" pos="word" start_char="6228">Related</TOKEN>
<TOKEN end_char="6243" id="token-53-1" morph="none" pos="word" start_char="6236">articles</TOKEN>
</SEG>
<SEG end_char="6295" id="segment-54" start_char="6246">
<ORIGINAL_TEXT>Editor’s note: This article originally appeared in</ORIGINAL_TEXT>
<TOKEN end_char="6253" id="token-54-0" morph="none" pos="word" start_char="6246">Editor’s</TOKEN>
<TOKEN end_char="6258" id="token-54-1" morph="none" pos="word" start_char="6255">note</TOKEN>
<TOKEN end_char="6259" id="token-54-2" morph="none" pos="punct" start_char="6259">:</TOKEN>
<TOKEN end_char="6264" id="token-54-3" morph="none" pos="word" start_char="6261">This</TOKEN>
<TOKEN end_char="6272" id="token-54-4" morph="none" pos="word" start_char="6266">article</TOKEN>
<TOKEN end_char="6283" id="token-54-5" morph="none" pos="word" start_char="6274">originally</TOKEN>
<TOKEN end_char="6292" id="token-54-6" morph="none" pos="word" start_char="6285">appeared</TOKEN>
<TOKEN end_char="6295" id="token-54-7" morph="none" pos="word" start_char="6294">in</TOKEN>
</SEG>
<SEG end_char="6319" id="segment-55" start_char="6298">
<ORIGINAL_TEXT>Perio-Implant Advisory</ORIGINAL_TEXT>
<TOKEN end_char="6310" id="token-55-0" morph="none" pos="unknown" start_char="6298">Perio-Implant</TOKEN>
<TOKEN end_char="6319" id="token-55-1" morph="none" pos="word" start_char="6312">Advisory</TOKEN>
</SEG>
<SEG end_char="6428" id="segment-56" start_char="6322">
<ORIGINAL_TEXT>, a chairside resource for dentists and hygienists that focuses on periodontal- and implant-related issues.</ORIGINAL_TEXT>
<TOKEN end_char="6322" id="token-56-0" morph="none" pos="punct" start_char="6322">,</TOKEN>
<TOKEN end_char="6324" id="token-56-1" morph="none" pos="word" start_char="6324">a</TOKEN>
<TOKEN end_char="6334" id="token-56-2" morph="none" pos="word" start_char="6326">chairside</TOKEN>
<TOKEN end_char="6343" id="token-56-3" morph="none" pos="word" start_char="6336">resource</TOKEN>
<TOKEN end_char="6347" id="token-56-4" morph="none" pos="word" start_char="6345">for</TOKEN>
<TOKEN end_char="6356" id="token-56-5" morph="none" pos="word" start_char="6349">dentists</TOKEN>
<TOKEN end_char="6360" id="token-56-6" morph="none" pos="word" start_char="6358">and</TOKEN>
<TOKEN end_char="6371" id="token-56-7" morph="none" pos="word" start_char="6362">hygienists</TOKEN>
<TOKEN end_char="6376" id="token-56-8" morph="none" pos="word" start_char="6373">that</TOKEN>
<TOKEN end_char="6384" id="token-56-9" morph="none" pos="word" start_char="6378">focuses</TOKEN>
<TOKEN end_char="6387" id="token-56-10" morph="none" pos="word" start_char="6386">on</TOKEN>
<TOKEN end_char="6399" id="token-56-11" morph="none" pos="word" start_char="6389">periodontal</TOKEN>
<TOKEN end_char="6400" id="token-56-12" morph="none" pos="punct" start_char="6400">-</TOKEN>
<TOKEN end_char="6404" id="token-56-13" morph="none" pos="word" start_char="6402">and</TOKEN>
<TOKEN end_char="6420" id="token-56-14" morph="none" pos="unknown" start_char="6406">implant-related</TOKEN>
<TOKEN end_char="6427" id="token-56-15" morph="none" pos="word" start_char="6422">issues</TOKEN>
<TOKEN end_char="6428" id="token-56-16" morph="none" pos="punct" start_char="6428">.</TOKEN>
</SEG>
<SEG end_char="6452" id="segment-57" start_char="6431">
<ORIGINAL_TEXT>Perio-Implant Advisory</ORIGINAL_TEXT>
<TOKEN end_char="6443" id="token-57-0" morph="none" pos="unknown" start_char="6431">Perio-Implant</TOKEN>
<TOKEN end_char="6452" id="token-57-1" morph="none" pos="word" start_char="6445">Advisory</TOKEN>
</SEG>
<SEG end_char="6468" id="segment-58" start_char="6455">
<ORIGINAL_TEXT>is part of the</ORIGINAL_TEXT>
<TOKEN end_char="6456" id="token-58-0" morph="none" pos="word" start_char="6455">is</TOKEN>
<TOKEN end_char="6461" id="token-58-1" morph="none" pos="word" start_char="6458">part</TOKEN>
<TOKEN end_char="6464" id="token-58-2" morph="none" pos="word" start_char="6463">of</TOKEN>
<TOKEN end_char="6468" id="token-58-3" morph="none" pos="word" start_char="6466">the</TOKEN>
</SEG>
<SEG end_char="6486" id="segment-59" start_char="6471">
<ORIGINAL_TEXT>Dental Economics</ORIGINAL_TEXT>
<TOKEN end_char="6476" id="token-59-0" morph="none" pos="word" start_char="6471">Dental</TOKEN>
<TOKEN end_char="6486" id="token-59-1" morph="none" pos="word" start_char="6478">Economics</TOKEN>
<TRANSLATED_TEXT>Dentalekonomi</TRANSLATED_TEXT><DETECTED_LANGUAGE>ca</DETECTED_LANGUAGE></SEG>
<SEG end_char="6491" id="segment-60" start_char="6489">
<ORIGINAL_TEXT>and</ORIGINAL_TEXT>
<TOKEN end_char="6491" id="token-60-0" morph="none" pos="word" start_char="6489">and</TOKEN>
</SEG>
<SEG end_char="6504" id="segment-61" start_char="6494">
<ORIGINAL_TEXT>DentistryIQ</ORIGINAL_TEXT>
<TOKEN end_char="6504" id="token-61-0" morph="none" pos="word" start_char="6494">DentistryIQ</TOKEN>
<TRANSLATED_TEXT>Dentistry</TRANSLATED_TEXT><DETECTED_LANGUAGE>no</DETECTED_LANGUAGE></SEG>
<SEG end_char="6514" id="segment-62" start_char="6507">
<ORIGINAL_TEXT>network.</ORIGINAL_TEXT>
<TOKEN end_char="6513" id="token-62-0" morph="none" pos="word" start_char="6507">network</TOKEN>
<TOKEN end_char="6514" id="token-62-1" morph="none" pos="punct" start_char="6514">.</TOKEN>
<TRANSLATED_TEXT>rete.</TRANSLATED_TEXT><DETECTED_LANGUAGE>af</DETECTED_LANGUAGE></SEG>
<SEG end_char="6596" id="segment-63" start_char="6516">
<ORIGINAL_TEXT>To read more articles, visit perioimplantadvisory.com and subscribe at this link.</ORIGINAL_TEXT>
<TOKEN end_char="6517" id="token-63-0" morph="none" pos="word" start_char="6516">To</TOKEN>
<TOKEN end_char="6522" id="token-63-1" morph="none" pos="word" start_char="6519">read</TOKEN>
<TOKEN end_char="6527" id="token-63-2" morph="none" pos="word" start_char="6524">more</TOKEN>
<TOKEN end_char="6536" id="token-63-3" morph="none" pos="word" start_char="6529">articles</TOKEN>
<TOKEN end_char="6537" id="token-63-4" morph="none" pos="punct" start_char="6537">,</TOKEN>
<TOKEN end_char="6543" id="token-63-5" morph="none" pos="word" start_char="6539">visit</TOKEN>
<TOKEN end_char="6568" id="token-63-6" morph="none" pos="unknown" start_char="6545">perioimplantadvisory.com</TOKEN>
<TOKEN end_char="6572" id="token-63-7" morph="none" pos="word" start_char="6570">and</TOKEN>
<TOKEN end_char="6582" id="token-63-8" morph="none" pos="word" start_char="6574">subscribe</TOKEN>
<TOKEN end_char="6585" id="token-63-9" morph="none" pos="word" start_char="6584">at</TOKEN>
<TOKEN end_char="6590" id="token-63-10" morph="none" pos="word" start_char="6587">this</TOKEN>
<TOKEN end_char="6595" id="token-63-11" morph="none" pos="word" start_char="6592">link</TOKEN>
<TOKEN end_char="6596" id="token-63-12" morph="none" pos="punct" start_char="6596">.</TOKEN>
</SEG>
<SEG end_char="6608" id="segment-64" start_char="6599">
<ORIGINAL_TEXT>References</ORIGINAL_TEXT>
<TOKEN end_char="6608" id="token-64-0" morph="none" pos="word" start_char="6599">References</TOKEN>
</SEG>
<SEG end_char="6658" id="segment-65" start_char="6611">
<ORIGINAL_TEXT>Ibarrondo FJ, Fulcher JA, Goodman-Meza D, et al.</ORIGINAL_TEXT>
<TOKEN end_char="6619" id="token-65-0" morph="none" pos="word" start_char="6611">Ibarrondo</TOKEN>
<TOKEN end_char="6622" id="token-65-1" morph="none" pos="word" start_char="6621">FJ</TOKEN>
<TOKEN end_char="6623" id="token-65-2" morph="none" pos="punct" start_char="6623">,</TOKEN>
<TOKEN end_char="6631" id="token-65-3" morph="none" pos="word" start_char="6625">Fulcher</TOKEN>
<TOKEN end_char="6634" id="token-65-4" morph="none" pos="word" start_char="6633">JA</TOKEN>
<TOKEN end_char="6635" id="token-65-5" morph="none" pos="punct" start_char="6635">,</TOKEN>
<TOKEN end_char="6648" id="token-65-6" morph="none" pos="unknown" start_char="6637">Goodman-Meza</TOKEN>
<TOKEN end_char="6650" id="token-65-7" morph="none" pos="word" start_char="6650">D</TOKEN>
<TOKEN end_char="6651" id="token-65-8" morph="none" pos="punct" start_char="6651">,</TOKEN>
<TOKEN end_char="6654" id="token-65-9" morph="none" pos="word" start_char="6653">et</TOKEN>
<TOKEN end_char="6657" id="token-65-10" morph="none" pos="word" start_char="6656">al</TOKEN>
<TOKEN end_char="6658" id="token-65-11" morph="none" pos="punct" start_char="6658">.</TOKEN>
</SEG>
<SEG end_char="6731" id="segment-66" start_char="6660">
<ORIGINAL_TEXT>Rapid decay of anti–SARS-CoV-2 antibodies in persons with mild COVID-19.</ORIGINAL_TEXT>
<TOKEN end_char="6664" id="token-66-0" morph="none" pos="word" start_char="6660">Rapid</TOKEN>
<TOKEN end_char="6670" id="token-66-1" morph="none" pos="word" start_char="6666">decay</TOKEN>
<TOKEN end_char="6673" id="token-66-2" morph="none" pos="word" start_char="6672">of</TOKEN>
<TOKEN end_char="6689" id="token-66-3" morph="none" pos="unknown" start_char="6675">anti–SARS-CoV-2</TOKEN>
<TOKEN end_char="6700" id="token-66-4" morph="none" pos="word" start_char="6691">antibodies</TOKEN>
<TOKEN end_char="6703" id="token-66-5" morph="none" pos="word" start_char="6702">in</TOKEN>
<TOKEN end_char="6711" id="token-66-6" morph="none" pos="word" start_char="6705">persons</TOKEN>
<TOKEN end_char="6716" id="token-66-7" morph="none" pos="word" start_char="6713">with</TOKEN>
<TOKEN end_char="6721" id="token-66-8" morph="none" pos="word" start_char="6718">mild</TOKEN>
<TOKEN end_char="6730" id="token-66-9" morph="none" pos="unknown" start_char="6723">COVID-19</TOKEN>
<TOKEN end_char="6731" id="token-66-10" morph="none" pos="punct" start_char="6731">.</TOKEN>
</SEG>
<SEG end_char="6745" id="segment-67" start_char="6734">
<ORIGINAL_TEXT>N Engl J Med</ORIGINAL_TEXT>
<TOKEN end_char="6734" id="token-67-0" morph="none" pos="word" start_char="6734">N</TOKEN>
<TOKEN end_char="6739" id="token-67-1" morph="none" pos="word" start_char="6736">Engl</TOKEN>
<TOKEN end_char="6741" id="token-67-2" morph="none" pos="word" start_char="6741">J</TOKEN>
<TOKEN end_char="6745" id="token-67-3" morph="none" pos="word" start_char="6743">Med</TOKEN>
</SEG>
<SEG end_char="6748" id="segment-68" start_char="6748">
<ORIGINAL_TEXT>.</ORIGINAL_TEXT>
<TOKEN end_char="6748" id="token-68-0" morph="none" pos="punct" start_char="6748">.</TOKEN>
</SEG>
<SEG end_char="6772" id="segment-69" start_char="6750">
<ORIGINAL_TEXT>2020;383(11):1085-1087.</ORIGINAL_TEXT>
<TOKEN end_char="6771" id="token-69-0" morph="none" pos="unknown" start_char="6750">2020;383(11):1085-1087</TOKEN>
<TOKEN end_char="6772" id="token-69-1" morph="none" pos="punct" start_char="6772">.</TOKEN>
<TRANSLATED_TEXT>2020; 383 (11): 1085-1087.</TRANSLATED_TEXT><DETECTED_LANGUAGE /></SEG>
<SEG end_char="6797" id="segment-70" start_char="6774">
<ORIGINAL_TEXT>doi:10.1056/NEJMc2025179</ORIGINAL_TEXT>
<TOKEN end_char="6797" id="token-70-0" morph="none" pos="unknown" start_char="6774">doi:10.1056/NEJMc2025179</TOKEN>
<TRANSLATED_TEXT>doi: 10.1056 / NEJMc2025179.</TRANSLATED_TEXT><DETECTED_LANGUAGE>pt</DETECTED_LANGUAGE></SEG>
<SEG end_char="6846" id="segment-71" start_char="6800">
<ORIGINAL_TEXT>Garcia-Beltran WF, Lam EC, Astudillo MG, et al.</ORIGINAL_TEXT>
<TOKEN end_char="6813" id="token-71-0" morph="none" pos="unknown" start_char="6800">Garcia-Beltran</TOKEN>
<TOKEN end_char="6816" id="token-71-1" morph="none" pos="word" start_char="6815">WF</TOKEN>
<TOKEN end_char="6817" id="token-71-2" morph="none" pos="punct" start_char="6817">,</TOKEN>
<TOKEN end_char="6821" id="token-71-3" morph="none" pos="word" start_char="6819">Lam</TOKEN>
<TOKEN end_char="6824" id="token-71-4" morph="none" pos="word" start_char="6823">EC</TOKEN>
<TOKEN end_char="6825" id="token-71-5" morph="none" pos="punct" start_char="6825">,</TOKEN>
<TOKEN end_char="6835" id="token-71-6" morph="none" pos="word" start_char="6827">Astudillo</TOKEN>
<TOKEN end_char="6838" id="token-71-7" morph="none" pos="word" start_char="6837">MG</TOKEN>
<TOKEN end_char="6839" id="token-71-8" morph="none" pos="punct" start_char="6839">,</TOKEN>
<TOKEN end_char="6842" id="token-71-9" morph="none" pos="word" start_char="6841">et</TOKEN>
<TOKEN end_char="6845" id="token-71-10" morph="none" pos="word" start_char="6844">al</TOKEN>
<TOKEN end_char="6846" id="token-71-11" morph="none" pos="punct" start_char="6846">.</TOKEN>
</SEG>
<SEG end_char="6918" id="segment-72" start_char="6848">
<ORIGINAL_TEXT>COVID-19-neutralizing antibodies predict disease severity and survival.</ORIGINAL_TEXT>
<TOKEN end_char="6868" id="token-72-0" morph="none" pos="unknown" start_char="6848">COVID-19-neutralizing</TOKEN>
<TOKEN end_char="6879" id="token-72-1" morph="none" pos="word" start_char="6870">antibodies</TOKEN>
<TOKEN end_char="6887" id="token-72-2" morph="none" pos="word" start_char="6881">predict</TOKEN>
<TOKEN end_char="6895" id="token-72-3" morph="none" pos="word" start_char="6889">disease</TOKEN>
<TOKEN end_char="6904" id="token-72-4" morph="none" pos="word" start_char="6897">severity</TOKEN>
<TOKEN end_char="6908" id="token-72-5" morph="none" pos="word" start_char="6906">and</TOKEN>
<TOKEN end_char="6917" id="token-72-6" morph="none" pos="word" start_char="6910">survival</TOKEN>
<TOKEN end_char="6918" id="token-72-7" morph="none" pos="punct" start_char="6918">.</TOKEN>
</SEG>
<SEG end_char="6924" id="segment-73" start_char="6921">
<ORIGINAL_TEXT>Cell</ORIGINAL_TEXT>
<TOKEN end_char="6924" id="token-73-0" morph="none" pos="word" start_char="6921">Cell</TOKEN>
</SEG>
<SEG end_char="6927" id="segment-74" start_char="6927">
<ORIGINAL_TEXT>.</ORIGINAL_TEXT>
<TOKEN end_char="6927" id="token-74-0" morph="none" pos="punct" start_char="6927">.</TOKEN>
</SEG>
<SEG end_char="6952" id="segment-75" start_char="6929">
<ORIGINAL_TEXT>2020;184(2):476-488.e11.</ORIGINAL_TEXT>
<TOKEN end_char="6951" id="token-75-0" morph="none" pos="unknown" start_char="6929">2020;184(2):476-488.e11</TOKEN>
<TOKEN end_char="6952" id="token-75-1" morph="none" pos="punct" start_char="6952">.</TOKEN>
<TRANSLATED_TEXT>2020; 184 (2): 476-488.e11.</TRANSLATED_TEXT><DETECTED_LANGUAGE>sq</DETECTED_LANGUAGE></SEG>
<SEG end_char="6983" id="segment-76" start_char="6954">
<ORIGINAL_TEXT>doi:10.1016/j.cell.2020.12.015</ORIGINAL_TEXT>
<TOKEN end_char="6983" id="token-76-0" morph="none" pos="unknown" start_char="6954">doi:10.1016/j.cell.2020.12.015</TOKEN>
<TRANSLATED_TEXT>doi: 10.1016 / j.cell.2020.12.015</TRANSLATED_TEXT><DETECTED_LANGUAGE>it</DETECTED_LANGUAGE></SEG>
<SEG end_char="7026" id="segment-77" start_char="6986">
<ORIGINAL_TEXT>Sahin U, Muik A, Derhovanessian E, et al.</ORIGINAL_TEXT>
<TOKEN end_char="6990" id="token-77-0" morph="none" pos="word" start_char="6986">Sahin</TOKEN>
<TOKEN end_char="6992" id="token-77-1" morph="none" pos="word" start_char="6992">U</TOKEN>
<TOKEN end_char="6993" id="token-77-2" morph="none" pos="punct" start_char="6993">,</TOKEN>
<TOKEN end_char="6998" id="token-77-3" morph="none" pos="word" start_char="6995">Muik</TOKEN>
<TOKEN end_char="7000" id="token-77-4" morph="none" pos="word" start_char="7000">A</TOKEN>
<TOKEN end_char="7001" id="token-77-5" morph="none" pos="punct" start_char="7001">,</TOKEN>
<TOKEN end_char="7016" id="token-77-6" morph="none" pos="word" start_char="7003">Derhovanessian</TOKEN>
<TOKEN end_char="7018" id="token-77-7" morph="none" pos="word" start_char="7018">E</TOKEN>
<TOKEN end_char="7019" id="token-77-8" morph="none" pos="punct" start_char="7019">,</TOKEN>
<TOKEN end_char="7022" id="token-77-9" morph="none" pos="word" start_char="7021">et</TOKEN>
<TOKEN end_char="7025" id="token-77-10" morph="none" pos="word" start_char="7024">al</TOKEN>
<TOKEN end_char="7026" id="token-77-11" morph="none" pos="punct" start_char="7026">.</TOKEN>
</SEG>
<SEG end_char="7081" id="segment-78" start_char="7028">
<ORIGINAL_TEXT>COVID-19 vaccine BNT162b1 elicits human antibody and T</ORIGINAL_TEXT>
<TOKEN end_char="7035" id="token-78-0" morph="none" pos="unknown" start_char="7028">COVID-19</TOKEN>
<TOKEN end_char="7043" id="token-78-1" morph="none" pos="word" start_char="7037">vaccine</TOKEN>
<TOKEN end_char="7052" id="token-78-2" morph="none" pos="word" start_char="7045">BNT162b1</TOKEN>
<TOKEN end_char="7060" id="token-78-3" morph="none" pos="word" start_char="7054">elicits</TOKEN>
<TOKEN end_char="7066" id="token-78-4" morph="none" pos="word" start_char="7062">human</TOKEN>
<TOKEN end_char="7075" id="token-78-5" morph="none" pos="word" start_char="7068">antibody</TOKEN>
<TOKEN end_char="7079" id="token-78-6" morph="none" pos="word" start_char="7077">and</TOKEN>
<TOKEN end_char="7081" id="token-78-7" morph="none" pos="word" start_char="7081">T</TOKEN>
</SEG>
<SEG end_char="7084" id="segment-79" start_char="7084">
<ORIGINAL_TEXT>H</ORIGINAL_TEXT>
<TOKEN end_char="7084" id="token-79-0" morph="none" pos="word" start_char="7084">H</TOKEN>
</SEG>
<SEG end_char="7105" id="segment-80" start_char="7087">
<ORIGINAL_TEXT>1 T cell responses.</ORIGINAL_TEXT>
<TOKEN end_char="7087" id="token-80-0" morph="none" pos="word" start_char="7087">1</TOKEN>
<TOKEN end_char="7089" id="token-80-1" morph="none" pos="word" start_char="7089">T</TOKEN>
<TOKEN end_char="7094" id="token-80-2" morph="none" pos="word" start_char="7091">cell</TOKEN>
<TOKEN end_char="7104" id="token-80-3" morph="none" pos="word" start_char="7096">responses</TOKEN>
<TOKEN end_char="7105" id="token-80-4" morph="none" pos="punct" start_char="7105">.</TOKEN>
<TRANSLATED_TEXT>1 T-celrespons</TRANSLATED_TEXT><DETECTED_LANGUAGE>ca</DETECTED_LANGUAGE></SEG>
<SEG end_char="7113" id="segment-81" start_char="7108">
<ORIGINAL_TEXT>Nature</ORIGINAL_TEXT>
<TOKEN end_char="7113" id="token-81-0" morph="none" pos="word" start_char="7108">Nature</TOKEN>
</SEG>
<SEG end_char="7116" id="segment-82" start_char="7116">
<ORIGINAL_TEXT>.</ORIGINAL_TEXT>
<TOKEN end_char="7116" id="token-82-0" morph="none" pos="punct" start_char="7116">.</TOKEN>
</SEG>
<SEG end_char="7140" id="segment-83" start_char="7118">
<ORIGINAL_TEXT>2020;586(7830):594–599.</ORIGINAL_TEXT>
<TOKEN end_char="7139" id="token-83-0" morph="none" pos="unknown" start_char="7118">2020;586(7830):594–599</TOKEN>
<TOKEN end_char="7140" id="token-83-1" morph="none" pos="punct" start_char="7140">.</TOKEN>
<TRANSLATED_TEXT>586 (7830): 594-599.</TRANSLATED_TEXT><DETECTED_LANGUAGE /></SEG>
<SEG end_char="7170" id="segment-84" start_char="7142">
<ORIGINAL_TEXT>doi:10.1038/s41586-020-2814-7</ORIGINAL_TEXT>
<TOKEN end_char="7170" id="token-84-0" morph="none" pos="unknown" start_char="7142">doi:10.1038/s41586-020-2814-7</TOKEN>
<TRANSLATED_TEXT>doi: 10.1038 / s41586-020-2814-7.</TRANSLATED_TEXT><DETECTED_LANGUAGE>pt</DETECTED_LANGUAGE></SEG>
<SEG end_char="7211" id="segment-85" start_char="7173">
<ORIGINAL_TEXT>Baden LR, El Sahly HM, Essink B, et al.</ORIGINAL_TEXT>
<TOKEN end_char="7177" id="token-85-0" morph="none" pos="word" start_char="7173">Baden</TOKEN>
<TOKEN end_char="7180" id="token-85-1" morph="none" pos="word" start_char="7179">LR</TOKEN>
<TOKEN end_char="7181" id="token-85-2" morph="none" pos="punct" start_char="7181">,</TOKEN>
<TOKEN end_char="7184" id="token-85-3" morph="none" pos="word" start_char="7183">El</TOKEN>
<TOKEN end_char="7190" id="token-85-4" morph="none" pos="word" start_char="7186">Sahly</TOKEN>
<TOKEN end_char="7193" id="token-85-5" morph="none" pos="word" start_char="7192">HM</TOKEN>
<TOKEN end_char="7194" id="token-85-6" morph="none" pos="punct" start_char="7194">,</TOKEN>
<TOKEN end_char="7201" id="token-85-7" morph="none" pos="word" start_char="7196">Essink</TOKEN>
<TOKEN end_char="7203" id="token-85-8" morph="none" pos="word" start_char="7203">B</TOKEN>
<TOKEN end_char="7204" id="token-85-9" morph="none" pos="punct" start_char="7204">,</TOKEN>
<TOKEN end_char="7207" id="token-85-10" morph="none" pos="word" start_char="7206">et</TOKEN>
<TOKEN end_char="7210" id="token-85-11" morph="none" pos="word" start_char="7209">al</TOKEN>
<TOKEN end_char="7211" id="token-85-12" morph="none" pos="punct" start_char="7211">.</TOKEN>
</SEG>
<SEG end_char="7268" id="segment-86" start_char="7213">
<ORIGINAL_TEXT>Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine.</ORIGINAL_TEXT>
<TOKEN end_char="7220" id="token-86-0" morph="none" pos="word" start_char="7213">Efficacy</TOKEN>
<TOKEN end_char="7224" id="token-86-1" morph="none" pos="word" start_char="7222">and</TOKEN>
<TOKEN end_char="7231" id="token-86-2" morph="none" pos="word" start_char="7226">safety</TOKEN>
<TOKEN end_char="7234" id="token-86-3" morph="none" pos="word" start_char="7233">of</TOKEN>
<TOKEN end_char="7238" id="token-86-4" morph="none" pos="word" start_char="7236">the</TOKEN>
<TOKEN end_char="7248" id="token-86-5" morph="none" pos="unknown" start_char="7240">mRNA-1273</TOKEN>
<TOKEN end_char="7259" id="token-86-6" morph="none" pos="unknown" start_char="7250">SARS-CoV-2</TOKEN>
<TOKEN end_char="7267" id="token-86-7" morph="none" pos="word" start_char="7261">vaccine</TOKEN>
<TOKEN end_char="7268" id="token-86-8" morph="none" pos="punct" start_char="7268">.</TOKEN>
</SEG>
<SEG end_char="7282" id="segment-87" start_char="7271">
<ORIGINAL_TEXT>N Engl J Med</ORIGINAL_TEXT>
<TOKEN end_char="7271" id="token-87-0" morph="none" pos="word" start_char="7271">N</TOKEN>
<TOKEN end_char="7276" id="token-87-1" morph="none" pos="word" start_char="7273">Engl</TOKEN>
<TOKEN end_char="7278" id="token-87-2" morph="none" pos="word" start_char="7278">J</TOKEN>
<TOKEN end_char="7282" id="token-87-3" morph="none" pos="word" start_char="7280">Med</TOKEN>
</SEG>
<SEG end_char="7285" id="segment-88" start_char="7285">
<ORIGINAL_TEXT>.</ORIGINAL_TEXT>
<TOKEN end_char="7285" id="token-88-0" morph="none" pos="punct" start_char="7285">.</TOKEN>
</SEG>
<SEG end_char="7307" id="segment-89" start_char="7287">
<ORIGINAL_TEXT>2021; 384(5):403-416.</ORIGINAL_TEXT>
<TOKEN end_char="7290" id="token-89-0" morph="none" pos="word" start_char="7287">2021</TOKEN>
<TOKEN end_char="7291" id="token-89-1" morph="none" pos="punct" start_char="7291">;</TOKEN>
<TOKEN end_char="7306" id="token-89-2" morph="none" pos="unknown" start_char="7293">384(5):403-416</TOKEN>
<TOKEN end_char="7307" id="token-89-3" morph="none" pos="punct" start_char="7307">.</TOKEN>
<TRANSLATED_TEXT>384 (5): 403-416.</TRANSLATED_TEXT><DETECTED_LANGUAGE /></SEG>
<SEG end_char="7333" id="segment-90" start_char="7309">
<ORIGINAL_TEXT>doi:10.1056/NEJMoa2035389</ORIGINAL_TEXT>
<TOKEN end_char="7333" id="token-90-0" morph="none" pos="unknown" start_char="7309">doi:10.1056/NEJMoa2035389</TOKEN>
<TRANSLATED_TEXT>doi: 10.1056 / NEJMoa2035389.</TRANSLATED_TEXT><DETECTED_LANGUAGE>pt</DETECTED_LANGUAGE></SEG>
<SEG end_char="7345" id="segment-91" start_char="7336">
<ORIGINAL_TEXT>TOI Staff.</ORIGINAL_TEXT>
<TOKEN end_char="7338" id="token-91-0" morph="none" pos="word" start_char="7336">TOI</TOKEN>
<TOKEN end_char="7344" id="token-91-1" morph="none" pos="word" start_char="7340">Staff</TOKEN>
<TOKEN end_char="7345" id="token-91-2" morph="none" pos="punct" start_char="7345">.</TOKEN>
</SEG>
<SEG end_char="7419" id="segment-92" start_char="7347">
<ORIGINAL_TEXT>Over 3 million receive 1st vaccine shot, but COVID outbreak still raging.</ORIGINAL_TEXT>
<TOKEN end_char="7350" id="token-92-0" morph="none" pos="word" start_char="7347">Over</TOKEN>
<TOKEN end_char="7352" id="token-92-1" morph="none" pos="word" start_char="7352">3</TOKEN>
<TOKEN end_char="7360" id="token-92-2" morph="none" pos="word" start_char="7354">million</TOKEN>
<TOKEN end_char="7368" id="token-92-3" morph="none" pos="word" start_char="7362">receive</TOKEN>
<TOKEN end_char="7372" id="token-92-4" morph="none" pos="word" start_char="7370">1st</TOKEN>
<TOKEN end_char="7380" id="token-92-5" morph="none" pos="word" start_char="7374">vaccine</TOKEN>
<TOKEN end_char="7385" id="token-92-6" morph="none" pos="word" start_char="7382">shot</TOKEN>
<TOKEN end_char="7386" id="token-92-7" morph="none" pos="punct" start_char="7386">,</TOKEN>
<TOKEN end_char="7390" id="token-92-8" morph="none" pos="word" start_char="7388">but</TOKEN>
<TOKEN end_char="7396" id="token-92-9" morph="none" pos="word" start_char="7392">COVID</TOKEN>
<TOKEN end_char="7405" id="token-92-10" morph="none" pos="word" start_char="7398">outbreak</TOKEN>
<TOKEN end_char="7411" id="token-92-11" morph="none" pos="word" start_char="7407">still</TOKEN>
<TOKEN end_char="7418" id="token-92-12" morph="none" pos="word" start_char="7413">raging</TOKEN>
<TOKEN end_char="7419" id="token-92-13" morph="none" pos="punct" start_char="7419">.</TOKEN>
</SEG>
<SEG end_char="7440" id="segment-93" start_char="7422">
<ORIGINAL_TEXT>The Times of Israel</ORIGINAL_TEXT>
<TOKEN end_char="7424" id="token-93-0" morph="none" pos="word" start_char="7422">The</TOKEN>
<TOKEN end_char="7430" id="token-93-1" morph="none" pos="word" start_char="7426">Times</TOKEN>
<TOKEN end_char="7433" id="token-93-2" morph="none" pos="word" start_char="7432">of</TOKEN>
<TOKEN end_char="7440" id="token-93-3" morph="none" pos="word" start_char="7435">Israel</TOKEN>
</SEG>
<SEG end_char="7443" id="segment-94" start_char="7443">
<ORIGINAL_TEXT>.</ORIGINAL_TEXT>
<TOKEN end_char="7443" id="token-94-0" morph="none" pos="punct" start_char="7443">.</TOKEN>
</SEG>
<SEG end_char="7461" id="segment-95" start_char="7445">
<ORIGINAL_TEXT>January 31, 2021.</ORIGINAL_TEXT>
<TOKEN end_char="7451" id="token-95-0" morph="none" pos="word" start_char="7445">January</TOKEN>
<TOKEN end_char="7454" id="token-95-1" morph="none" pos="word" start_char="7453">31</TOKEN>
<TOKEN end_char="7455" id="token-95-2" morph="none" pos="punct" start_char="7455">,</TOKEN>
<TOKEN end_char="7460" id="token-95-3" morph="none" pos="word" start_char="7457">2021</TOKEN>
<TOKEN end_char="7461" id="token-95-4" morph="none" pos="punct" start_char="7461">.</TOKEN>
</SEG>
<SEG end_char="7488" id="segment-96" start_char="7463">
<ORIGINAL_TEXT>Accessed February 3, 2021.</ORIGINAL_TEXT>
<TOKEN end_char="7470" id="token-96-0" morph="none" pos="word" start_char="7463">Accessed</TOKEN>
<TOKEN end_char="7479" id="token-96-1" morph="none" pos="word" start_char="7472">February</TOKEN>
<TOKEN end_char="7481" id="token-96-2" morph="none" pos="word" start_char="7481">3</TOKEN>
<TOKEN end_char="7482" id="token-96-3" morph="none" pos="punct" start_char="7482">,</TOKEN>
<TOKEN end_char="7487" id="token-96-4" morph="none" pos="word" start_char="7484">2021</TOKEN>
<TOKEN end_char="7488" id="token-96-5" morph="none" pos="punct" start_char="7488">.</TOKEN>
</SEG>
<SEG end_char="7591" id="segment-97" start_char="7490">
<ORIGINAL_TEXT>https://www.timesofisrael.com/over-3-million-receive-1st-vaccine-shot-but-covid-outbreak-still-raging/</ORIGINAL_TEXT>
<TOKEN end_char="7591" id="token-97-0" morph="none" pos="url" start_char="7490">https://www.timesofisrael.com/over-3-million-receive-1st-vaccine-shot-but-covid-outbreak-still-raging/</TOKEN>
<TRANSLATED_TEXT>https: / / www.timesofisrael.com / over-3-million-receive-1st-vaccine-shot-but-covid-outbreak-still-raging /</TRANSLATED_TEXT><DETECTED_LANGUAGE /></SEG>
<SEG end_char="7633" id="segment-98" start_char="7594">
<ORIGINAL_TEXT>Jabal KA, Ben-Amram H, Beiruti K, et al.</ORIGINAL_TEXT>
<TOKEN end_char="7598" id="token-98-0" morph="none" pos="word" start_char="7594">Jabal</TOKEN>
<TOKEN end_char="7601" id="token-98-1" morph="none" pos="word" start_char="7600">KA</TOKEN>
<TOKEN end_char="7602" id="token-98-2" morph="none" pos="punct" start_char="7602">,</TOKEN>
<TOKEN end_char="7612" id="token-98-3" morph="none" pos="unknown" start_char="7604">Ben-Amram</TOKEN>
<TOKEN end_char="7614" id="token-98-4" morph="none" pos="word" start_char="7614">H</TOKEN>
<TOKEN end_char="7615" id="token-98-5" morph="none" pos="punct" start_char="7615">,</TOKEN>
<TOKEN end_char="7623" id="token-98-6" morph="none" pos="word" start_char="7617">Beiruti</TOKEN>
<TOKEN end_char="7625" id="token-98-7" morph="none" pos="word" start_char="7625">K</TOKEN>
<TOKEN end_char="7626" id="token-98-8" morph="none" pos="punct" start_char="7626">,</TOKEN>
<TOKEN end_char="7629" id="token-98-9" morph="none" pos="word" start_char="7628">et</TOKEN>
<TOKEN end_char="7632" id="token-98-10" morph="none" pos="word" start_char="7631">al</TOKEN>
<TOKEN end_char="7633" id="token-98-11" morph="none" pos="punct" start_char="7633">.</TOKEN>
<TRANSLATED_TEXT>Jabal KA, Ben-Amram H, Beirut K, et al.</TRANSLATED_TEXT><DETECTED_LANGUAGE>id</DETECTED_LANGUAGE></SEG>
<SEG end_char="7866" id="segment-99" start_char="7635">
<ORIGINAL_TEXT>Impact of age, gender, ethnicity and prior disease status on immunogenicity following administration of a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from Israeli healthcare workers, December–January 2020.</ORIGINAL_TEXT>
<TOKEN end_char="7640" id="token-99-0" morph="none" pos="word" start_char="7635">Impact</TOKEN>
<TOKEN end_char="7643" id="token-99-1" morph="none" pos="word" start_char="7642">of</TOKEN>
<TOKEN end_char="7647" id="token-99-2" morph="none" pos="word" start_char="7645">age</TOKEN>
<TOKEN end_char="7648" id="token-99-3" morph="none" pos="punct" start_char="7648">,</TOKEN>
<TOKEN end_char="7655" id="token-99-4" morph="none" pos="word" start_char="7650">gender</TOKEN>
<TOKEN end_char="7656" id="token-99-5" morph="none" pos="punct" start_char="7656">,</TOKEN>
<TOKEN end_char="7666" id="token-99-6" morph="none" pos="word" start_char="7658">ethnicity</TOKEN>
<TOKEN end_char="7670" id="token-99-7" morph="none" pos="word" start_char="7668">and</TOKEN>
<TOKEN end_char="7676" id="token-99-8" morph="none" pos="word" start_char="7672">prior</TOKEN>
<TOKEN end_char="7684" id="token-99-9" morph="none" pos="word" start_char="7678">disease</TOKEN>
<TOKEN end_char="7691" id="token-99-10" morph="none" pos="word" start_char="7686">status</TOKEN>
<TOKEN end_char="7694" id="token-99-11" morph="none" pos="word" start_char="7693">on</TOKEN>
<TOKEN end_char="7709" id="token-99-12" morph="none" pos="word" start_char="7696">immunogenicity</TOKEN>
<TOKEN end_char="7719" id="token-99-13" morph="none" pos="word" start_char="7711">following</TOKEN>
<TOKEN end_char="7734" id="token-99-14" morph="none" pos="word" start_char="7721">administration</TOKEN>
<TOKEN end_char="7737" id="token-99-15" morph="none" pos="word" start_char="7736">of</TOKEN>
<TOKEN end_char="7739" id="token-99-16" morph="none" pos="word" start_char="7739">a</TOKEN>
<TOKEN end_char="7746" id="token-99-17" morph="none" pos="word" start_char="7741">single</TOKEN>
<TOKEN end_char="7751" id="token-99-18" morph="none" pos="word" start_char="7748">dose</TOKEN>
<TOKEN end_char="7754" id="token-99-19" morph="none" pos="word" start_char="7753">of</TOKEN>
<TOKEN end_char="7758" id="token-99-20" morph="none" pos="word" start_char="7756">the</TOKEN>
<TOKEN end_char="7767" id="token-99-21" morph="none" pos="word" start_char="7760">BNT162b2</TOKEN>
<TOKEN end_char="7772" id="token-99-22" morph="none" pos="word" start_char="7769">mRNA</TOKEN>
<TOKEN end_char="7781" id="token-99-23" morph="none" pos="unknown" start_char="7774">COVID-19</TOKEN>
<TOKEN end_char="7789" id="token-99-24" morph="none" pos="word" start_char="7783">vaccine</TOKEN>
<TOKEN end_char="7790" id="token-99-25" morph="none" pos="punct" start_char="7790">:</TOKEN>
<TOKEN end_char="7801" id="token-99-26" morph="none" pos="unknown" start_char="7792">real-world</TOKEN>
<TOKEN end_char="7810" id="token-99-27" morph="none" pos="word" start_char="7803">evidence</TOKEN>
<TOKEN end_char="7815" id="token-99-28" morph="none" pos="word" start_char="7812">from</TOKEN>
<TOKEN end_char="7823" id="token-99-29" morph="none" pos="word" start_char="7817">Israeli</TOKEN>
<TOKEN end_char="7834" id="token-99-30" morph="none" pos="word" start_char="7825">healthcare</TOKEN>
<TOKEN end_char="7842" id="token-99-31" morph="none" pos="word" start_char="7836">workers</TOKEN>
<TOKEN end_char="7843" id="token-99-32" morph="none" pos="punct" start_char="7843">,</TOKEN>
<TOKEN end_char="7860" id="token-99-33" morph="none" pos="unknown" start_char="7845">December–January</TOKEN>
<TOKEN end_char="7865" id="token-99-34" morph="none" pos="word" start_char="7862">2020</TOKEN>
<TOKEN end_char="7866" id="token-99-35" morph="none" pos="punct" start_char="7866">.</TOKEN>
</SEG>
<SEG end_char="7875" id="segment-100" start_char="7869">
<ORIGINAL_TEXT>medRxiv</ORIGINAL_TEXT>
<TOKEN end_char="7875" id="token-100-0" morph="none" pos="word" start_char="7869">medRxiv</TOKEN>
</SEG>
<SEG end_char="7878" id="segment-101" start_char="7878">
<ORIGINAL_TEXT>.</ORIGINAL_TEXT>
<TOKEN end_char="7878" id="token-101-0" morph="none" pos="punct" start_char="7878">.</TOKEN>
</SEG>
<SEG end_char="7914" id="segment-102" start_char="7880">
<ORIGINAL_TEXT>Published online: January 31, 2021.</ORIGINAL_TEXT>
<TOKEN end_char="7888" id="token-102-0" morph="none" pos="word" start_char="7880">Published</TOKEN>
<TOKEN end_char="7895" id="token-102-1" morph="none" pos="word" start_char="7890">online</TOKEN>
<TOKEN end_char="7896" id="token-102-2" morph="none" pos="punct" start_char="7896">:</TOKEN>
<TOKEN end_char="7904" id="token-102-3" morph="none" pos="word" start_char="7898">January</TOKEN>
<TOKEN end_char="7907" id="token-102-4" morph="none" pos="word" start_char="7906">31</TOKEN>
<TOKEN end_char="7908" id="token-102-5" morph="none" pos="punct" start_char="7908">,</TOKEN>
<TOKEN end_char="7913" id="token-102-6" morph="none" pos="word" start_char="7910">2021</TOKEN>
<TOKEN end_char="7914" id="token-102-7" morph="none" pos="punct" start_char="7914">.</TOKEN>
</SEG>
<SEG end_char="7962" id="segment-103" start_char="7916">
<ORIGINAL_TEXT>doi:https://doi.org/10.1101/2021.01.27.21250567</ORIGINAL_TEXT>
<TOKEN end_char="7962" id="token-103-0" morph="none" pos="unknown" start_char="7916">doi:https://doi.org/10.1101/2021.01.27.21250567</TOKEN>
<TRANSLATED_TEXT>doi: https: / / doi.org / 10.1101 / 2021.01.27.21250567.</TRANSLATED_TEXT><DETECTED_LANGUAGE>pt</DETECTED_LANGUAGE></SEG>
<SEG end_char="8004" id="segment-104" start_char="7965">
<ORIGINAL_TEXT>Sabino EC, Buss LF, Carvalho MPS, et al.</ORIGINAL_TEXT>
<TOKEN end_char="7970" id="token-104-0" morph="none" pos="word" start_char="7965">Sabino</TOKEN>
<TOKEN end_char="7973" id="token-104-1" morph="none" pos="word" start_char="7972">EC</TOKEN>
<TOKEN end_char="7974" id="token-104-2" morph="none" pos="punct" start_char="7974">,</TOKEN>
<TOKEN end_char="7979" id="token-104-3" morph="none" pos="word" start_char="7976">Buss</TOKEN>
<TOKEN end_char="7982" id="token-104-4" morph="none" pos="word" start_char="7981">LF</TOKEN>
<TOKEN end_char="7983" id="token-104-5" morph="none" pos="punct" start_char="7983">,</TOKEN>
<TOKEN end_char="7992" id="token-104-6" morph="none" pos="word" start_char="7985">Carvalho</TOKEN>
<TOKEN end_char="7996" id="token-104-7" morph="none" pos="word" start_char="7994">MPS</TOKEN>
<TOKEN end_char="7997" id="token-104-8" morph="none" pos="punct" start_char="7997">,</TOKEN>
<TOKEN end_char="8000" id="token-104-9" morph="none" pos="word" start_char="7999">et</TOKEN>
<TOKEN end_char="8003" id="token-104-10" morph="none" pos="word" start_char="8002">al</TOKEN>
<TOKEN end_char="8004" id="token-104-11" morph="none" pos="punct" start_char="8004">.</TOKEN>
</SEG>
<SEG end_char="8075" id="segment-105" start_char="8006">
<ORIGINAL_TEXT>Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence.</ORIGINAL_TEXT>
<TOKEN end_char="8015" id="token-105-0" morph="none" pos="word" start_char="8006">Resurgence</TOKEN>
<TOKEN end_char="8018" id="token-105-1" morph="none" pos="word" start_char="8017">of</TOKEN>
<TOKEN end_char="8027" id="token-105-2" morph="none" pos="unknown" start_char="8020">COVID-19</TOKEN>
<TOKEN end_char="8030" id="token-105-3" morph="none" pos="word" start_char="8029">in</TOKEN>
<TOKEN end_char="8037" id="token-105-4" morph="none" pos="word" start_char="8032">Manaus</TOKEN>
<TOKEN end_char="8038" id="token-105-5" morph="none" pos="punct" start_char="8038">,</TOKEN>
<TOKEN end_char="8045" id="token-105-6" morph="none" pos="word" start_char="8040">Brazil</TOKEN>
<TOKEN end_char="8046" id="token-105-7" morph="none" pos="punct" start_char="8046">,</TOKEN>
<TOKEN end_char="8054" id="token-105-8" morph="none" pos="word" start_char="8048">despite</TOKEN>
<TOKEN end_char="8059" id="token-105-9" morph="none" pos="word" start_char="8056">high</TOKEN>
<TOKEN end_char="8074" id="token-105-10" morph="none" pos="word" start_char="8061">seroprevalence</TOKEN>
<TOKEN end_char="8075" id="token-105-11" morph="none" pos="punct" start_char="8075">.</TOKEN>
</SEG>
<SEG end_char="8083" id="segment-106" start_char="8078">
<ORIGINAL_TEXT>Lancet</ORIGINAL_TEXT>
<TOKEN end_char="8083" id="token-106-0" morph="none" pos="word" start_char="8078">Lancet</TOKEN>
<TRANSLATED_TEXT>Lancet.</TRANSLATED_TEXT><DETECTED_LANGUAGE>fr</DETECTED_LANGUAGE></SEG>
<SEG end_char="8086" id="segment-107" start_char="8086">
<ORIGINAL_TEXT>.</ORIGINAL_TEXT>
<TOKEN end_char="8086" id="token-107-0" morph="none" pos="punct" start_char="8086">.</TOKEN>
</SEG>
<SEG end_char="8111" id="segment-108" start_char="8088">
<ORIGINAL_TEXT>2021;397(10273):452-455.</ORIGINAL_TEXT>
<TOKEN end_char="8110" id="token-108-0" morph="none" pos="unknown" start_char="8088">2021;397(10273):452-455</TOKEN>
<TOKEN end_char="8111" id="token-108-1" morph="none" pos="punct" start_char="8111">.</TOKEN>
<TRANSLATED_TEXT>397 (10273): 452-455.</TRANSLATED_TEXT><DETECTED_LANGUAGE /></SEG>
<SEG end_char="8145" id="segment-109" start_char="8113">
<ORIGINAL_TEXT>doi:10.1016/S0140-6736(21)00183-5</ORIGINAL_TEXT>
<TOKEN end_char="8145" id="token-109-0" morph="none" pos="unknown" start_char="8113">doi:10.1016/S0140-6736(21)00183-5</TOKEN>
<TRANSLATED_TEXT>doi: 10.1016 / S0140-6736 (21) 00183-5.</TRANSLATED_TEXT><DETECTED_LANGUAGE>pt</DETECTED_LANGUAGE></SEG>
<SEG end_char="8180" id="segment-110" start_char="8148">
<ORIGINAL_TEXT>Cele S, Gazy I, Jackson L, et al.</ORIGINAL_TEXT>
<TOKEN end_char="8151" id="token-110-0" morph="none" pos="word" start_char="8148">Cele</TOKEN>
<TOKEN end_char="8153" id="token-110-1" morph="none" pos="word" start_char="8153">S</TOKEN>
<TOKEN end_char="8154" id="token-110-2" morph="none" pos="punct" start_char="8154">,</TOKEN>
<TOKEN end_char="8159" id="token-110-3" morph="none" pos="word" start_char="8156">Gazy</TOKEN>
<TOKEN end_char="8161" id="token-110-4" morph="none" pos="word" start_char="8161">I</TOKEN>
<TOKEN end_char="8162" id="token-110-5" morph="none" pos="punct" start_char="8162">,</TOKEN>
<TOKEN end_char="8170" id="token-110-6" morph="none" pos="word" start_char="8164">Jackson</TOKEN>
<TOKEN end_char="8172" id="token-110-7" morph="none" pos="word" start_char="8172">L</TOKEN>
<TOKEN end_char="8173" id="token-110-8" morph="none" pos="punct" start_char="8173">,</TOKEN>
<TOKEN end_char="8176" id="token-110-9" morph="none" pos="word" start_char="8175">et</TOKEN>
<TOKEN end_char="8179" id="token-110-10" morph="none" pos="word" start_char="8178">al</TOKEN>
<TOKEN end_char="8180" id="token-110-11" morph="none" pos="punct" start_char="8180">.</TOKEN>
<TRANSLATED_TEXT>Cele S, Gazi I, Jackson L, et al.</TRANSLATED_TEXT><DETECTED_LANGUAGE>fr</DETECTED_LANGUAGE></SEG>
<SEG end_char="8262" id="segment-111" start_char="8182">
<ORIGINAL_TEXT>Escape of SARS-CoV-2 501Y.V2 variants from neutralization by convalescent plasma.</ORIGINAL_TEXT>
<TOKEN end_char="8187" id="token-111-0" morph="none" pos="word" start_char="8182">Escape</TOKEN>
<TOKEN end_char="8190" id="token-111-1" morph="none" pos="word" start_char="8189">of</TOKEN>
<TOKEN end_char="8201" id="token-111-2" morph="none" pos="unknown" start_char="8192">SARS-CoV-2</TOKEN>
<TOKEN end_char="8209" id="token-111-3" morph="none" pos="unknown" start_char="8203">501Y.V2</TOKEN>
<TOKEN end_char="8218" id="token-111-4" morph="none" pos="word" start_char="8211">variants</TOKEN>
<TOKEN end_char="8223" id="token-111-5" morph="none" pos="word" start_char="8220">from</TOKEN>
<TOKEN end_char="8238" id="token-111-6" morph="none" pos="word" start_char="8225">neutralization</TOKEN>
<TOKEN end_char="8241" id="token-111-7" morph="none" pos="word" start_char="8240">by</TOKEN>
<TOKEN end_char="8254" id="token-111-8" morph="none" pos="word" start_char="8243">convalescent</TOKEN>
<TOKEN end_char="8261" id="token-111-9" morph="none" pos="word" start_char="8256">plasma</TOKEN>
<TOKEN end_char="8262" id="token-111-10" morph="none" pos="punct" start_char="8262">.</TOKEN>
</SEG>
<SEG end_char="8271" id="segment-112" start_char="8265">
<ORIGINAL_TEXT>medRxiv</ORIGINAL_TEXT>
<TOKEN end_char="8271" id="token-112-0" morph="none" pos="word" start_char="8265">medRxiv</TOKEN>
</SEG>
<SEG end_char="8274" id="segment-113" start_char="8274">
<ORIGINAL_TEXT>.</ORIGINAL_TEXT>
<TOKEN end_char="8274" id="token-113-0" morph="none" pos="punct" start_char="8274">.</TOKEN>
</SEG>
<SEG end_char="8310" id="segment-114" start_char="8276">
<ORIGINAL_TEXT>Published online: January 26, 2021.</ORIGINAL_TEXT>
<TOKEN end_char="8284" id="token-114-0" morph="none" pos="word" start_char="8276">Published</TOKEN>
<TOKEN end_char="8291" id="token-114-1" morph="none" pos="word" start_char="8286">online</TOKEN>
<TOKEN end_char="8292" id="token-114-2" morph="none" pos="punct" start_char="8292">:</TOKEN>
<TOKEN end_char="8300" id="token-114-3" morph="none" pos="word" start_char="8294">January</TOKEN>
<TOKEN end_char="8303" id="token-114-4" morph="none" pos="word" start_char="8302">26</TOKEN>
<TOKEN end_char="8304" id="token-114-5" morph="none" pos="punct" start_char="8304">,</TOKEN>
<TOKEN end_char="8309" id="token-114-6" morph="none" pos="word" start_char="8306">2021</TOKEN>
<TOKEN end_char="8310" id="token-114-7" morph="none" pos="punct" start_char="8310">.</TOKEN>
</SEG>
<SEG end_char="8358" id="segment-115" start_char="8312">
<ORIGINAL_TEXT>doi:https://doi.org/10.1101/2021.01.26.21250224</ORIGINAL_TEXT>
<TOKEN end_char="8358" id="token-115-0" morph="none" pos="unknown" start_char="8312">doi:https://doi.org/10.1101/2021.01.26.21250224</TOKEN>
<TRANSLATED_TEXT>doi: https: / / doi.org / 10.1101 / 2021.01.26.21250224.</TRANSLATED_TEXT><DETECTED_LANGUAGE>pt</DETECTED_LANGUAGE></SEG>
<SEG end_char="8394" id="segment-116" start_char="8361">
<ORIGINAL_TEXT>Wu K, Werner AP, Moliva JI, et al.</ORIGINAL_TEXT>
<TOKEN end_char="8362" id="token-116-0" morph="none" pos="word" start_char="8361">Wu</TOKEN>
<TOKEN end_char="8364" id="token-116-1" morph="none" pos="word" start_char="8364">K</TOKEN>
<TOKEN end_char="8365" id="token-116-2" morph="none" pos="punct" start_char="8365">,</TOKEN>
<TOKEN end_char="8372" id="token-116-3" morph="none" pos="word" start_char="8367">Werner</TOKEN>
<TOKEN end_char="8375" id="token-116-4" morph="none" pos="word" start_char="8374">AP</TOKEN>
<TOKEN end_char="8376" id="token-116-5" morph="none" pos="punct" start_char="8376">,</TOKEN>
<TOKEN end_char="8383" id="token-116-6" morph="none" pos="word" start_char="8378">Moliva</TOKEN>
<TOKEN end_char="8386" id="token-116-7" morph="none" pos="word" start_char="8385">JI</TOKEN>
<TOKEN end_char="8387" id="token-116-8" morph="none" pos="punct" start_char="8387">,</TOKEN>
<TOKEN end_char="8390" id="token-116-9" morph="none" pos="word" start_char="8389">et</TOKEN>
<TOKEN end_char="8393" id="token-116-10" morph="none" pos="word" start_char="8392">al</TOKEN>
<TOKEN end_char="8394" id="token-116-11" morph="none" pos="punct" start_char="8394">.</TOKEN>
</SEG>
<SEG end_char="8499" id="segment-117" start_char="8396">
<ORIGINAL_TEXT>mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants.</ORIGINAL_TEXT>
<TOKEN end_char="8404" id="token-117-0" morph="none" pos="unknown" start_char="8396">mRNA-1273</TOKEN>
<TOKEN end_char="8412" id="token-117-1" morph="none" pos="word" start_char="8406">vaccine</TOKEN>
<TOKEN end_char="8420" id="token-117-2" morph="none" pos="word" start_char="8414">induces</TOKEN>
<TOKEN end_char="8433" id="token-117-3" morph="none" pos="word" start_char="8422">neutralizing</TOKEN>
<TOKEN end_char="8444" id="token-117-4" morph="none" pos="word" start_char="8435">antibodies</TOKEN>
<TOKEN end_char="8452" id="token-117-5" morph="none" pos="word" start_char="8446">against</TOKEN>
<TOKEN end_char="8458" id="token-117-6" morph="none" pos="word" start_char="8454">spike</TOKEN>
<TOKEN end_char="8466" id="token-117-7" morph="none" pos="word" start_char="8460">mutants</TOKEN>
<TOKEN end_char="8471" id="token-117-8" morph="none" pos="word" start_char="8468">from</TOKEN>
<TOKEN end_char="8478" id="token-117-9" morph="none" pos="word" start_char="8473">global</TOKEN>
<TOKEN end_char="8489" id="token-117-10" morph="none" pos="unknown" start_char="8480">SARS-CoV-2</TOKEN>
<TOKEN end_char="8498" id="token-117-11" morph="none" pos="word" start_char="8491">variants</TOKEN>
<TOKEN end_char="8499" id="token-117-12" morph="none" pos="punct" start_char="8499">.</TOKEN>
</SEG>
<SEG end_char="8508" id="segment-118" start_char="8502">
<ORIGINAL_TEXT>bioRxiv</ORIGINAL_TEXT>
<TOKEN end_char="8508" id="token-118-0" morph="none" pos="word" start_char="8502">bioRxiv</TOKEN>
<TRANSLATED_TEXT>BioRxiv</TRANSLATED_TEXT><DETECTED_LANGUAGE>hr</DETECTED_LANGUAGE></SEG>
<SEG end_char="8511" id="segment-119" start_char="8511">
<ORIGINAL_TEXT>.</ORIGINAL_TEXT>
<TOKEN end_char="8511" id="token-119-0" morph="none" pos="punct" start_char="8511">.</TOKEN>
</SEG>
<SEG end_char="8547" id="segment-120" start_char="8513">
<ORIGINAL_TEXT>Published online: January 25, 2021.</ORIGINAL_TEXT>
<TOKEN end_char="8521" id="token-120-0" morph="none" pos="word" start_char="8513">Published</TOKEN>
<TOKEN end_char="8528" id="token-120-1" morph="none" pos="word" start_char="8523">online</TOKEN>
<TOKEN end_char="8529" id="token-120-2" morph="none" pos="punct" start_char="8529">:</TOKEN>
<TOKEN end_char="8537" id="token-120-3" morph="none" pos="word" start_char="8531">January</TOKEN>
<TOKEN end_char="8540" id="token-120-4" morph="none" pos="word" start_char="8539">25</TOKEN>
<TOKEN end_char="8541" id="token-120-5" morph="none" pos="punct" start_char="8541">,</TOKEN>
<TOKEN end_char="8546" id="token-120-6" morph="none" pos="word" start_char="8543">2021</TOKEN>
<TOKEN end_char="8547" id="token-120-7" morph="none" pos="punct" start_char="8547">.</TOKEN>
</SEG>
<SEG end_char="8593" id="segment-121" start_char="8549">
<ORIGINAL_TEXT>doi:https://doi.org/10.1101/2021.01.25.427948</ORIGINAL_TEXT>
<TOKEN end_char="8593" id="token-121-0" morph="none" pos="unknown" start_char="8549">doi:https://doi.org/10.1101/2021.01.25.427948</TOKEN>
<TRANSLATED_TEXT>doi: https: / / doi.org / 10.1101 / 2021.01.25.427948.</TRANSLATED_TEXT><DETECTED_LANGUAGE>pt</DETECTED_LANGUAGE></SEG>
<SEG end_char="8668" id="segment-122" start_char="8596">
<ORIGINAL_TEXT>Novavax COVID-19 vaccine demonstrates 89.3% efficacy in UK phase 3 trial.</ORIGINAL_TEXT>
<TOKEN end_char="8602" id="token-122-0" morph="none" pos="word" start_char="8596">Novavax</TOKEN>
<TOKEN end_char="8611" id="token-122-1" morph="none" pos="unknown" start_char="8604">COVID-19</TOKEN>
<TOKEN end_char="8619" id="token-122-2" morph="none" pos="word" start_char="8613">vaccine</TOKEN>
<TOKEN end_char="8632" id="token-122-3" morph="none" pos="word" start_char="8621">demonstrates</TOKEN>
<TOKEN end_char="8637" id="token-122-4" morph="none" pos="unknown" start_char="8634">89.3</TOKEN>
<TOKEN end_char="8638" id="token-122-5" morph="none" pos="punct" start_char="8638">%</TOKEN>
<TOKEN end_char="8647" id="token-122-6" morph="none" pos="word" start_char="8640">efficacy</TOKEN>
<TOKEN end_char="8650" id="token-122-7" morph="none" pos="word" start_char="8649">in</TOKEN>
<TOKEN end_char="8653" id="token-122-8" morph="none" pos="word" start_char="8652">UK</TOKEN>
<TOKEN end_char="8659" id="token-122-9" morph="none" pos="word" start_char="8655">phase</TOKEN>
<TOKEN end_char="8661" id="token-122-10" morph="none" pos="word" start_char="8661">3</TOKEN>
<TOKEN end_char="8667" id="token-122-11" morph="none" pos="word" start_char="8663">trial</TOKEN>
<TOKEN end_char="8668" id="token-122-12" morph="none" pos="punct" start_char="8668">.</TOKEN>
</SEG>
<SEG end_char="8682" id="segment-123" start_char="8670">
<ORIGINAL_TEXT>News release.</ORIGINAL_TEXT>
<TOKEN end_char="8673" id="token-123-0" morph="none" pos="word" start_char="8670">News</TOKEN>
<TOKEN end_char="8681" id="token-123-1" morph="none" pos="word" start_char="8675">release</TOKEN>
<TOKEN end_char="8682" id="token-123-2" morph="none" pos="punct" start_char="8682">.</TOKEN>
</SEG>
<SEG end_char="8691" id="segment-124" start_char="8684">
<ORIGINAL_TEXT>Novavax.</ORIGINAL_TEXT>
<TOKEN end_char="8690" id="token-124-0" morph="none" pos="word" start_char="8684">Novavax</TOKEN>
<TOKEN end_char="8691" id="token-124-1" morph="none" pos="punct" start_char="8691">.</TOKEN>
</SEG>
<SEG end_char="8709" id="segment-125" start_char="8693">
<ORIGINAL_TEXT>January 28, 2021.</ORIGINAL_TEXT>
<TOKEN end_char="8699" id="token-125-0" morph="none" pos="word" start_char="8693">January</TOKEN>
<TOKEN end_char="8702" id="token-125-1" morph="none" pos="word" start_char="8701">28</TOKEN>
<TOKEN end_char="8703" id="token-125-2" morph="none" pos="punct" start_char="8703">,</TOKEN>
<TOKEN end_char="8708" id="token-125-3" morph="none" pos="word" start_char="8705">2021</TOKEN>
<TOKEN end_char="8709" id="token-125-4" morph="none" pos="punct" start_char="8709">.</TOKEN>
</SEG>
<SEG end_char="8736" id="segment-126" start_char="8711">
<ORIGINAL_TEXT>Accessed January 28, 2021.</ORIGINAL_TEXT>
<TOKEN end_char="8718" id="token-126-0" morph="none" pos="word" start_char="8711">Accessed</TOKEN>
<TOKEN end_char="8726" id="token-126-1" morph="none" pos="word" start_char="8720">January</TOKEN>
<TOKEN end_char="8729" id="token-126-2" morph="none" pos="word" start_char="8728">28</TOKEN>
<TOKEN end_char="8730" id="token-126-3" morph="none" pos="punct" start_char="8730">,</TOKEN>
<TOKEN end_char="8735" id="token-126-4" morph="none" pos="word" start_char="8732">2021</TOKEN>
<TOKEN end_char="8736" id="token-126-5" morph="none" pos="punct" start_char="8736">.</TOKEN>
</SEG>
<SEG end_char="8774" id="segment-127" start_char="8738">
<ORIGINAL_TEXT>https://ir.novavax.com/node/15506/pdf</ORIGINAL_TEXT>
<TOKEN end_char="8774" id="token-127-0" morph="none" pos="url" start_char="8738">https://ir.novavax.com/node/15506/pdf</TOKEN>
<TRANSLATED_TEXT>https: / / ir.novavax.com / node / 15506 / pdf</TRANSLATED_TEXT><DETECTED_LANGUAGE /></SEG>
<SEG end_char="8817" id="segment-128" start_char="8777">
<ORIGINAL_TEXT>Andreano E, Piccini G, Licastro D, et al.</ORIGINAL_TEXT>
<TOKEN end_char="8784" id="token-128-0" morph="none" pos="word" start_char="8777">Andreano</TOKEN>
<TOKEN end_char="8786" id="token-128-1" morph="none" pos="word" start_char="8786">E</TOKEN>
<TOKEN end_char="8787" id="token-128-2" morph="none" pos="punct" start_char="8787">,</TOKEN>
<TOKEN end_char="8795" id="token-128-3" morph="none" pos="word" start_char="8789">Piccini</TOKEN>
<TOKEN end_char="8797" id="token-128-4" morph="none" pos="word" start_char="8797">G</TOKEN>
<TOKEN end_char="8798" id="token-128-5" morph="none" pos="punct" start_char="8798">,</TOKEN>
<TOKEN end_char="8807" id="token-128-6" morph="none" pos="word" start_char="8800">Licastro</TOKEN>
<TOKEN end_char="8809" id="token-128-7" morph="none" pos="word" start_char="8809">D</TOKEN>
<TOKEN end_char="8810" id="token-128-8" morph="none" pos="punct" start_char="8810">,</TOKEN>
<TOKEN end_char="8813" id="token-128-9" morph="none" pos="word" start_char="8812">et</TOKEN>
<TOKEN end_char="8816" id="token-128-10" morph="none" pos="word" start_char="8815">al</TOKEN>
<TOKEN end_char="8817" id="token-128-11" morph="none" pos="punct" start_char="8817">.</TOKEN>
</SEG>
<SEG end_char="8901" id="segment-129" start_char="8819">
<ORIGINAL_TEXT>SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma.</ORIGINAL_TEXT>
<TOKEN end_char="8828" id="token-129-0" morph="none" pos="unknown" start_char="8819">SARS-CoV-2</TOKEN>
<TOKEN end_char="8835" id="token-129-1" morph="none" pos="word" start_char="8830">escape</TOKEN>
<TOKEN end_char="8838" id="token-129-2" morph="none" pos="word" start_char="8837">in</TOKEN>
<TOKEN end_char="8844" id="token-129-3" morph="none" pos="word" start_char="8840">vitro</TOKEN>
<TOKEN end_char="8849" id="token-129-4" morph="none" pos="word" start_char="8846">from</TOKEN>
<TOKEN end_char="8851" id="token-129-5" morph="none" pos="word" start_char="8851">a</TOKEN>
<TOKEN end_char="8858" id="token-129-6" morph="none" pos="word" start_char="8853">highly</TOKEN>
<TOKEN end_char="8871" id="token-129-7" morph="none" pos="word" start_char="8860">neutralizing</TOKEN>
<TOKEN end_char="8880" id="token-129-8" morph="none" pos="unknown" start_char="8873">COVID-19</TOKEN>
<TOKEN end_char="8893" id="token-129-9" morph="none" pos="word" start_char="8882">convalescent</TOKEN>
<TOKEN end_char="8900" id="token-129-10" morph="none" pos="word" start_char="8895">plasma</TOKEN>
<TOKEN end_char="8901" id="token-129-11" morph="none" pos="punct" start_char="8901">.</TOKEN>
</SEG>
<SEG end_char="8910" id="segment-130" start_char="8904">
<ORIGINAL_TEXT>bioRxiv</ORIGINAL_TEXT>
<TOKEN end_char="8910" id="token-130-0" morph="none" pos="word" start_char="8904">bioRxiv</TOKEN>
<TRANSLATED_TEXT>BioRxiv</TRANSLATED_TEXT><DETECTED_LANGUAGE>hr</DETECTED_LANGUAGE></SEG>
<SEG end_char="8913" id="segment-131" start_char="8913">
<ORIGINAL_TEXT>.</ORIGINAL_TEXT>
<TOKEN end_char="8913" id="token-131-0" morph="none" pos="punct" start_char="8913">.</TOKEN>
</SEG>
<SEG end_char="8950" id="segment-132" start_char="8915">
<ORIGINAL_TEXT>Published online: December 28, 2020.</ORIGINAL_TEXT>
<TOKEN end_char="8923" id="token-132-0" morph="none" pos="word" start_char="8915">Published</TOKEN>
<TOKEN end_char="8930" id="token-132-1" morph="none" pos="word" start_char="8925">online</TOKEN>
<TOKEN end_char="8931" id="token-132-2" morph="none" pos="punct" start_char="8931">:</TOKEN>
<TOKEN end_char="8940" id="token-132-3" morph="none" pos="word" start_char="8933">December</TOKEN>
<TOKEN end_char="8943" id="token-132-4" morph="none" pos="word" start_char="8942">28</TOKEN>
<TOKEN end_char="8944" id="token-132-5" morph="none" pos="punct" start_char="8944">,</TOKEN>
<TOKEN end_char="8949" id="token-132-6" morph="none" pos="word" start_char="8946">2020</TOKEN>
<TOKEN end_char="8950" id="token-132-7" morph="none" pos="punct" start_char="8950">.</TOKEN>
</SEG>
<SEG end_char="8996" id="segment-133" start_char="8952">
<ORIGINAL_TEXT>doi:https://doi.org/10.1101/2020.12.28.424451</ORIGINAL_TEXT>
<TOKEN end_char="8996" id="token-133-0" morph="none" pos="unknown" start_char="8952">doi:https://doi.org/10.1101/2020.12.28.424451</TOKEN>
<TRANSLATED_TEXT>doi: https: / / doi.org / 10.1101 / 2020.12.28.424451.</TRANSLATED_TEXT><DETECTED_LANGUAGE>pt</DETECTED_LANGUAGE></SEG>
<SEG end_char="9017" id="segment-134" start_char="8999">
<ORIGINAL_TEXT>Moore JP, Offit PA.</ORIGINAL_TEXT>
<TOKEN end_char="9003" id="token-134-0" morph="none" pos="word" start_char="8999">Moore</TOKEN>
<TOKEN end_char="9006" id="token-134-1" morph="none" pos="word" start_char="9005">JP</TOKEN>
<TOKEN end_char="9007" id="token-134-2" morph="none" pos="punct" start_char="9007">,</TOKEN>
<TOKEN end_char="9013" id="token-134-3" morph="none" pos="word" start_char="9009">Offit</TOKEN>
<TOKEN end_char="9016" id="token-134-4" morph="none" pos="word" start_char="9015">PA</TOKEN>
<TOKEN end_char="9017" id="token-134-5" morph="none" pos="punct" start_char="9017">.</TOKEN>
</SEG>
<SEG end_char="9079" id="segment-135" start_char="9019">
<ORIGINAL_TEXT>SARS-CoV-2 vaccines and the growing threat of viral variants.</ORIGINAL_TEXT>
<TOKEN end_char="9028" id="token-135-0" morph="none" pos="unknown" start_char="9019">SARS-CoV-2</TOKEN>
<TOKEN end_char="9037" id="token-135-1" morph="none" pos="word" start_char="9030">vaccines</TOKEN>
<TOKEN end_char="9041" id="token-135-2" morph="none" pos="word" start_char="9039">and</TOKEN>
<TOKEN end_char="9045" id="token-135-3" morph="none" pos="word" start_char="9043">the</TOKEN>
<TOKEN end_char="9053" id="token-135-4" morph="none" pos="word" start_char="9047">growing</TOKEN>
<TOKEN end_char="9060" id="token-135-5" morph="none" pos="word" start_char="9055">threat</TOKEN>
<TOKEN end_char="9063" id="token-135-6" morph="none" pos="word" start_char="9062">of</TOKEN>
<TOKEN end_char="9069" id="token-135-7" morph="none" pos="word" start_char="9065">viral</TOKEN>
<TOKEN end_char="9078" id="token-135-8" morph="none" pos="word" start_char="9071">variants</TOKEN>
<TOKEN end_char="9079" id="token-135-9" morph="none" pos="punct" start_char="9079">.</TOKEN>
</SEG>
<SEG end_char="9085" id="segment-136" start_char="9082">
<ORIGINAL_TEXT>JAMA</ORIGINAL_TEXT>
<TOKEN end_char="9085" id="token-136-0" morph="none" pos="word" start_char="9082">JAMA</TOKEN>
</SEG>
<SEG end_char="9088" id="segment-137" start_char="9088">
<ORIGINAL_TEXT>.</ORIGINAL_TEXT>
<TOKEN end_char="9088" id="token-137-0" morph="none" pos="punct" start_char="9088">.</TOKEN>
</SEG>
<SEG end_char="9124" id="segment-138" start_char="9090">
<ORIGINAL_TEXT>Published online: January 28, 2021.</ORIGINAL_TEXT>
<TOKEN end_char="9098" id="token-138-0" morph="none" pos="word" start_char="9090">Published</TOKEN>
<TOKEN end_char="9105" id="token-138-1" morph="none" pos="word" start_char="9100">online</TOKEN>
<TOKEN end_char="9106" id="token-138-2" morph="none" pos="punct" start_char="9106">:</TOKEN>
<TOKEN end_char="9114" id="token-138-3" morph="none" pos="word" start_char="9108">January</TOKEN>
<TOKEN end_char="9117" id="token-138-4" morph="none" pos="word" start_char="9116">28</TOKEN>
<TOKEN end_char="9118" id="token-138-5" morph="none" pos="punct" start_char="9118">,</TOKEN>
<TOKEN end_char="9123" id="token-138-6" morph="none" pos="word" start_char="9120">2021</TOKEN>
<TOKEN end_char="9124" id="token-138-7" morph="none" pos="punct" start_char="9124">.</TOKEN>
</SEG>
<SEG end_char="9151" id="segment-139" start_char="9126">
<ORIGINAL_TEXT>doi:10.1001/jama.2021.1114</ORIGINAL_TEXT>
<TOKEN end_char="9151" id="token-139-0" morph="none" pos="unknown" start_char="9126">doi:10.1001/jama.2021.1114</TOKEN>
<TRANSLATED_TEXT>doi: 10.1001 / jama.2021.1114.</TRANSLATED_TEXT><DETECTED_LANGUAGE>pt</DETECTED_LANGUAGE></SEG>
<SEG end_char="9169" id="segment-140" start_char="9156">
<ORIGINAL_TEXT>Christopher H.</ORIGINAL_TEXT>
<TOKEN end_char="9166" id="token-140-0" morph="none" pos="word" start_char="9156">Christopher</TOKEN>
<TOKEN end_char="9168" id="token-140-1" morph="none" pos="word" start_char="9168">H</TOKEN>
<TOKEN end_char="9169" id="token-140-2" morph="none" pos="punct" start_char="9169">.</TOKEN>
</SEG>
<SEG end_char="9342" id="segment-141" start_char="9171">
<ORIGINAL_TEXT>Jen Kin, DDS, is a general dentist in Pacifica, California, who is currently on staff in the surgery department at Mills-Peninsula Medical Center in Burlingame, California.</ORIGINAL_TEXT>
<TOKEN end_char="9173" id="token-141-0" morph="none" pos="word" start_char="9171">Jen</TOKEN>
<TOKEN end_char="9177" id="token-141-1" morph="none" pos="word" start_char="9175">Kin</TOKEN>
<TOKEN end_char="9178" id="token-141-2" morph="none" pos="punct" start_char="9178">,</TOKEN>
<TOKEN end_char="9182" id="token-141-3" morph="none" pos="word" start_char="9180">DDS</TOKEN>
<TOKEN end_char="9183" id="token-141-4" morph="none" pos="punct" start_char="9183">,</TOKEN>
<TOKEN end_char="9186" id="token-141-5" morph="none" pos="word" start_char="9185">is</TOKEN>
<TOKEN end_char="9188" id="token-141-6" morph="none" pos="word" start_char="9188">a</TOKEN>
<TOKEN end_char="9196" id="token-141-7" morph="none" pos="word" start_char="9190">general</TOKEN>
<TOKEN end_char="9204" id="token-141-8" morph="none" pos="word" start_char="9198">dentist</TOKEN>
<TOKEN end_char="9207" id="token-141-9" morph="none" pos="word" start_char="9206">in</TOKEN>
<TOKEN end_char="9216" id="token-141-10" morph="none" pos="word" start_char="9209">Pacifica</TOKEN>
<TOKEN end_char="9217" id="token-141-11" morph="none" pos="punct" start_char="9217">,</TOKEN>
<TOKEN end_char="9228" id="token-141-12" morph="none" pos="word" start_char="9219">California</TOKEN>
<TOKEN end_char="9229" id="token-141-13" morph="none" pos="punct" start_char="9229">,</TOKEN>
<TOKEN end_char="9233" id="token-141-14" morph="none" pos="word" start_char="9231">who</TOKEN>
<TOKEN end_char="9236" id="token-141-15" morph="none" pos="word" start_char="9235">is</TOKEN>
<TOKEN end_char="9246" id="token-141-16" morph="none" pos="word" start_char="9238">currently</TOKEN>
<TOKEN end_char="9249" id="token-141-17" morph="none" pos="word" start_char="9248">on</TOKEN>
<TOKEN end_char="9255" id="token-141-18" morph="none" pos="word" start_char="9251">staff</TOKEN>
<TOKEN end_char="9258" id="token-141-19" morph="none" pos="word" start_char="9257">in</TOKEN>
<TOKEN end_char="9262" id="token-141-20" morph="none" pos="word" start_char="9260">the</TOKEN>
<TOKEN end_char="9270" id="token-141-21" morph="none" pos="word" start_char="9264">surgery</TOKEN>
<TOKEN end_char="9281" id="token-141-22" morph="none" pos="word" start_char="9272">department</TOKEN>
<TOKEN end_char="9284" id="token-141-23" morph="none" pos="word" start_char="9283">at</TOKEN>
<TOKEN end_char="9300" id="token-141-24" morph="none" pos="unknown" start_char="9286">Mills-Peninsula</TOKEN>
<TOKEN end_char="9308" id="token-141-25" morph="none" pos="word" start_char="9302">Medical</TOKEN>
<TOKEN end_char="9315" id="token-141-26" morph="none" pos="word" start_char="9310">Center</TOKEN>
<TOKEN end_char="9318" id="token-141-27" morph="none" pos="word" start_char="9317">in</TOKEN>
<TOKEN end_char="9329" id="token-141-28" morph="none" pos="word" start_char="9320">Burlingame</TOKEN>
<TOKEN end_char="9330" id="token-141-29" morph="none" pos="punct" start_char="9330">,</TOKEN>
<TOKEN end_char="9341" id="token-141-30" morph="none" pos="word" start_char="9332">California</TOKEN>
<TOKEN end_char="9342" id="token-141-31" morph="none" pos="punct" start_char="9342">.</TOKEN>
</SEG>
<SEG end_char="9427" id="segment-142" start_char="9344">
<ORIGINAL_TEXT>Dr. Jen Kin earned his DDS degree at the University of the Pacific in San Francisco.</ORIGINAL_TEXT>
<TOKEN end_char="9345" id="token-142-0" morph="none" pos="word" start_char="9344">Dr</TOKEN>
<TOKEN end_char="9346" id="token-142-1" morph="none" pos="punct" start_char="9346">.</TOKEN>
<TOKEN end_char="9350" id="token-142-2" morph="none" pos="word" start_char="9348">Jen</TOKEN>
<TOKEN end_char="9354" id="token-142-3" morph="none" pos="word" start_char="9352">Kin</TOKEN>
<TOKEN end_char="9361" id="token-142-4" morph="none" pos="word" start_char="9356">earned</TOKEN>
<TOKEN end_char="9365" id="token-142-5" morph="none" pos="word" start_char="9363">his</TOKEN>
<TOKEN end_char="9369" id="token-142-6" morph="none" pos="word" start_char="9367">DDS</TOKEN>
<TOKEN end_char="9376" id="token-142-7" morph="none" pos="word" start_char="9371">degree</TOKEN>
<TOKEN end_char="9379" id="token-142-8" morph="none" pos="word" start_char="9378">at</TOKEN>
<TOKEN end_char="9383" id="token-142-9" morph="none" pos="word" start_char="9381">the</TOKEN>
<TOKEN end_char="9394" id="token-142-10" morph="none" pos="word" start_char="9385">University</TOKEN>
<TOKEN end_char="9397" id="token-142-11" morph="none" pos="word" start_char="9396">of</TOKEN>
<TOKEN end_char="9401" id="token-142-12" morph="none" pos="word" start_char="9399">the</TOKEN>
<TOKEN end_char="9409" id="token-142-13" morph="none" pos="word" start_char="9403">Pacific</TOKEN>
<TOKEN end_char="9412" id="token-142-14" morph="none" pos="word" start_char="9411">in</TOKEN>
<TOKEN end_char="9416" id="token-142-15" morph="none" pos="word" start_char="9414">San</TOKEN>
<TOKEN end_char="9426" id="token-142-16" morph="none" pos="word" start_char="9418">Francisco</TOKEN>
<TOKEN end_char="9427" id="token-142-17" morph="none" pos="punct" start_char="9427">.</TOKEN>
</SEG>
<SEG end_char="9573" id="segment-143" start_char="9429">
<ORIGINAL_TEXT>He is a fellow in the International Congress of Oral Implantologists as well as an associate fellow in the American Academy of Implant Dentistry.</ORIGINAL_TEXT>
<TOKEN end_char="9430" id="token-143-0" morph="none" pos="word" start_char="9429">He</TOKEN>
<TOKEN end_char="9433" id="token-143-1" morph="none" pos="word" start_char="9432">is</TOKEN>
<TOKEN end_char="9435" id="token-143-2" morph="none" pos="word" start_char="9435">a</TOKEN>
<TOKEN end_char="9442" id="token-143-3" morph="none" pos="word" start_char="9437">fellow</TOKEN>
<TOKEN end_char="9445" id="token-143-4" morph="none" pos="word" start_char="9444">in</TOKEN>
<TOKEN end_char="9449" id="token-143-5" morph="none" pos="word" start_char="9447">the</TOKEN>
<TOKEN end_char="9463" id="token-143-6" morph="none" pos="word" start_char="9451">International</TOKEN>
<TOKEN end_char="9472" id="token-143-7" morph="none" pos="word" start_char="9465">Congress</TOKEN>
<TOKEN end_char="9475" id="token-143-8" morph="none" pos="word" start_char="9474">of</TOKEN>
<TOKEN end_char="9480" id="token-143-9" morph="none" pos="word" start_char="9477">Oral</TOKEN>
<TOKEN end_char="9496" id="token-143-10" morph="none" pos="word" start_char="9482">Implantologists</TOKEN>
<TOKEN end_char="9499" id="token-143-11" morph="none" pos="word" start_char="9498">as</TOKEN>
<TOKEN end_char="9504" id="token-143-12" morph="none" pos="word" start_char="9501">well</TOKEN>
<TOKEN end_char="9507" id="token-143-13" morph="none" pos="word" start_char="9506">as</TOKEN>
<TOKEN end_char="9510" id="token-143-14" morph="none" pos="word" start_char="9509">an</TOKEN>
<TOKEN end_char="9520" id="token-143-15" morph="none" pos="word" start_char="9512">associate</TOKEN>
<TOKEN end_char="9527" id="token-143-16" morph="none" pos="word" start_char="9522">fellow</TOKEN>
<TOKEN end_char="9530" id="token-143-17" morph="none" pos="word" start_char="9529">in</TOKEN>
<TOKEN end_char="9534" id="token-143-18" morph="none" pos="word" start_char="9532">the</TOKEN>
<TOKEN end_char="9543" id="token-143-19" morph="none" pos="word" start_char="9536">American</TOKEN>
<TOKEN end_char="9551" id="token-143-20" morph="none" pos="word" start_char="9545">Academy</TOKEN>
<TOKEN end_char="9554" id="token-143-21" morph="none" pos="word" start_char="9553">of</TOKEN>
<TOKEN end_char="9562" id="token-143-22" morph="none" pos="word" start_char="9556">Implant</TOKEN>
<TOKEN end_char="9572" id="token-143-23" morph="none" pos="word" start_char="9564">Dentistry</TOKEN>
<TOKEN end_char="9573" id="token-143-24" morph="none" pos="punct" start_char="9573">.</TOKEN>
</SEG>
</TEXT>
</DOC>
</LCTL_TEXT>